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SUMMARY
The idea behind this thesis developed during my employment 
at the Gastroenterology Laboratory at the Royal Infirmary 
Glasgow. The Laboratory is one of very few that has been 
established over the years as a centre for gastrointestinal 
research and also routine gastrointestinal investigations. 
In comparison to the 'high tech' biochemical investigations 
of other organs, the evaluation of gut function is 
decidedly 'low tech', frequently involving cumbersome 
tests, time-consuming analyses, and interpretative 
difficulties. This project concerns itself with the 
potential role of the clinical biochemistry laboratory in 
one aspect of gastrointestinal tests, namely the 
investigation of chronic diarrhoea.
For obvious reasons this is not a 'popular' area of 
academic interest and, perhaps as a result, much of the 
existing information is patchy and based on few and 
sometimes incomplete studies. The main objective was to 
fill some of the voids that exist in the current knowledge, 
with particular attention to methodological considerations. 
It consisted of four main themes.
The first aspect considered was the role of electrolyte and 
osmolality measurements of the stool water as a simple 
preliminary test. Electrolyte measurements on their own 
are of limited value but are thought to be useful when 
expressed in terms of the osmotic gap or potassium/sodium 
ratios.
The osmotic gap is considered to be of potential value in
14
* S a u i r y
the early diagnostic classification of the diarrhoea as 
either secretory or osmotic. However, there is doubt as to 
the most appropriate way of its calculation, namely whether 
the measured stool osmolality or the plasma osmolality 
should be used. This controversy was initially studied and 
convincing evidence was found to support the use of the 
latter approach. However, having established the best
procedure and defined working reference ranges it was 
subsequently concluded that there was little value in 
measuring the osmotic gap: the concept of using only sodium 
and potassium concentrations to calculate the osmotic gap 
is too simplistic since it is also significantly
contributed to by other cations; its use does little to 
narrow the diagnostic possibilities; and misleading results 
can be produced because of frequent large variations in
results in consecutively collected stools. The only useful 
role that envisaged was in order to exclude a diagnosis of 
secretory or osmotic diarrhoea.
There has been a suggestion that the site of diarrhoea can 
be determined as being colonic or ileal depending on the 
potassium/sodium ratio. Our results have shown quite 
clearly that there is no clinical diagnostic benefit to be 
accrued from this investigation.
The diagnostic possibility of laxative abuse is well
documented but in this part of Scotland had not been widely 
considered in practice because of the lack of a screening
15
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test. A thin layer chromatographic test was therefore 
established to provide both a routine service and 
information regarding the incidence of laxative induced 
diarrhoea. The test was found to be simple, cheap and 
effective in this respect and consequently a number of 
cases were detected which otherwise might have been missed. 
Methods for the diagnosis of saline laxative abuse were 
also established.
The incidence of laxative induced diarrhoea in new patients 
attending the Gastroenterology clinic for investigation of 
diarrhoea was found to be 4%, and in patients who had been 
diagnosed as .having idiopathic diarrhoea, 20%. More 
importantly the diagnosis was clinically unsuspected in 
most instances being most frequently labeled as irritable 
bowel syndrome.
To avoid further missed diagnoses it is suggested that a 
laxative screening test be employed routinely as an early 
investigative test in all patients with diarrhoea of 
unknown aetiology.
* * * * * *
The Gastroenterology Laboratory in Glasgow Royal Infirmary 
has been responsible for evaluating a unique fat absorption 
test. This dual isotope method is based on the oral 
administration and subsequent measurement of stool ratios 
of isotopically labeled absorbable and non-absorbable 
markers. Further work was performed to assess the validity 
of using 3H-triether and 51chromium chloride as non­
absorbable probes. We concluded that the dual isotope test
16
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is the best available method for identifying patients with 
malabsorption and can justifiably claim to be the method of 
choice for evaluating alternative approaches.
The triolein breath test has been gaining popularity as a 
simpler and less unpleasant way of determining fat 
absorptive capacity. We expanded upon some of the limited 
studies already performed to evaluate this approach. Our 
conclusions place some doubt as to the role of this test. 
Although it was found to be capable of identifying patients 
with severe malabsorption it could not reliably detect 
patients with only mild degrees of malabsorption.
* * * * * *
Finally the diagnosis of bile acid induced diarrhoea was 
considered. Initially the measurement of the faecal 
concentration of the dihydroxy bile acids, chenodeoxycholic 
acid and deoxycholic acid, was established as the most 
appropriate means for its diagnosis. Because of the 
complexity of the analysis involved, an alternative test 
based on a modification of the SeHCAT test was evaluated 
but unfortunately found to be unreliable. The reason for 
the poor diagnostic capability of this test was 
subsequently found to be due to the non-physiological 
behaviour of the synthetic bile acid SeHCAT.
L
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PREFACE
There will be few people who have not experienced diarrhoea 
from time to time, perhaps as a result of simple food
poisoning or travellers' diarrhoea. Although these 
conditions are usually minor and short-lived they are 
unpleasant and may give some insight into the debilitating 
effect that chronic diarrhoea can have. Such patients 
usually suffer from more than the symptom itself. The 
urgency which frequently goes along with diarrhoea means 
that the victim must plan any activities carefully and so a 
simple trip to the shops requires a knowledge of the 
locations of public conveniences to avoid their being
'caught short'. Even the trip to the out-patients' 
department for investigations may be taken with some 
trepidation. Holidays, while not impossible, are often 
avoided because of the worry of unpredictable travel 
arrangements, lack of knowledge of toilet facilities and 
possibility of making matters worse by contracting 
travellers' diarrhoea. Social activities may be curtailed 
because of embarrassment over the frequency of having to
'excuse' oneself. It may be impossible to conceal the 
complaint in the workplace; one patient in this study was 
forced into giving up her work because the staff were 
concerned that they might 'catch something'.
The word 'diarrhoea' is derived from the Greek 'dia'
(through) and 'rhein' (to flow) and is defined in the 
shorter English dictionary as being 'a disorder consisting
18
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of the too frequent evacuation of too fluid faeces'. This 
definition is also close to the medical understanding of 
the term: an increase in the volume, frequency and/or
liquidity of stool. However, it is probably more important 
to know what the patient presenting with diarrhoea 
understands by the term. Although many individuals 
complaining of diarrhoea have increased frequency, urgency 
and liquidity of bowel motions, many do not. Thus, well- 
formed motions passed frequently may be described as 
diarrhoea as may the relatively infrequent passage of 
poorly-formed stools. Similarly, the presence of blood and 
mucus with normal motions in patients with colonic 
carcinoma may also be described as diarrhoea' (2) and people 
with faecal incontinence often euphamistically describe 
their symptoms as diarrhoea (3). Consequently it is not 
sufficient to accept the patients' description of their 
complaint without further enquiries or objective 
measurements.
The daily faecal output averages at just over lOOg (4,5) in 
Westernised society but women tend to have substantially 
lower stool weights (4) . The type of diet also affects 
stool volume: increasing dietary intake of bran for example 
results in increased stool weight and frequency (6). There 
is also evidence suggesting that faecal volume is affected 
by personality traits: people with positive outgoing
personalities having a higher daily output (6)!
Stool frequency has been assessed mainly by means of 
questionnaires and has been found to vary quite widely: 99%
19
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of two populations studied, a factory population and GP 
population, had more than 3 motions per week and less than 
4 motions per day (7). Another study found that 52.7% of 
those asked passed one stool per day and 41% more than one 
daily (8).
With such a widespread variation in healthy subjects and 
differing concepts of normality, careful questioning is 
essential when investigating a patient presenting with 
diarrhoea. However, most patients will only become 
concerned when their bowel habit changes.
In the investigation of individuals with diarrhoea, the 
expertise of different specialities is often engaged. In 
acute infectious forms of diarrhoea the condition is 
usually short-lived and is allowed to 'run' its course. 
Few, if any, investigations are required except possibly 
the use of Bacteriology Laboratory to identify the 
infectious agent and occasionally the Biochemistry 
Department to monitor the acid/base and hydration status 
when the diarrhoea is severe.
The investigation of chronic diarrhoea offers more of a 
diagnostic challenge. This study specifically addresses 
the role of the clinical biochemisty laboratory in the 
diagnostic work-up of such patients.
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Chapter 1 - Introduction
PHYSIOLOGY OF INTESTINAI.
WATER AND ELECTROLYTE 
TRANS JE>CDRT
INTRODUCTION
To understand the mechanisms of diarrhoea more fully it is 
worthwhile to have a knowledge of the intestinal physiology 
for handling water.. All movement of water within the gut, 
and indeed within other systems of the body, is almost 
certainly passive - that is does not require the input of 
energy. The transport of water follows osmotic gradients 
which are generated by the active movement of solutes, the 
most important of which is sodium. To understand the 
causes of diarrhoea the normal physiology of water 
absorption and ionic fluxes within the intestine will 
initially be illustrated.
Although the oral intake of fluid is in the order of two 
litres per day and faecal water losses are about 100ml the 
intestine handles in the order of nine litres of fluid 
daily and has the capacity to absorb up to double this 
volume (9). The missing seven litres in this equation are 
accounted for by gastrointestinal secretions of the 
salivary glands, stomach, gallbladder, pancreas, and 
duodenal Brunners' glands. The approximate daily volumes 
of these fluids and their electrolyte compositions are 
listed in Table 1.1 (10).
As well as these obligatory fluid secretions the mucosa of
22
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the small intestine secretes and absorbs fluid and 
electrolytes in order to regulate the luminal contents in 
terms of its pH, osmolality and electrolyte composition.
Volume
i.(i) i
Sodium
(mmol)
Potassium
(mmol)
Chloride
(mmol)
Diet 2 150 50 200
Saliva 1 50 20 40
Gastric Juice 2 100 15 280
Bile 1 200 5 40
Pancreatic Juice 2 150 5 40
Succus entericus 1 150 5 100
Table 1.1 - Approximate daily composition of dietary and 
gastrointestinal secretions (10).
METHODS USED FOR ELUCIDATING ELECTROLYTE FLUXES IN THE
INTESTINE
The current knowledge of electrolyte movement in the gut is 
based on several different experimental techniques and 
animal systems, and studies of gall bladder, trachea, 
kidney and bladder as well as intestine. The present 
understanding is based on an amalgam of knowledge from 
these heterogeneous sources and is by no means complete.
The in vivo method of intestinal perfusion has frequently 
been used (11). In this technique a segment of gut is 
perfused with a solution of known composition and the 
perfusate is collected and analysed. Altering the 
concentrations of the perfused electrolytes gives 
additional useful information. Studies of transmucosal 
electro-potential differences have been performed both in 
vivo and on isolated sheets of short-circuited mucosa using 
the classic Ussing Chamber. In vitro vesicles can be
23
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prepared from basolateral or apical cell membranes allowing 
their properties to be assessed separately (12). The 
effect of drugs which modify specific protein functions has 
been used to obtain additional information. Drugs commonly 
used are acetazolamide (an inhibitor of carbonic 
anhydrase); the glycoside ouabain (inhibitor of Na^/R*-- 
ATPase); propranolol (inhibitor of adenylate cyclase); and 
amiloride and frusemide (which block Na^- and Cl~-specific 
ion channels respectively) (13, 14, 15)
MECHANISMS OF WATER AND ELECTROLYTE FLUXES WITHIN THE
INTESTINE
There are five principal mechanisms which govern the 
intestinal absorption of electrolytes and water. To 
understand these systems it is useful to have a visual 
concept of a typical enterocyte as depicted in figure 1.1.
Enterocytes have microvilli on their mucosal surface in 
order to enhance intestinal surface area and so increase 
the efficiency of absorption. The luminal half of 
neighbouring cells are intimate having frequent 
interdigitations on their lateral surfaces. The
intercellular spaces that separate adjacent cells are 
narrowest at the luminal junction where they are referred 
to as tight or occluding junctions (See figure 1.1). Tight 
junctions are approximately 300nms deep and 0.2 - 0.9nm 
wide.
The epithelial surface of enterocytes is covered with pores 
which allow the passive movement of water and solutes. The
24
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size of these has been calculated by studying the 
transraucosal permeability of different sized molecules. By
LUMEN
Mucosal Side
intercellular
pore
tight junction
apical
membrane
intercellular space
Na-/K-- -
ATPase pump
^potassium 
ion channel aso-lateral
membrane
Serosal Side
Figure 1.1 - Diagram of a Typical Enterocyte
this means the apparent pore size has been calculated at 
0.7 - 0.85nm in the duodenum and jejunum, falling distally 
to 0.4nm in the ileum, and 0.2nm in the colon (16, 17) (lnm 
= lOAngstrom). There has been some uncertainty about the 
location of these aqueous pores: initially they were
thought to be found on the enterocyte membrane but it is 
more likely that they are sited at the tight junctions.
1. Active Transport
Many intestinal transport processes require the input of
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energy and exist as proteins located on both apical and 
basolateral membranes. The best studied and the most 
important one in the intestine is the Na^/K-^-ATPase pump. 
This protein is located on the basolateral membrane of all
enterocytes and directly influences absorption by the
development of transmucosal electrochemical gradients.
2. Movement Across Electrochemical Gradients
The Na-^/K-^-ATPase system pumps three molecules of sodium 
out of the enterocyte forj every j two potassium molecules 
pumped in. Excess potassium which enters the cell by this 
process 'leaks' back into the interstitial space down K-*--
specific ion channels in the basolateral membrane. By
means of this pump the intracellular concentrations of 
sodium and potassium are maintained at approximately 
15mmol/l and 75mmol/l respectively (18). As a consequence 
of the unbalanced ion movements of sodium and potassium, a 
potential difference of 30 - 40mV is generated across the 
apical membrane of the enterocytes with the interior of the 
cell being electronegative. There is also a transmucosal 
electropotential difference, the size of which varies 
inversely to the radius of the aqueous pores. Hence in the 
jejunum where the aqueous pores are relatively large the 
transmucosal electropotential difference is small, while in 
the colon the reverse holds (see figure 1.2). The 
electrochemical potential gradient allows the passive 
movement of certain ions - predominantly sodium - across 
the mucosa through specific protein systems called ion 
channels.
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(a) Jejunum (b) Ileum (c) Colon
Figure 1.2 - Relationship of Transmucosal Electropotential 
Difference to Size of Tight Junctions in Jejunum, Ileum and
Colon.
A current is invoked by this movement of electrically 
charged species and so this system of transport is referred 
to as electrogenic or rheogenic.
3. Osmotic Pressure
As previously mentioned the absorption of water is 
entirely passive being controlled by osmotic pressure 
differences across the mucosa. The osmotic gradient 
develops as solutes such as glucose and sodium are actively 
transferred across the semi-permeable mucosal membrane and 
subsequently into the lateral intercellular spaces. It is 
thought that relatively small osmotic differences - in the 
order of 3.5mosmol/Kg - are required to drive this movement 
of water (19).
The rate of this transmucosal flow of water is governed by
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the size of aqueous pores. In the duodenum and jejunum the 
relatively large pores confer a low hydraulic resistance 
allowing the ready movement of water. This explains the 
rapid equilibration of hyperosmotic or hypo-osmotic fluids 
in the duodenum and jejunum. The sizes of the aqueous 
pores decreases distally and consequently in the colon 
where they are approximately 0.2nm water transport is much 
slower.
The direction of water flow - absorption or secretion - is 
dependent on the direction of the osmotic gradient. 
However, the intercellular spaces are smaller during 
secretion and so there is more resistance to the outflow of 
water (20, 21) . Consequently even in circumstances in
which the lumen is hyperosmotic there is a mechanism for 
the conservation of water.
4. Solvent Drag
Any movement of water also results in a passive non­
specific 'drag' of solutes through intercellular spaces and 
across mucosal membranes. The efficiency of solvent drag 
(also called convective flow or entrainment) is dependent 
on the size of these pores in the same way as is the 
osmotically driven movement of water. Thus in the duodenum 
and jejunum, where the pores are largest, the majority of 
sodium absorption is accounted for by solvent drag (22). 
Further down the intestine, where the pore size decreases, 
solvent drag is less important as an absorptive mechanism. 
In general, cations and uncharged species are dragged
28
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preferentially to anions because the intercellular spaces 
have a negatively-charged lining.
5. Hydrostatic Forces
Hydrostatic forces on either side of the mucosa also play a 
relatively minor role in governing water and electrolyte 
transport. Thus an increased serosal pressure, caused 
perhaps by hypertension, favours secretion, whereas volume 
depletion encourages absorption.
■k * * * ★
Each portion of the intestine has specific functions and 
this is reflected by differences in the handling of water 
and electrolytes. There is little net absorption of water 
above the duodenum and so ionic fluxes in the stomach and 
oesophagus will not be considered further. Ionic fluxes in 
the duodenum, jejunum, ileum, and colon which are mutually 
quite distinct, will be discussed separately. For 
practical purposes each part of the intestine is considered 
to be a uniform entity with similar functions throughout. 
However, in practice there are probably gradual changes 
through each system. The distal colon for example is known 
to have several quite different features from the proximal 
colon (23) and the same is probably true of the jejunum and 
ileum. In addition the gut has an impressive capacity to 
adapt to pathology. For example in cases of small bowel 
resection the colon can develop functions normally 
associated with the small intestine (24, 25). The converse 
holds with the small bowel of ileostomists whose colon is
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effectively missing (26, 21).
IONIC FLUXES IN THE DUODENUM
The general function of the duodenum - rather than being 
one of absorption - is to adjust the pH and osmolality of 
luminal contents in preparation for digestion and 
absorption.
1. Control of pH
Gastric chyme entering the duodenum has a very acidic pH 
and so is potentially damaging. Neutralisation of pH is 
mainly achieved by dilution of the gastric outflow with 
pancreatic juices and succus entericus - the secretion of 
the duodenal Brunners Glands - both of which have a high 
bicarbonate content. The distribution of the Brunners 
glands - being numerous in the duodenal cap and proximal 
half of the descending duodenum - supports this concept of 
their function. The release of bicarbonate from the 
pancreas and Brunners glands is stimulated ultimately by 
the concentration of hydrogen ions in the duodenum. The 
individual cells of the duodenal mucosa also have the 
capacity to secrete bicarbonate, again in response to the 
presence of acid in the duodenal lumen (28) and this may 
well act as a fine control of pH.
There are two probable mechanisms for bicarbonate secretion 
from the enterocytes (29) . One process is dependent on the 
presence of luminal chloride and exists as an electrically 
silent exchange of chloride for bicarbonate (figure 1.3a).
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In the other there is secretion of bicarbonate, produced 
from carbonic acid, down its specific ion-channel into the 
lumen. Hydrogen ions which are produced at the same time
HCOs- HC03-
/VV\AA/VV^JA/VVV'
HCO
HC03- Na
(a)
Figure 1.3 - Two Possible Mechanisms for Bicarbonate 
Secretion into the Duodenal Lumen.
as bicarbonate are exchanged for sodium on the basolateral 
membrane (See figure 1.3b). Although both of these 
mechanisms have been demonstrated it is likely that the 
former is the more important: acetazolamide which causes 
99% inhibition of carbonic anhydrase does not inhibit 
secretion of bicarbonate implying that the source of 
secreted bicarbonate is extracellular (30) (see figure 
1.3a).
To facilitate pH adjustment in the duodenum the emptying of
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gastric contents is carefully controlled. The activation 
of duodenal pH receptors is one of a number of triggers for 
inhibition of gastric emptying. The overall result is the 
frequent release of small quantities of gastric contents 
into the duodenum.
2. Control of Osmolality
Although the osmolality of systemic fluids is regulated 
within very narrow specifications the intestine can readily 
cope with large ranges of osmotic intakes. For example 
water has zero osmotic pressure while pineapple juice has 
an osmolality of about 900mosmol/Kg. Furthermore, in the 
measurement of intestinal permeability a test solution with 
an osmolality of 1500 mosmol/Kg is taken orally with no 
untoward reaction.
The stomach seems to have little role in equilibrating 
osmolality of ingested foods. For example after a steak 
meal the gastric osmolality was measured at 243mosmol/Kg 
and this did not change over 90 minutes. Following a 
higher osmolality meal of doughnut and milk the gastric 
osmolality was 440mosmol/Kg with little change over a two 
hour period (31).
The duodenum on the other hand has a direct control on 
luminal osmolality. As described above the relatively wide 
intercellular spaces in the duodenum allow ready 
equilibration of any osmotic gradient over the mucosa. 
Consequently by the time luminal contents reach the 
ligament of Treitz the osmolality is nearly isotonic (32) .
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The duodenum contains osmoreceptors which, like duodenal pH 
receptors, have a feedback control on gastric emptying. 
Molecules which contribute the most to osmolality, such as 
amino acids, salt, sugars, and alcohol, stimulate these 
osmoreceptors.
The combined effect of duodenal pH and osmolality on 
gastric emptying is the controlled periodic release of 
gastric chyme into the duodenum. The importance of this 
gradual stomach emptying can be appreciated when the system 
is impaired. In dumping syndrome there is loss of duodenal 
sphincter control usually as a consequence of gastric 
surgery. The consequence of this is an uncontrolled 
release of gastric contents into the duodenum and
subsequently an osmotically driven flow of fluid into the
lumen. This may be severe enough to cause hypotension with 
up to 20% of the plasma volume being lost into the 
intestine. Symptoms can be controlled by adjusting the
diet to small frequent meals of low osmotic load. This 
goes some way to restoring the normal physiological state 
of regular release of stomach contents.
JEJUNAL IONIC FLUXES
The jejunum is the predominant site for absorption of
nutrients, water, and electrolytes. Sodium, the
predominant cation, is absorbed both actively and 
passively. Most sodium is probably passively absorbed here 
by means of solvent drag (16) . However, since this 
movement of sodium is passive an unfavourable
33
Chapter 1 - Introduction
concentration gradient cannot be created and so when 
luminal sodium concentrations are less than about 135mmol/l 
sodium absorption will cease because of back diffusion 
through the relatively wide tight junctions.
Sodium absorption also occurs as a dual transport, or 
symport, system coupled to the absorption of a variety of 
nutrients such as glucose, galactose, diglycerides, 
triglycerides, some vitamins, bile salts, amino acids, and 
chloride (figure 1.4b). This process may be passive with 
the 'downhill' entry of sodium powering the uphill entry of 
the corresponding solute. The presence of these luminal 
nutrients markedly increases sodium and, in turn, water 
absorption. This seemingly minor fact has had major life- 
saving implications in the treatment of infectious watery 
diarrhoea in Third World countries. By the simple 
expedient of giving 'a little sugar and salt' the huge 
water and electrolyte losses associated with conditions 
such as cholera can be minimised. This modest therapy has 
been described as the worlds' most successful health 
programme (33) . The continual Na^/K-^-ATPase activity 
'recharges the batteries' of the cell making this system 
possible. The concentration of solute in the cell is 
higher than the serosal solution and so the basolateral 
exit is probably passive. However, since the solutes are, 
in general, large molecules exceeding 0.4 - 0.5nm it is
likely that diffusion occurs as a carrier-mediated 
facilitated process.
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H- + HCOa-
Solute* Na
Cl ci-Na
K+ K+K+
Na+ Na+
(a) (b) (c)
Figure 1.4 - Mechanism of Sodium Absorption in Jejunum: (a)
electrogenic absorption; (b) dual transport system; (c) 
Na^ /H-*- pump. (~ See text for appropriate solutes) .
Sodium is also actively absorbed in exchange for protons, 
probably by an apical membrane Na^/H^-ATPase pump. This 
system requires intraluminal bicarbonate - which is in 
plentiful supply - and possibly results in the formation of 
carbonic acid which can then be reabsorbed as carbon 
dioxide and water as depicted in figure 1.4c (16, 34).
This may account for the avid absorption of bicarbonate 
found in the jejunum.
Once sodium is absorbed into the enterocyte it is actively 
extruded by the Na^/K-^-ATPase pump. This pump, by 
generating a transmucosal potential difference of 3mV - 
5mV, powers the electrogenic absorption of chloride and 
other anions by way of the tight junctions and
3 5
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intercellular spaces. Potassium is also absorbed passively 
into the cell by an electrogenic process.
The ileal lumen contains less in the way of digested foods 
such as glucose and amino acids and so the coupled 
transport of sodium with these nutrients is less important 
than in the jejunum. Some electrolyte absorption occurs by 
the solvent drag mechanism but this process is limited 
because the intercellular spaces are smaller in the ileum. 
Active mechanisms for electrolyte absorption are therefore 
more important. Sodium and chloride are absorbed in a 
mutually dependent manner which is achieved probably by a 
double ion exchange system involving Na^ /H-*- and C1-/HC03- 
interchanges (figure 1.5). The result is absorption of
IONIC FLUXES IN THE ILEUM.
p y V \ ^ l | v A ^ A A A Q  
H- + HCO3- H2C03  ; C02 + HsO
A I 1 1  7 ' »
Ka / O a a a q
Na- cl- k k
HC03-
Figure 1.5 - Ionic Fluxes within the Ileum.
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sodium chloride and secretion of carbonic acid (in the form 
of hydrogen ions and bicarbonate) which may be subsequently 
reabsorbed as carbon dioxide and water. Carbonic anhydrase 
which catalyses the interconversion of carbonic acid to 
water and carbon dioxide plays a role in this process which 
is blocked in the presence of acetazolamide - a carbonic 
anhydrase inhibitor (35) . In the rare congenital condition 
of chloridorrhoea there is a large faecal loss of chloride 
along with a metabolic alkalosis (in contrast to the 
acidosis usually associated with diarrhoea). This is 
thought to be due to an absent or reversed CI-/HCO3- pump 
(36).
Chloride ions which are absorbed into the enterocyte are 
subsequently extruded over the basolateral membrane either 
by means of a potassium/chloride parallel system or a 
chloride/bicarbonate exchange mechanism (figure 1.5) (37).
Potassium absorption in the ileum, as in other parts of the 
small intestine, is passive via K--specific ion channels 
down a favourable electrochemical gradient.
The total absorptive capacity of the small intestine can be 
assessed with a knowledge of the composition of the luminal 
fluid reaching the terminal ileum. This was initially 
estimated by collecting fluid directly from patients with 
ileostomies (table 1.2) (38). However, these figures
may
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Daily Ileal Fluid Concentration
24 hour Volume 
Sodium 
Potassium 
pH
606 ± 287 ml/day 
71 ± 36 mmol/day
5.1 ± 3.9 mmol/day
7.1 ± 0.9
117mmol/l 
8.4mmol/l
Table 1.2 Daily Composition of Ileostomy Fluid (38).
not be an accurate representation of the situation in 
normal subjects. The intestine has a remarkable capacity 
to adapt and in ileostomists the ileum, at least distally, 
probably functions more like the colon.
A more realistic idea of terminal ileal composition has 
been achieved by direct aspiration and measurement of 
caecal fluid (table 1.3). In total the small bowel absorbs 
some 80% of fluid introduced into the intestine. The one
and a half or so litres which enters the colon has an
electrolyte composition not dissimilar to that of plasma.
IONIC FLUXES IN THE COLON
In the small intestine as a whole, water and electrolyte 
absorption is rapid but incomplete. The converse is true 
in the colon which conserves water and electrolytes very 
efficiently but over a longer period of time. These
functional variations between small and large bowel
are reflected in their differing mechanisms of electrolyte 
and water absorption. Nutrient-associated sodium
absorption does not occur in the colon (17) and solvent 
drag plays a minimal role.
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Terminal Ileal 
Fluid
Range Mean
Cone.
Volume 1524 ± 49 ml/day (1255 - 1751)
Sodium 196 ± 19 mmol/day (139 - 243) 128mmol/l
Potassium 9.3 ± 0.9 mmol/day (6.8 - 11.3) 6.lmmol/1
Chloride 103 ± 20 mmol/day (63 - 123) 68mmol/l
Table 1.3 - Composition of terminal ileal fluid in normal
subjects (39).
Sodium and water are absorbed in the colon by two principal 
mechanisms, an electrically-silent sodium chloride 
transport involving Na^/H-4- and CI-/HCO3- exchanges as found 
in the ileum (figure 1.4), and an electrogenic process. 
The transmucosal electropotential difference is 20mV in the 
colon because the tight junctions, being very narrow here, 
limit the back diffusion of electrolytes into the lumen. 
Consequently the electrogenic mechanism is very effective 
in absorbing sodium against unfavourable concentration 
gradients and is of particular importance in the distal 
colon. However, if the tight junctions are widened by 
treatment with oxyphenisatin (a diphenylmethane laxative) 
or bile acid then sodium and water are pushed back into the 
lumen (40).
Sodium movement in the colon is controlled by aldosterone 
and glucocorticoids which, as in the kidney, promote its 
retention. Enhanced secretion of aldosterone results in an 
increase in the number of sodium-specific ion channels and 
a subsequent increase in activity of the Na-*-/K--ATPase 
pump. There is a resultant increase in the transmucosal 
electropotential difference, the measurement of which has
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been suggested as a rapid screening test for aldosteronism 
(41).
There is an active electrically silent absorption of 
potassium into enterocytes, probably by a K^ /H-*- exchange 
mechanism (42) . This is opposed by an active potassium 
secretory mechanism in which potassium initially enters the 
cell by the Na-K/K-H-ATPase pump and is secreted through 
potassium-specific ion channels on the apical membrane. 
The balance between absorption or secretion of potassium in 
the normal colon is controlled by aldosterone and depends 
in part on the dietary intake of potassium. For example, 
with high intakes of potassium, secretion predominates 
(43). In addition to the active secretion of potassium 
there is a passive electrogenic leakage of potassium from 
serosal fluid via the tight junctions.
It is emerging that the colon has a role in nutrient 
absorption as well as water and electrolyte conservation. 
Dietary fibre has long been thought to pass through the gut 
unchanged, however both this, and other unabsorbed 
carbohydrates that reach the colon, are metabolised by 
bacteria with the production of short chain fatty acids 
(SCFA), primarily acetic, propionic and butyric acids. 
These are then efficiently absorbed by the colon, probably 
passively, (44) and may be a significant source of energy 
(45) particularly for colonocytes. The absorption of SCFA 
is associated with an increase in luminal bicarbonate and 
pH (46) suggesting that a HC03~/SCFA exchange system may 
operate.
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By comparing the composition of fluid entering the colon 
(table 1.3) with the faecal composition (table 1.4) the 
overall function of the colon with respect to handling of 
water and electrolytes can be gauged. This exercise has 
revealed that the colon absorbs 97% of the water and over 
99% of the sodium and chloride presented to it (39) . The 
colonic absorption of potassium is lower and is also highly 
variable (15% - 84%) . It has since been established that 
faecal potassium loss is related to dietary intake and this 
probably explains the latter finding.
The capacity of the colon, however, is considerably greater 
than this and has been calculated by colonic perfusion to 
be 5700ml of water, 816mmol of sodium, and 44mmol of 
potassium per day (47) . In the same study the daily flow 
of fluid into the caecum was estimated at 1940ml/day (1300 
- 2660).
Analyte Daily Faecal 
Loss (median ± sem)
Daily Colonic 
Absorption
Water
Sodium
Potassium
Chloride
47 ± 5 (ml)
0.6 ± 0.3 (mmol) 
4.7 ± 1.0 (mmol) 
0.3 ± 0.1 (mmol)
1190 - 1718 (ml) 
137 - 242 (mmol) 
1.3 - 7.2 (mmol) 
62 - 123 (mmol)
Table 1.4 - Daily Stool Composition and Colonic Absorption 
of Water and Electrolytes (39).
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PATHOPHYSIOLOGY OF WATER AND 
ELECTROLYTE ABSORPTION
From the above it was noted that the average small bowel 
absorbs 81 of fluid daily and the colon absorbs 0.91 with a 
total capacity of 3 - 41. The colon therefore can
compensate for abnormally high volumes of fluid from the 
small bowel. In this situation diarrhoea will occur only 
when the colonic capacity is exceeded. If colonic function 
is impaired however, there are no further distal 
compensating mechanisms and diarrhoea may result, (figure 
1.6) .
In practice, diarrhoea can be classified into three main 
types; secretory, osmotic, and altered motility. Despite 
the use of these convenient categories there are probably 
few examples of diarrhoea caused exclusively by a single 
mechanism. In exudative diarroea, which is often listed as 
a fourth category, there is loss of blood or interstitial 
fluid through inflamed or breached mucosa, but relatively
small volumes are lost by exudation and it is more likely 
that diarrhoea is the caused by one of the other three 
mechanisms.
SECRETORY DIARRHOEA.
This type of diarrhoea is caused by an abnormal electrolyte 
flux in which there is inhibition of electrolyte 
absorption, secretion of electrolytes, or both. The best 
understood and documented type of secretory diarrhoea is
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the infectious diarrhoea caused by cholera. It is 
characterised by dehydration, metabolic acidosis, 
hypotension and severe diarrhoea frequently in excess of 1 
litre per day. In cholera the pathogen Vibrio cholerae 
colonises the small bowel and produces an enterotoxin which 
binds to the mucosal cell surface. The enterotoxin splits 
into its two component subunits, the A unit of which enters 
the cell and stimulates
the adenylate cyclase complex on the basolateral membrane. 
The cyclic adenyl monophosphate (cAMP) whose production is 
catalysed by this enzyme, acts as the intracellular 
mediator for the abnormal electrolyte flux which follows. 
The abnormal secretion induced by V. Cholera in in vitro 
studies can be replicated by providing cAMP alone (48) . 
Perfusion studies in patients with diarrhoea caused by 
cholera or E. Coli have demonstrated that sodium, 
potassium, chloride, and bicarbonate are secreted, 
predominantly into the jejunum but also into the ileum, 
with resultant fluid secretion (49). This fluid and 
electrolyte secretion continues after the diarrhoea is 
resolved indicating that the colon conserves sufficient 
water to avoid diarrhoea (cf. figure 1.6b).
It is likely that among these electrolytes only chloride is 
actively secreted in the small intestine. Normally the 
apical membrane is relatively impermeable to the movement 
of chloride, however, cAMP allows the ready loss of 
chloride down these channels by an electrogenic process. 
The chloride that is lost initially enters the enterocyte
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by a co-transport system on the basolateral membrane 
involving simultaneous transfer of sodium and potassium 
(Figure 1.7). The driving force behind this passive flow 
of the three ions is the Na^/K^-ATPase pump. Cyclic AMP 
also causes an increase in the number or activity of 
potassium-specific ion channels on the basolateral membrane
Cl-
/^V/\A/VAAAy\/\|t
Cl- K+ Na+
Figure 1.7 - Proposed Mechanism of Chloride Secretion.
and as potassium leaves the cell by this route the 
transmucosal electropotential difference increases, thus 
accelerating the secretion of chloride into the lumen (50).
Secretory diarrhoea which is induced by cAMP is also found 
in non-infectious diseases. A syndrome similar to that of 
cholera, in fact sometimes referred to as pancreatic 
cholera, consisting of watery diarrhoea, weight loss, and 
hypokalaemia was described and given the eponymous title
seriesWerner and Morrison syndrome (51). In the | largest 
of patients with this condition, elevated plasma 
concentrations of vasoactive intestinal peptide (VIP)
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originating mainly from pancreatic tumours were found (52). 
Receptors for VIP are found on the basolateral membrane of 
enterocytes and its action is, like the cholera toxin, 
mediated by cAMP with secretion of chloride and inhibition 
of sodium absorption (53).
Cyclic AMP was the first intracellular mediator identified 
but it is now apparent that secretion can also be mediated 
by cyclic guanosine monophosphate (cGMP) and calcium. 
Escherichia coli and Yersinia enterocolitica colonise the 
small bowel producing toxins which invoke diarrhoea by a 
mechanism involving increased cellular cGMP (54, 55). The 
result, however, is similar to cholera toxin with increased 
chloride secretion and decreased sodium absorption (56).
The diarrhoea associated with the endotoxin from 
Clostridium difficile and with serotonin (carcinoid 
syndrome) is mediated by increased intracellular calcium 
concentrations. Studies using isolated rabbit ileum have 
shown that these two substances promote secretion of 
chloride and inhibition of sodium absorption. These 
effects were abolished by removal of serosal calcium or by 
verapamil - a calcium-channel blocker (57,58). Similarly 
an anthraquinone laxative has also been shown to cause 
colonic secretion which is mediated by calcium (59).
1. Secretion from Intestine with Blunted Villi
Mucosal cells have a relatively short life span and rapid 
turnover, being formed in crypts and then migrating to the 
villus. As they move their properties alter: Na--/K--ATPase
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activity declines, permeability to sodium increases, and 
the ability to absorb sodium in concert with actively 
transported nutrients develops (60). These changing 
properties reflect functional developments and, with regard 
to electrolyte fluxes, a convincing body of indirect 
evidence has been accumulating to suggest that absorption 
occurs via villus cells while secretion takes place through 
crypt cells (61) . This evidence can be summarised as 
follows. (a) When jejunal mucosa is exposed to hypertonic 
solutions the absorptive capacity of villi is impaired 
while secretion can still be stimulated (62). (b) Exposure
of mucosa to cycloheximide, which prevents mitosis, causes 
morphological damage to the crypt cells while villus cell 
structure is maintained. In mucosa subjected to this agent 
absorption can still be stimulated but secretion cannot 
(63). (c) Gall bladder epithelia and flounder intestine
absorb electrolytes by similar mechanisms to mammalial
mucosa, but these tissues do not contain crypts and cannot
be made to secrete (64) . (d) After pretreatment with
theophylline, which induces secretion, electrolyte fluxes 
were detected in the intervillus but not villus cells (65) . 
(e) When intestinal secretion is stimulated, the crypt 
cells can be seen to dilate (66).
The hypothesis that secretion occurs in the crypts has been 
more recently substantiated by two experimental studies 
(67) : (a) When secretion was stimulated in the large
intestine, droplets of fluid could be seen on the oil- 
covered mucosal surface directly over crypt duct openings;
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(b) Using micro-electrodes to study the membrane potentials 
of villus and crypt cells, patterns associated with 
secretion were found only in the crypt cells.
The above theory has evolved following studies in which
abnormal secretory states were experimentally produced.
Less is known about the secretory status of crypt cells in
healthy intestine, but there is probably a he
intestine, but there is probably a low-level
secretion from crypt cells occurring at the same time as
absorption from the villi (68).
If the ratio of villus cells to crypt cells fell then it 
would be expected that the balance of these two 
simultaneous processes would favour secretion. This 
situation has been demonstrated in conditions such as 
coeliac disease, tropical sprue (69) and viral enteritis 
(70). In these diseases where there is villus shortening 
and crypt hyperplasia, water and electrolytes are secreted 
into the intestinal lumen with resultant diarrhoea.
2. Bile acid induced diarrhoea
Diarrhoea commonly occurs after resection of the terminal 
ileum because of increased colonic concentrations of bile 
acids. The terminal ileum is the site of bile acid 
absorption and so in its absence more bile acids are 
delivered to the colon. The corresponding drop in the body 
pool of bile acids stimulates hepatic 7a-hydroxylase to 
increase bile acid production and this further increases 
the colonic concentration of bile acids. Hofmann
originally postulated that malabsorbed bile acids caused
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diarrhoea (71) which could be prevented by treatment with 
the binding agent, cholestyramine (72). This finding 
accorded with existing knowledge that deoxycholic acid 
impairs sodium and water absorption in both small and large 
bowel (73). It was subsequently demonstrated that the 
dihydroxy bile acids deoxycholic and chenodeoxycholic acids 
were most effective in promoting this fluid secretion (74). 
Increases in mucosal permeability (75) and enterocyte cAMP 
(76) have both been implicated in the mechanism although 
the former is probably of minor importance (77).
3. Fatty Acid Induced Diarrhoea
There is persuasive evidence to suggest that malabsorbed 
fatty acids may induce diarrhoea in the same way as bile 
acids. Hofmanns' group showed that the diarrhoea
associated with ileal resection sometimes responded to 
replacement of dietary long chain fatty acids with medium 
chain fatty acids. They demonstrated that this subgroup of 
patients had high concentrations of faecal hydroxy fatty 
acids which fell after treatment was initiated (78) . They 
later found that in patients with steatorrhoea secondary to 
|gastric j surgery, small bowel disease, or pancreatic 
insufficiency, the presence of diarrhoea was associated 
with high concentrations of faecal hydroxy fatty acids
(79), although this finding was subsequently challenged
(80) . The possible implication of hydroxy fatty acids in 
causing diarrhoea is especially attractive because 
ricinoleic acid, the active ingredient in the powerful 
aperient castor oil, is an hydroxylated fatty acid.
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Experimental evidence also supports this. During
intestinal perfusion of the colon with ricinoleic and 
hydroxystearic acid respectively a decrease in 
water/electrolyte absorption by 75% and 57% occurred (81) . 
Secretion of colonic electrolytes and water by hydroxy 
fatty acids is associated with stimulation of adenylate 
cyclase supporting the theory that cAMP is the 
intracellular mediator (82). However, as in bile acid- 
induced diarrhoea it is possible that increased colonic 
permeability may also have a role in the mechanism (82, 
83) .
Most studies on the mechanism of fatty acid induced 
diarrhoea have concentrated on the effects of the 
hydroxylated fatty acids. It seems, however, that non- 
hydroxylated fatty acids may play as important a role as 
the hydroxylated form (84). Although their potency is less 
they are present is much higher concentrations than the 
hydroxylated form.
4. Prostaglandins and diarrhoea
Prostaglandins have a cytoprotective role in the stomach 
and duodenum and have gained some credibility in the 
treatment of duodenal ulcers and prevention of intestinal 
lesions caused by non-steroidal anti-inflammatory drugs. 
However, one of the most common side-effects of this 
treatment is diarrhoea, which is almost certainly secretory 
in nature. Exposure of intestinal mucosa to prostaglandins 
results in fluid and electrolyte secretion (85) which is
50
Chapter 1 - Introduction
associated with increased cAMP production (86) . The 
diarrhoea associated with ulcerative colitis may also be 
caused by increased prostaglandin production (87) and can 
be effectively treated by inhibitors of cyclo-oxygenase. 
Similarly indomethacin has been useful in treating the 
secretory diarrhoea of villous adenoma which may also be 
caused by prostaglandins (88).
OSMOTIC DIARRHOEA.
As previously mentioned, the absorption of water is 
governed by the presence of an osmotic gradient from lumen 
to interstitium. Conversely, loss of water into the lumen 
would be expected if the osmotic gradient was in the 
opposite direction. This process occurs normally in the 
duodenum but, as nutrients are absorbed further down the 
gut, the luminal osmotic pressure decreases resulting in 
net absorption.
If a poorly absorbed substance is consumed in sufficient 
quantities then its presence in the intestine draws fluid 
into the intestinal lumen. This is the basis of the action 
of the saline laxatives such as magnesium sulphate whose 
two constituent ions are poorly absorbed causing a 
hyperosmotic luminal fluid. There is a subsequent rapid 
equilibration of osmolality by the movement of water from 
interstitial spaces. Electrolyte absorption in the small 
intestine continues and the larger volume of fluid reaching 
the colon is comprised predominantly of the unabsorbed 
ions; as the fluid passes through the colon little more
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absorption of water or electrolytes can occur. If
sufficient magnesium sulphate is taken the result is
diarrhoea.
The diarrhoea often associated with disaccharidase 
deficiency is caused in a similar way. In subjects with 
lactase deficiency/ intake of lactose results in a luminal 
osmotic load due to the unabsorbed sugar. Perfusion
studies have demonstrated jejunal secretion of water and 
electrolytes (the latter presumably by solvent drag) and a 
rapid small intestinal transit time caused by the increased 
volume (89). The situation with disaccharidase deficiency 
is complicated by colonic fermentation of the sugar with 
the production of SCFA; It was originally thought that 
these moieties increased the osmotic load further but it 
has since been demonstrated (90) that the increase in 
faecal water is correlated to the unabsorbed sugar rather 
than the SCFAs which are in fact rapidly absorbed (44).
Non-pancreatic causes of malabsorption will also produce a 
diarrhoea which is due, at least in part, to the osmotic 
load caused by digested but malabsorbed nutrients. The 
diarrhoea found in dumping syndrome is also partially 
osmotic in nature (see page 33).
Congenital chloridorrhoea caused by a defective C1-/HC03- 
pump is a rare cause of osmotic diarrhoea. The chloride 
ion which cannot be absorbed effectively acts as the 
osmotic agent and is found in very high concentrations in 
the stool water (36) (See page 37).
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For the efficient absorption of water and electrolytes, as 
well as nutrients, intestinal fluid requires to be in 
contact with mucosa for an adequate period of time. 
Reduction of this time, as would be the case in 
hypermotility syndromes, might be expected to cause 
diarrhoea. There is a dearth of direct evidence to support 
this theory. However, it has been examined using an animal 
model in which saline solutions were infused into the small 
bowel of dogs. Predictably, as the rate of infusion was 
increased, diarrhoea (referred to as 'volumogenic' 
diarrhoea) resulted, the severity of which was proportional 
to the infusion rate (91). Conversely the passage of 
abnormally high fluid loads through the intestine results 
in a decreased intestinal transit time (81, 92) . The ileo- 
caecal sphincter normally serves to control the entry of 
fluid into the colon in the same way as the pyloric 
sphincter allows small regular delivery of chyme from 
stomach to duodenum. However, ileal distension due to high 
fluid volumes causes its relaxation (93), preventing it 
from ameliorating diarrhoea in such situations.
Post-vagotomy diarrhoea may be a special case where there 
is rapid emptying of the terminal ileum caused by the ileo- 
caecal valve (whose action is controlled by the vagus 
nerve) not closing effectively. Consequently there is
less time available for terminal ileal absorptive processes 
(including bile acid absorption). It is known that 
diarrhoea is associated with truncal vagotomy rather than
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selective vagotomy in which the nerve fibres serving the 
ileo-caecal valve are maintained (94) .
Intestinal smooth muscle activity is partly controlled by 
hormonal influences and it is probable that the diarrhoea 
associated with VlPoma, thyrotoxicosis, carcinoid syndrome 
and prostaglandins is partly due to hypermotility. 
Similarly bile acids, fatty acids, and some laxatives 
stimulate colonic motility, and indeed it seems likely that 
most causes of diarrhoea have a hypermotility component in 
their pathogenesis.
An obvious exception to this is the paradoxical diarrhoea 
associated with gut hypo-motility. An adequate flow of 
luminal contents is important in maintaining sterility in 
the small bowel (95) . Consequently when the flow rate is 
compromised as in scleroderma or blind loop syndrome, small 
bowel overgrowth may occur resulting in diarrhoea due to 
fat malabsorption and/or toxin-stimulated secretion.
Lastly, premature emptying of the colon may partially 
account for the diarrhoea sometimes associated with 
irritable bowel syndrome in which there may be increased 
smooth muscle activity (96).
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INTRODUCTION
Most infectious causes of diarrhoea are relatively easily 
diagnosed by microbiological culture of organisms in a 
sample of faeces. In a similar way it is attractive to 
speculate that faeces from patients with other types of 
diarrhoea contains information which, by simple chemical 
analysis, might reveal the cause of diarrhoea.
Stool normally consists of between 65% and 80% water by 
weight. About a third of the dry weight of stool is 
comprised of bacteria and the remainder consists of 
undigested roughage, fat, mucus, desquamated epithelia and 
small amounts of protein. The relative proportions of 
these are predominantly dependent on the diet. In cases of 
diarrhoea it is unlikely that the composition of the solid 
portion will vary significantly. Perhaps some useful 
information can be gleaned by analysing the water phase of 
diarrhoeal stools. In Chapter 1 it was indicated that the 
excess water excreted in diarrhoea is ultimately controlled 
by electrolyte movements within the intestine. 
Consequently there has been some interest in the 
measurement of stool water electrolytes as a potential aid 
in the differential diagnosis of diarrhoea.
Water in faeces exists either in the intracellular 
compartment or as free intercellular water. The latter is 
in immediate contact with enterocytes and so is thought to 
be of particular relevance since its composition is 
directly affected by secretory or absorptive processes.
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This component is variously described as stool water or 
faecal fluid.
PREPARATION OF STOOL WATER
Diarrhoeal stool water can readily be prepared by 
centrifugation of loose or watery faeces. Unfortunately 
comparative data from healthy individuals is more difficult 
to acquire since centrifugation of normal stools does not 
usually yield a supernatant. Alternative methods are 
required in such circumstances and four in particular have 
been employed.
1. Addition of water
In early studies of the electrolyte composition of stool 
water, a faecal sample was initially made fluid by adding 
water and homogenising. The electrolyte content of a 
protein-precipitated homogenate was measured and related to 
the water content which was estimated gravimetrically by 
evaporation of an aliquot to dryness (98) . Unfortunately 
this method makes no distinction between intracellular 
water and free water.
In other studies sufficient water was added to normal stool 
so that an homogenate could be prepared and then 
centrifuged with the production of a supernatant (99, 100) . 
However, without the use of a marker which does not enter 
the cell, this technique does not allow the original free 
water content to be calculated, so depreciating the value 
of subsequent analyses. Furthermore it is possible that
57
Chapter 2 - Preliminary Investigations of Stool Water
the addition of water may cause cell lysis resulting in 
contamination of the supernatant with intracellular fluid.
2. In vivo dialysis
In 1965 Wrongs' group devised an ingenious means of 
preparing stool water by an in vivo dialysis procedure 
(101). Small dialysis bags containing an inert colloidal 
solution were swallowed and after their passage through the 
intestine, were retrieved from stool. The composition of 
the faecal dialysate obtained was then analysed. 
Equilibration of dialysate with surrounding fluid was shown 
to be complete after an hours' incubation in an electrolyte 
solution. Since the bags were found to be within the colon 
for much longer periods of time, equilibration from colonic 
contents was assumed to be complete by the time of 
defaecation. Dialysates from bags inserted into the rectum 
of a healthy subject were also obtained. The electrolyte 
composition fell within the - very broad - normal range 
they had established using bags which had traversed the 
entire alimentary tract. Thus they concluded that the 
dialysate represented equilibration within the rectum 
rather than from proximal colon where the contents are more 
fluid. In addition the electrolyte composition in primary 
aldosteronism was shown to change in a predictable manner 
following surgery; the high potassium and low sodium 
concentrations found preoperatively were normalised post- 
operatively (102).
The results from this and further studies from the same
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group have been widely quoted since and it is clear that 
they have played a significant role in the subsequent 
development of ideas and theories. The validation of this 
method of preparing stool water must, however, be 
considered as incomplete. It was difficult for the authors 
to achieve a more comprehensive evaluation because their 
studies were entirely original and so could not be 
meaningfully compared with other techniques. Some of their 
results seem surprising and could be interpreted as 
originating from an ineffective procedure. For example the 
concentration ranges found in normal subjects (n = 8) were 
very wide: 4.4 - 112mmol/l for sodium and 29 - 147mmol/l
for potassium; there were wide intra-individual variations 
in dialysate composition; the composition of dialysates 
obtained from the same stool also varied widely.
Moreover, the validity of the in vivo technique has been 
questioned in a more recent study which compared it with a 
centrifugation method (103) . Statistically significant 
differences were demonstrated for most of the analytes 
studied especially osmolality, SCFAs and bicarbonate. It 
also confirmed Wrongs' finding that there are significant 
differences in the composition of dialysates of bags taken 
from the same stool sample and concluded that the the 
dialysate is not in equilibrium with free faecal water. 
This conclusion concurs with results of an in vitro 
dialysis procedure in which it was shown that 18 - 24 hours 
was required for complete equilibration of dialysis fluid 
and faeces (104).
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In another brief report comparing the composition of in 
vivo dialysates with ultracentrifuged supernatants 
significant difference were found for all analytes measured 
except sodium and potassium (105). However, the speed of 
ultracentrifugation (160,000g) may have caused some 
disruption to bacterial cells thereby altering the 
composition of the faecal fluid. Consequently the 
conclusions of this study are in question.
3. Ultrafiltration
The development of commercially available membrane filters 
has provided an alternative means of preparing stool fluid. 
This was initially evaluated by comparison with fluid 
obtained from dialysis bags after a 24 hour incubation with 
stool (104). The composition of faecal fluid by these two 
procedures was virtually identical except for diarrhoea 
samples when sodium and chloride were slightly (4%) lower 
in dialysate compared to ultrafiltrate. Several
ultrafiltrates prepared from the same stool sample gave 
reproducible results (106). (This again contradicts in 
vivo dialysis results in which several dialysates from the 
same stool showed gross variations.) This system has been 
used to determine stool water characteristics in fifty 
healthy individuals (106).
4. In vitro dialysis
The preparation of stool water by this method is comparable 
to the in vivo technique except that dialysis bags are 
incubated for 24 hours in a refrigerated stool collection.
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Results from this method were compared with those obtained 
using ultrafiltration (104) and high speed centrifugation 
(103) . In both studies similar stool water compositions 
were found.
STOOL ELECTROLYTES AND OSMOLALITY
The main reason for developing a method of obtaining faecal 
fluid from normal stools is to have data on electrolyte 
composition for comparative purposes. At present five 
studies have been performed to provide this information but 
methodological problems probably invalidate all but one. 
In three, water or an aqueous solution was added to the 
stool to prepare the homogenate for centrifugation (98,99, 
104) and another used the method of in vivo dialysis which 
is probably not a valid procedure and has certainly not 
been effectively evaluated. This leaves Costongs' data 
obtained from ultrafiltered stools (106) and these are 
shown in table 2.1 along with the figures obtained from the 
other studies mentioned. It is surprising that these 
results are broadly comparable to all of the other methods 
despite their inherent errors.
A faecal ionogram prepared using these data enables the 
composition of normal stool water to be visually assessed 
(figure 2.1). Potassium is the predominant cation in 
faecal water obtained from normal subjects, being present 
at about 80mmol/l concentrations as compared with sodium at 
about 20mmol/l. In patients with diarrhoea the
concentrations of these cations varies. In general as the
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Sample Sodium
(mmol/1)
Potassium
(mmol/1)
Chloride
(mmol/1)
Osmolality
(mosm/Kg)
Ultrafiltrate
(106)
17
(3 - 79)
80
(44 - 132)
11
(0 - 32)
308 
(179 -472)
Dialysate
(101)
32
(5 - 112)
75
(29 - 147)
16
(5 - 38)
376 
(336 -423)
Supernatant
(98)
36
(16 - 38)
99
(57 - 214)
nm nm
Supernatant
(99)
15
(15 - 79)
77
(44 - 131)
21
(5 - 31)
321 
(254 - 464)
Supernatant
(104)
19
sd = 2.4
79
sd = 7.1
12
sd = 1.4
324 
Sd = 16
Table 2.1 - Electrolytes in faecal fluids prepared by 
different methods. (Bracketed figures refer to ranges.
nm - not measured.)
severity of diarrhoea increases the sodium and chloride 
concentrations rise while the potassium concentration falls 
slightly (figure 2.2) (107). This may be due to increased
flow through the intestine resulting in incomplete 
sodium absorption and potassium secretion. Magnesium and 
calcium are also important faecal cations being dependent 
on dietary intake. Urea is the source of faecal ammonia, 
being digested by mucosal ureases or colonic bacterial 
enzymes. Ammonia exists either as NH3 or NH4-*- according to 
the equilibrium of the reaction:
NH*- + HCOs- fr H2CO3 + NH3 (pKa = 9.0)
Ammonium and bicarbonate concentrations and pH are 
interrelated: as pH falls, NH3 is produced and then
passively absorbed by mucosa; bicarbonate concentrations 
vary in proportion to those of ammonium (108).
It can be seen that the chloride and bicarbonate
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Figure 2.2 - Relationship between stool water and 
cations in different diarrhoea diseases (107).
6 4
Ciapter 2 - Preliminary Investigations of Stool ffater
concentrations only account for a fraction of the total 
anions. The 'missing' anions are the SCFAs, principally 
propionate, acetate, and butyrate. Sulphate and phosphate 
are minor electrolytes whose concentrations are dependent 
on diet.
The measured stool osmolality is usually hypertonic to 
plasma and tends to increase if a stool sample is left at 
room temperature, because of continuing bacterial 
degradation of carbohydrates. For this reason, in most 
studies faeces are refrigerated or frozen until analysis. 
One study using immediately processed samples has reported 
isotonic or minimally hypertonic results (285 - 330
mosmol/Kg) and suggest that results higher than this are 
due to improper storage (109). Interestingly this study 
measured osmolality by a decrease in vapour pressure rather 
than freezing point depression, which was the method used 
in other studies.
DIFFERENTIATION OF SECRETORY AND OSMOTIC DIARRHOEA - FAECAL
OSMOTIC GAP
Chronic diarrhoea may have many different causes and the 
diagnosis can be difficult to make. In such circumstances 
an initial differentiation between secretory and osmotic 
diarrhoea would be useful. Such a classification is 
thought to be possible by monitoring the effect of fasting 
on the diarrhoea. Osmotic diarrhoea is caused ultimately 
by dietary factors such as milk in lactose intolerance or 
magnesium salts in saline laxative abuse. It is apparent 
therefore that fasting should resolve this type of
65
Chapter 2 - Preliminary Investigations of Stool Water
diarrhoea but should have no effect on secretory causes. 
Although the effect of fasting has been widely suggested as 
a useful preliminary test it is not foolproof: when
patients are admitted to hospital, their diarrhoea tends to 
resolve irrespective of the cause; osmotic diarrhoea 
induced by saline laxative ingestion may continue during 
fasting (110, 109); and secretory diarrhoea caused by bile 
acids would not be expected to persist during fasting
because of minimal bile acid ! release from the gall
bladder. During the investigative work-up of 2 7 patients 
with chronic diarrhoea of unknown cause, the effect of 
fasting was found to be of no diagnostic value (111).
An alternative means of differentiating osmotic and 
secretory diarrhoea is to measure the osmotic gap (OG) in 
stool water prepared by an appropriate method. Sodium and 
potassium are the predominant cations present in faecal 
water in secretory diarrhoea and so by summing the sodium 
and potassium concentrations and doubling this figure (to 
account for anions) a calculated approximation can be made 
of its osmolality. When the diarrhoea is osmotic in nature 
the calculated figure is lower than the measured 
osmolality. Consequently, measuring the OG as shown in 
equation 1 (OG1) may be of value in the differential
diagnosis of secretory and osmotic diarrhoeas.
Equation 1: Osmotic Gap (OG1) = Osmolality - [2x(Na- + K^)]
One problem in measuring the OG is that stool osmolality 
tends to increase quite rapidly as any unabsorbed
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carbohydrate is metabolised by faecal bacteria. It is 
thought that this may even occur in samples that are 
immediately refrigerated (112). As a result the OG1 may be 
overestimated. A possible solution to this problem is to 
subtract the calculated osmolality from the osmolality of 
plasma (equation 2) . Since the colon has no capacity to 
concentrate or dilute, stool water should theoretically be 
isotonic in the absence of substrates such as carbohydrates 
for bacterial metabolism. The use of equation 2 to 
calculate OG (OG2) would seem to be a logical alternative 
especially since the use of antibiotics to prevent 
bacterial action in vivo, results in stool water that is 
isotonic (109, 113).
Equation 2\ Osmotic Gap (OG2) =
Plasma Osmolality - [2x(Na-*- + K-*-) ]
The use of the osmotic gap has been pioneered by Fordtrans' 
group (114) who initially suggested using equation 1 for 
its calculation but subsequently favoured equation 2. Both 
methods of calculation have been used and several cut-off 
points have been suggested as shown in table 2.2. There is
Reference Equation Osmotic Gap 
Osmotic Secretory 
Diarrhoea Diarrhoea
111 1 > 100 —
115 1 >50 < 40
109 1 > 160 < 0
112 2 > 50 —
116 1 > 40 0
117 1 > 15 —
Table 2.2. - Osmotic gaps suggested for distinguishing 
osmotic and secretory diarrhoea.
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clearly a sizeable disparity in the various OGs suggested 
as cut-off points between secretory and osmotic diarrhoea.
There is currently some doubt as to the value of measuring 
the OG. It has been suggested that the osmotic gap may be 
of clinical value in the differential diagnosis of 
diarrhoea (109, 112) but only one evaluatory study has been 
carried out (118). In this study, diarrhoea was initially 
categorised as being secretory or osmotic on the basis of 
OG1 results. This classification was then compared with 
two alternative systems for distinguishing osmotic and 
secretory diarrhoea; the response of diarrhoea to fasting, 
and a classification based on current assumptions regarding 
pathogenesis of diarrhoea (128). However, neither of the 
two comparative methods can be considered as being 
definitive. Disadvantages of monitoring the response of 
diarrhoea to fasting have already been mentioned (page 66), 
while the theoretical classification according to current 
knowledge is over-simplistic, based on unjustifiable 
assumptions, and allows no differentiation into a mixed 
osmotic/secretory category.
* * * * * *
There is little information as to which electrolytes should 
be measured in order to reliably measure the OG. In plasma 
samples the OG can be calculated simply by doubling the 
concentrations of sodium and potassium. Because other 
cations and neutral solutes are present in such small 
quantities they do not require to be taken into account.
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Whether the same is true with respect to stool water is 
open to question. All studies so far have considered only 
the sodium and potassium concentrations in computing the 
OG. However, as indicated previously (figure 2.1, page 63) 
magnesium, calcium and ammonium are also present in 
significant concentrations.
USEFULNESS OF FAECAL WATER POTASSIUM/SODIUM RATIO
In the luminal contents of the terminal ileum, sodium and 
potassium concentrations are close to those found in the 
plasma and the potassium/sodium ratio (K/Na) is relatively 
constant at about 0.06. The role of the colon in 
preserving sodium and secreting potassium, results in much 
higher K/Na ratios from 1.6 - 6 in stool water (99). It 
has been suggested that the measurement of this ratio may 
provide information as to the region of the gut 
predominantly responsible for diarrhoea - ileum or colon 
(117). In colonic disorders the ratio would theoretically 
be low and the converse would hold with ileal disease. For 
example in patients with a total colectomy the ratio was 
found to be low (0.05 - 0.1) but was 0.94 and 3.6 when 50% 
and 29% respectively of the colon was resected (119) . 
Similarly, in patients with extensive ulcerative colitis 
the ratio was low (mean = 0.55, sd = 0.36) but when the 
disease was confined to the rectosigmoid area the ratio was 
nearer normal (mean = 3.64, sd = 2.2) (99). Apart from
small incidental studies of this nature the usefulness of 
K/Na ratios has not been assessed.
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OBJECTIVES
1. TO VALIDATE THE USE OF ULTRAFILTRATION MEMBRANES IN THE
PREPARATION OF STOOL WATER.
The ultrafiltration method for the preparation of stool 
water has only been validated by comparison with an in 
vitro dialysis method (104). Unfortunately the latter 
method itself has not been evaluated, indeed the only 
approved method is by centrifugation. It was intended to 
compare the results of the ultracentrifugation and 
ultrafiltration methods using samples obtained from 
patients with loose or poorly formed bowel motions.
2. TO COMPARE FAECAL WATER OSMOLALITIES MEASURED BY 
FREEZING POINT DEPRESSION AND VAPOUR PRESSURE ELEVATION.
One study (109) has reported average stool osmolalities 
which are considerably lower than other studies. There 
were two notable differences in the way this group 
processed the results: osmolalities were measured by vapour 
pressure lowering rather than by freezing point depression; 
and samples were processed immediately after collection 
rather than being frozen.
In order to determine whether the different methodology for 
measuring osmolality caused this, several faecal fluids 
were assayed by both methods and the results compared.
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3. TO DETERMINE THE EFFECT OF FREEZING STOOL COLLECTIONS
PRIOR TO ANALYSIS.
As a follow-up to the previous objective, stool samples 
obtained from several patients with diarrhoea were 
aliquotted into two samples, one of which was analysed 
immediately and the other was initially frozen. 
Electrolytes, pH and osmolality were measured in each and 
the results compared.
4. TO DETERMINE WHICH EQUATION IS MOST APPROPRIATE IN 
CALCULATING THE FAECAL OSMOTIC GAP.
The main reasons for using equation 2 (page 67) when 
calculating the faecal osmotic gap are because of rapid 
changes in faecal osmolality even when samples are 
immediately frozen, and because equation 1 does not produce 
a result which correlates with the degree of diarrhoea. 
The appropriateness of each equation to calculate the 
osmotic gap was investigated by a) monitoring of the rate 
of change of osmolality in faecal homogenate and the effect 
of temperature on any change; b) calculating the osmotic 
gap by each method and comparing the results with the 
severity of osmotic diarrhoea; c) by comparing the intra­
individual variabilities of 0G1 and 0G2.
5. TO DETERMINE THE CLINICAL VALUE OF THE FAECAL OSMOTIC
GAP.
Before faecal osmotic gaps can be meaningfully used, an 
appropriate reference range must first be established, 
based on results from patients known to have a pure 
secretory or pure osmotic diarrhoea. Patients in these two
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categories were recruited and the ranges calculated were 
used as reference points for further evaluation of the use 
of OG. Unfortunately there are few candidates who have 
purely osmotic or secretory diarrhoeas. Examples of a pure 
osmotic diarrhoea are found in patients with saline 
laxative induced diarrhoea or specific carbohydrate 
malabsorption such as lactose intolerance. As examples of 
pure secretory diarrhoea, patients with various infectious 
and hormone-induced diarrhoeas, and colonic stimulant 
laxatives abusers, were recruited.
To be of value the osmotic gap should be reproducible 
within patients with diarrhoea. For this reason the intra­
individual variability of the osmotic gap in patients with 
diarrhoea was also measured.
The benefit of OG was also assessed retrospectively in 
patients presenting with diarrhoea.
6. TO DETERMINE WHETHER CATIONS OTHER THAN SODIUM AND 
POTASSIUM CONTRIBUTE SIGNIFICANTLY TO THE OSMOTIC GAP.
When calculating the faecal OG it has been assumed that 
only sodium and potassium concentrations require to be 
considered. That is, the contribution of other cations to 
the osmotic gap is believed to be relatively unimportant 
because they are present in small and constant 
concentrations. However, their concentrations have only 
been measured in the faecal fluid from healthy subjects. 
For this reason the relative importance of these previously 
neglected cations, such as calcium, magnesium and ammonium,
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in calculating OGs was considered in patients with 
diarrhoea.
7. TO EVALUATE POTASSIUM/SODIUM RATIOS IN DETERMINING
WHETHER DIARRHOEA IS PREDOMINANTLY ILEAL OR COLONIC.
Although the use of potassium/sodium ratios has been 
proposed as a useful preliminary investigation in order to 
distinguish ileal and colonic causes of diarrhoea (117), no 
evaluatory work has been reported. The ideal means of 
achieving this is by recruiting patients with diarrhoea 
known to be either ileal or colonic in nature and 
determining appropriate reference ranges. Examples of 
colonic causes of diarrhoea are ulcerative colitis, Crohn's 
disease limited to the colon, bile acid induced diarrheoa 
and infectious diarrhoeas such as those caused by Shigella 
or Campylobacter or acute Eschericia coli (120). 
Unfortunately diarrhoeal diseases associated with small 
bowel pathophysiology, such as Vibro cholerae, Escherichia 
coli, and Giardia lamblia are rare in this country. 
Therefore patients with small bowel causes of diarrhoea 
were limited to those with Salmonella, in whom the 
infection principally affects the ileum (120). Two other 
comparative groups were recruited; patients with a probable 
mixed ileal/colonic diarrhoea, and those with bile acid 
induced diarrhoea.
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PATIENTS „ MATERIALS A3SIX>
METHODS
PATIENTS
Stool samples were collected from three categories of 
patients: inpatients and outpatients under investigation
of diarrhoea; patients admitted to the Infectious Diseases 
wards of Monklands District General Hospital and Ruchill 
Hospital for investigation of suspected infectious 
•diarrhoea; healthy volunteers in whom diarrhoea was 
induced by means of administration of saline laxatives (see 
pages 149 - 150) .
METHODS
Patients were asked to defaecate, avoiding urinary 
contamination, directly into 2.51 plastic containers and to 
immediately transfer the container to a -208C freezer. (A 
portable freezer was delivered to the homes of outpatients 
and volunteers for this purpose.) In the case of watery 
samples collected in Infectious Diseases wards, the 
patients defaecated into papier-mache disposable trays and 
a nurse transferred an aliquot by means of a syringe into a 
25ml universal container. The nurses were instructed to 
immediately place the sample into the portable freezer or 
into an insulated box or thermos flask containing dry ice.
Stool samples thus collected were semi-thawed and 
homogenised without the addition of water. Aliquots were 
transferred to appropriate tubes, weighed, and centrifuged
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at 12,000rpm for one hour. The supernatant was decanted 
into a stainless steel filter unit and filtered through 
paper prefilter discs (Millipore Ltd, England). The 
centrifuge tube was reweighed and the weights of 
supernatant and sediment were calculated. The degree of 
liquidity of stool was expressed as the percentage by 
weight of supernatant compared to the total homogenate 
centrifuged (PWC).
PWC = (Weight of superantant) x 100/(Weight of Homogenate)
Ultrafiltrates were obtained by transferring a weighed 
aliquot into Centriflo membrane filter cones (Centriflo 
CF50A filters from Amicon Ltd, Stonehouse, Gloucestershire) 
and centrifuging at l,000rpm for 30 minutes. A value 
equivalent to the PWC and coined the 'centrifugated water 
content7 by the group who described this method of faecal 
fluid preparation (106) was also calculated by dividing the 
volume of the faecal fluid by the weight of the original 
faecal sample.
An HPLC method was established for the measurement of 
anions. By this method, anions in the injected sample 
displace light-absorbing counter anions, phthalate from 
potassium hydrogen phthalate (KHP, from BDH), from their 
attachment to an ion-pairing reagent, tetrabutylammonium 
hydroxide (TBAH, Sigma Chemical Co, Poole). Each anion- 
TBAH complex is separated on an ODS column and is measured 
as a negative absorption peak at 270nm. Using pure 
standards of bicarbonate and chloride linear responses were
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produced up to concentrations of 1.5mmol/l. Stool 
supernatant was diluted 25 fold in distilled water and also 
injected onto the column, but many peaks were detected 
around the retention times for the anions of interest. 
Initial decolourisation of the samples by the addition of 
500mg of activated charcoal effected some improvement, but 
there was still too much contamination to be able to 
measure the anions reliably. Standard techniques were 
subsequently used for the measurement of anions.
The various faecal analytes were measured as follows: 
sodium and potassium by flame emission spectrophotometry; 
chloride by electrometric titration with silver ions; 
calcium and magnesium by dilution and atomic absorption 
spectrophotometry (see page 144 - 146); osmolality by
freezing point depression (Advanced Digimatic Osmometer 
Model 3DII from Advanced Instruments Inc.) and by vapour 
pressure elevation (5100C Osmometer form Wescor Inc.); 
ammonium by enzymatic assay (see below) (170-UV kit from 
Sigma Chemical Co, Poole, Dorset).
INACTIVATION OF PATHOGENIC BACTERIA IN STOOL
Since some of the stool samples analysed were obtained from 
patients with infectious diarrhoea, it was considered 
prudent to inactivate any pathogens prior to analysis. Two 
bacteriocidal methods were tested; pasteurisation (heating 
at 60°C for 30 minutes) and chemical treatment with 2% 
glutaraldehyde (ASEP from Galen Ltd, Craigallan, Northern 
Ireland). Each method was initially assessed using
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supernatants from patients with non-infectious diarrhoea:
bacteriology was performed on the treated specimen to
determine how effectively bacteria were destroyed; 
electrolytes were measured in treated and untreated 
duplicate samples to determine whether results could be
calculated accurately.
Both methods of bacteriocide were effective in destroying 
aerobic bacteria but in pasteurised samples the osmolality 
rose sharply, the pH fell, and the precision of electrolyte 
measurements deteriorated significantly.
The effect oh the electrolyte content of ASEP was corrected 
for in ASEP-diluted supernatants (0.5ml of ASEP to 2ml of 
supernatant) by the following equation.
[analyte] s = ([analyte]a.s x 5) - [ a n a l y t e ] / 4
where [analyte]s, [ analyte ]a.s and [analyte]aseP are the
concentrations of analyte in the supernatant, ASEP-diluted 
supernatant, and ASEP respectively.
The correlations between the actual and calculated 
electrolyte concentrations were very good: r = 0.999, 0.999 
and 0.998 for sodium, potassium and chloride respectively, 
but was poor for osmolality and pH.
Consequently electrolytes were measured using an ASEP- 
dilution of the supernatant but osmolality and pH were 
measured using the original supernatant. This was felt to 
be an acceptable procedure especially since sampling 
handling is minimal for the latter estimations and the
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instrument could be easily decontaminated after analysis.
MEASUREMENT OF FAECAL AMMONIA
In general, the strong colour of faecal samples makes it 
difficult to measure analytes by means of 
spectrophotometric methods. For this reason an enzymatic 
method (121) using a commercial kit was used for the 
measurement of faecal ammonia. The method monitors the 
decrease in optical density caused by NADH (reduced 
nicotinamide-adenine dinucleotide) being consumed by the 
following reaction, catalysed by glutamate dehydrogenase 
(GLDH).
2-ketoglutarate + Ammonia + NADH Glutamate + NAD
Briefly, to 3ml of NADH/buffer solution was added 0.2ml of 
sample (stool samples were diluted thirty-fold with 0.9% 
saline). After five minutes equilibration, the optical 
density was measured and then 0.02ral of GLDH was added to 
initiate the enzymic reaction. The absorbance fell, as 
NADH was consumed, until a final absorbance was reached 
after 5 - 1 0  minutes. The change in absorbance was 
proportional to the ammonia concentration.
When stool supernatants were used it was found that the 
absorbance fell gradually even before the GLDH was added, 
suggesting that NADH was being oxidised by other enzymes. 
In addition, with standards and controls the reaction 
reached completion within ten minutes, but when stool 
supernatants were used an end-point was not attained ie.
78
Chapter 2 -Preliminary Investigations of Stool Water
the optical density continued to fall. This could have 
been due to continued activity of urease and subsequent 
production of ammonia.
To avoid these problems a prior protein precipitation step 
was included to destroy any enzymes present. Three 
different precipitation methods were tested using 
sulphosalicylic acid (100g/l), methanol, and magnesium 
chloride (100mg/l). Stool supernatants were diluted 50:50 
with each of the precipitants and then diluted fifteen-fold 
to reach a thirty-fold dilution in total. In the case of 
methanol and magnesium chloride, distilled water was used 
as diluent but with sulphosalicylic acid 0.2M phosphate 
buffer pH 7.4 was used in order to increase the pH to a 
suitable level for GLDH activity. A volume of 0.02ml was 
then added to the substrate/buffer solution and the ammonia 
method carried out asj described above j
With the use of methanol and magnesium chloride there was 
still a continual fall in absorbance before the GLDH was 
added and the reaction did not reach completion. The 
results using sulphosalicylic acid were successful in that 
an equilibrium was reached when NADH solution was added and 
the reaction reached completion after 5 - 1 0  minutes in the 
same way as for the standards and controls. This finding 
substantiated the supposition that the problems were caused 
by enzymes in the sample which consumed NADH and produced 
ammonia.
The method was modified to include this prior precipitation
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step and recovery experiments were performed by spiking 
stool supernatants with 125^1 of 100mmol/l ammonium 
chloride solution.
Because of the presence of urease in stool supernatants it 
was important to determine the stability of the samples. 
Accordingly, samples were divided into six aliquots of 1ml, 
and 0.05ml of lmol/1 hydrochloric acid was added to three 
in an attempt to stabilise the analyte as ammonium. 
Samples were stored at either room temperature, 4°C or 
-20 °C.
The samples which were not treated with acid gave lower 
results suggesting that ammonia was lost. More
surprisingly, the higher the temperature used for storage, 
the higher was the ammonia result. The probable 
explanation for this was that ammonia continued to be 
generated, presumably from urea or other nitrogenous 
substrates present in the stool sample.
A second stability experiment was then performed, with 
samples being diluted 50:50 with 100g/l sulphosalicylic 
acid to prevent enzymatic production of ammonia and then 
stored at either 4°C or 25°C. There was no significant 
change in ammonia concentration over a one week period when 
samples were stored at either 4°C or at 25°C. When further 
aliquots were measured after a month there was an increase 
in ammonia concentration at both temperatures.
A further experiment was performed in order to determine 
whether ammonia was sufficiently stable in stool samples
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over the short period of time required for processing. A 
diarrhoea stool sample was aliquotted immediately after 
collection and one aliquot centrifuged immediately. The 
stool supernatant was diluted 50:50 with 100g/l 
sulphosalicylic acid. Other aliquots of stool were allowed 
to stand at room temperature for 30, 60, and 120 minutes
before processing as above. One further aliquot was stored 
frozen and the following morning was thawed and processed 
as above. The ammonium concentrations were: 23.4, 23.4,
29.7 and 32.0mmol/l in samples processed at 0, 30, 60, and 
120 minutes, and 15.8mmol/l in the frozen sample.
It was concluded that if stool samples are not processed 
within 30 minutes the ammonium concentration is
overestimated. In addition, in stool samples that are 
frozen until analysis, the ammonia concentration is 
underestimated.
OSMOLALITY MEASUREMENTS
Osmolality results were compared on the same stool water 
samples by two methods, freezing point depression and 
vapour pressure lowering. The samples were analysed within 
ninety minutes of each other and were stored at 4°C to 
minimise any change in osmolality due to bacterial
metabolism.
Recovery experiments were performed by measuring the
percentage recovery in seventeen samples. A volume of 
0.25ml of either 470mmol/l or 1264mmol/l sodium chloride 
solution was added to 1ml of faecal fluid. At these
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concentrations the saline solutions have a fractional 
dissociation constant of 0.91, and so their calculated 
osmolalities were 850 and 2300mosmol/Kg/ respectively.
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RESULTS AND DISCUSSION
EVALUATION OF CENTRIFLO MEMBRANES IN THE PREPARATION OF
STOOL WATER
The first step in any simple preliminary examination of 
stool for the purposes of investigation of diarrhoea, 
requires the preparation of faecal fluid. When the stool 
is watery there is little difficulty since a stool 
supernatant is readily prepared by centrifugation. 
Preparation of stool water from a semi-formed diarrhoeal 
sample is more difficult and there are pros and cons 
regarding existing techniques. As described earlier we 
concluded on the basis of existing literature that the in 
vivo dialysis procedure on which data from normal 
individuals is primarily based, is suspect. The most 
practicable method involves the use of commercially 
available membrane filters but unfortunately this method 
has not previously been evaluated. In the initial part of 
this study an assessment was made of this approach.
The composition of stool water prepared by filtration 
through Centriflo membranes was compared with that 
obtained by centrifugation/filtration. (To avoid confusion 
the resultant fluids are termed j filtrate and supernatant 
respectively.) A filtration step was also included in the 
centrifugation step to ensure that no cell debris was 
present. We had initially compared the composition of 
filtered and unfiltered supernatants and found them to be 
similar.
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After a thirty-minute spin through the Centriflo membrane 
the contents of the cone were usually still moist and so 
the filtrate was removed and the centrifugation step was 
repeated for a further thirty minutes and a second 
filtrate collected. Thus two filtrates were obtained from 
most of the samples. The data were compared to determine 
whether the composition of supernatant and filtrates were 
similar. The results of this experiment are tabulated 
(table 2.3).
Supernatant 
Mean ± sem
Filtrate 1 
Mean ± sem
Filtrate 2 
Mean ± sem
pH
Osmolality
Sodium
Potassium
Chloride
7.34 ± 0.24* 
378 ± 26* 
55.5 ± 6.7
58.8 ± 5.2
33.9 ± 3.5
7.44 ± 0.26A 
366 ± 27 
55.6 ± 6.7 
58.1 ± 5.2 
33.8 ± 3.4
7.88 ± 0.33 
383 ± 32
54.3 ± 9.0 
59 ± 8.3
40.4 ± 4.5
Table 2.3 - Comparison of stool water composition when 
prepared by centrifugation and Centriflo filtration. (* - 
p < 0.05 vs filtrate 1, A - p < 0.05 vs filtrate 2). (n = 
21 for the first two groups but only 14 for filtrate 2 
group, therefore means are not directly comparable.)
There were no statistically discernible differences in the 
concentrations of sodium, potassium and chloride between 
the filtrates and supernatants. However, the osmolality 
of filtrate 1 was significantly lower (p = 0.04) and pH 
significantly higher (p = 0.02) than in the supernatant, 
and the pH of the first filtrate was significantly lower 
than that of the second (p = 0.02) (See Statistical 
Appendix, note 1).
The correlations between each group were high as expected 
(Statistical Appendix, note 2) and are illustrated in 
figures 2.3 to 2.7 (pages 85 - 89).
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Figure 2.3 - Effect of method of stool water 
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TECHNICAL FACTORS IN THE PREPARATION OF STOOL WATER
1. Rate of Change of Stool Composition
Some studies have demonstrated that the composition of 
faecal fluid varies if the stool is allowed to stand at 
room temperature for significant periods of time in excess 
of one day (103, 109). We investigated possible changes
that may occur during the shorter time periods involved in 
sample preparation. Accordingly, several aliquots were 
made of three stools and these were then incubated at room 
temperature (approximately 24°C) for time periods of up to 
two hours.
Over the course of two hours there was no apparent change 
in the pH or concentrations of sodium, potassium and 
chloride but the osmolality rose by an average of 
11.5mosmol/kg per hour (figure 2.8).
Although there was a definite rise in osmolality over 
short periods of time this was relatively small and was 
therefore considered unlikely to affect results in the 
time normally taken to process samples.
We also incubated stools at lower temperatures and 
confirmed previous findings (103, 109, 118) that stools
could be stored refrigerated (4°C) for two days with no 
significant alterations in the composition of the 
resultant faecal fluid.
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When four stool samples were incubated at room temperature 
over a two day period of time, the change in osmolality 
was marked, increasing by an average of 128mosmol/kg/day. 
This concurs with a previous study which also demonstrated 
significant increases in osmolality over extended time 
periods (109). These changes in osmolality are caused by 
metabolic processes catalysed by faecal bacteria. For 
example Shiau et al showed that when stools were collected 
from patients receiving antibiotics, there was no change 
in osmolality when faeces were incubated for a two day 
period at 25°C (109) . In vivo dialysates of faeces were 
also shown to be significantly lower (304 vs 357mosmol/kg) 
when normal subjects ingested antibiotics (122).
This latter study also recorded decreased ammonia and 
increased urea concentrations in dialysates obtained from 
subjects taking antibiotics, suggesting that bacteria 
normally metabolise urea with the production of ammonia.
We also found evidence to suggest that stool pH tends to 
decrease with time although this was not as marked as the 
drop in osmolality. When stools were left for two days at 
room temperature the pH of the resultant faecal fluid fell 
by approximately 0.15/day. This agrees with a previous 
study which documents a decrease in pH of 0.35/day in 
stools kept at room temperature (118). This probably 
reflects increased production of SCFAs by bacterial 
action.
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2. Effect of Freezing on Stool Composition
For reasons of practicability it was more convenient to 
store stools so that they could be processed at a suitable 
time. Consequently, they were initially frozen to limit 
any changes in composition. However, subsequent thawing 
of stools could, depending on the size of the collection, 
take several hours. When Shiau et al processed samples 
immediately, they found considerably lower osmolalities 
than had previously been documented using samples that 
were frozen and thawed before preparation of stool water 
(109). For these reasons the effect of freezing and 
subsequent thawing on stool composition was studied.
Four stools were collected and aliquots taken for either 
immediate processing or freezing overnight before thawing 
and processing. Table 2.4 shows the results of this 
process, on the osmolality, pH, and electrolyte 
concentrations.
Analyte Stool 1 Stool 2 Stool 3 Stool 4
I F I F I F I F
Osmolality 310 280 418 431 343 360 265 266
pH 8.35 8.15 5.22 5.4 5.53 5.55 7.01 7.4
sodium 131 132 85 88 66 64 33 34
Potassium 34 39 60 50 30 27 56 52
Chloride 31 21 52 59 10 10 22 23
Table 2.4 - Comparison of analytes measured in stool water 
prepared immediately (I) and after freezing (F).
There was no apparent trend in any of the results although 
the reproducibility was poor for osmolality and pH. 
Therefore freezing and thawing of stools had little
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apparent effect on the composition of faecal fluid.
In stools processed immediately the mean osmolality was 
334mosmol/kg/ but there was a large range in the 
osmolality results, from 265 to 418mosmol/kg. This would 
suggest that the cause of the lower osmolality of 
295mosmol/kg (range of 285 - 330mosmol/kg) found by Shiau 
et al was not related to their practice of immediate 
processing of samples (109).
3. Measurement of Stool Osmolality
The study by Shiau et al (109), as well as processing 
samples immediately, also measured osmolality by a method 
monitoring vapour pressure lowering (VPL), rather than the 
more commonly employed technique of freezing point 
depression (FPD) used by ourselves and other workers.
As a preliminary experiment to determine if the two 
techniques of measuring osmolality, FPD and VPL, were 
producing different results fourteen stool water samples 
were analysed, in duplicate, by each method. Figure 2.9, 
which depicts the correlation achieved and the line of 
regression, shows that the results using the FPD method 
are, on average, 11.2% higher than the VPL method (see 
Statistical Appendix, note 2). The precision of each 
method was good: sd = 4.6mosmol/Kg, cv = 1.3% for FPD, and 
sd = 2.lmosmol/Kg, cv = 0.5% for VPL.
To determine whether this discrepancy was found only with 
stool samples, eighteen plasma or plasma/saline samples
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were measured by each method. Since the osmolality of 
plasma is within a tightly defined reference range, some 
plasmas were spiked with saline in order to assess other 
ranges of osmolality.
There was a very close agreement between the two methods 
using these samples, with results from the FPD method 
higher by just 1%. This initially suggested that the 
error found with stool samples was due to a matrix effect 
by one of the methods.
In order to determine which of the two methods was 
inaccurate, recovery experiments were performed. However, 
this demonstrated that the accuracy of both methods was 
very high: 101.4% (sd = 2.03%) for the VPL method,
compared with 99.6% (sd = 2.87%) for the FPD method.
Despite the relative bias between the two methods both 
were very reliable, giving excellent precision and 
accuracy when stool samples were used. One of the few 
ways of interpreting this seeming paradox is that the 
methods measure different osmotically active species. The 
reason for this became apparent when the variations in 
methodology were considered. The VPL method measures the 
depression of dew point temperature caused by particles in 
solution. However, the presence of volatile species in 
solution have little effect on this property. The reason 
for the difference between the two methods can therefore 
be explained by the presence of volatile substances in 
stool water, such as SCFAs, ammonium, and bicarbonate.
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stool water, such as SCFAs, ammonium, and bicarbonate. 
Since the VPL method only measures non-volatile substances 
these components are not detected.
MEASUREMENT OF OSMOTIC GAP
Before considering the potential value of osmotic gap 
measurements a decision had to be made on the most 
appropriate way for its calculation, ie. the use of a 
measured stool osmolality or a figure of 290mosmol/kg (see 
page 67). We decided to opt for the latter measurement 
for the reasons quoted below.
a) As mentioned above, VPL methods underestimate the true 
osmolality because they do not account for the presence of 
volatile species. However, Shiau argues (123) that these 
components are not the result of altered intestinal 
electrolyte transport and so are irrelevant when 
considering the cause of diarrhoea. However, without 
knowledge of the extent and variability that VPL methods 
'ignore' the various volatile components, this conclusion 
is very speculative.
A simple experiment was performed to investigate this 
assumption of Shiau, that the VPL method does not measure 
osmotically active species that are the result of 
bacterial metabolism. Six stool supernatants were 
aliquotted into pairs and then incubated for two days at 
either 24°C or 0°C. The osmolalities of samples were then 
measured by both methods. The osmolalities of the samples 
incubated at 24° should increase because of bacterial
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metabolism. If Shiau's theory is correct then there 
should be no increase in osmolality measured by the VPL 
method. However, the results in table 2.5 demonstrate 
that there were significant increases in stool osmolality
Increase in Osmolality 
(mosmol/kg/2days)
Sample VPL method FPD method
1 16 26
2 106 159
3 38 59
4 14 16
5 21 36
6 13 22
Table 2.5 - Increase in stool osmolalities, measured by 
VPL and FPD methods, after a two day incubation at 24°C.
by both methods. The increase in osmolality was less for 
the VPL method (by an an average of 34%) suggesting that 
some of the products of metabolism were volatile in 
nature.
This experiment did not demonstrate whether the VPL method 
measures only a proportion of volatile substances, or 
whether bacterial action also produces non-volatile 
substances. However, since the experiment demonstrated 
that the VPL method is inappropriate for the determination 
of stool osmolality, this point is largely academic.
b) Krejs and Fordtran concluded on the basis of 
unpublished observations (112) that osmolality increased 
rapidly when a stool collection was made, even if a sample 
was processed immediately. However, the present study 
found that osmolality in fact only increases slowly with
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time and insufficiently to account for the large stool 
osmolalities sometimes encountered. This would imply that 
the bacterial action that causes the production of more 
osmotically active species is occurring in the colonic 
lumen and that insufficient water is drawn into the lumen 
to normalise osmolality. This would make teleological 
sense since it would be inappropriate for the body to 
loose water solely for the purpose of maintaining iso- 
osmolality of the distal colonic contents and faeces which 
are of no physiological importance. It is also known that 
the rectosigmoid colon is capable of extracting small 
amounts of water from the faecal material. Therefore the 
longer that the faeces are stored here the higher the 
osmolality is likely to rise.
Shiau et al suggest that the distal colon in patients with 
diarrhoea has little opportunity for bacterial metabolism 
and that this explains the lower osmolality that they 
found in diarrhoeal stool water (109). However, since 
their VPL method of measuring osmolality does not 'see' 
all of the predominantly volatile products of bacterial 
metabolism, this conclusion is unfounded. In conflict 
with this assumption we found a high faecal fluid 
osmolality (418mosmol/kg) in one of our patients whose 
sample was processed immediately.
c) Two of the patients who were found to have a secretory 
cause of diarrhoea (see page 107) produced stools which 
gave negative OGs (-46 and -4) when a figure of 290 had 
been used for its estimation, but gave high figures of 64
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and 153 when the stool osmolality had been used in the 
calculation of the osmotic gap.
d) If it is assumed that the mechanism of diarrhoea 
remains the same in individual patients, then it would be 
expected that the OG would not vary significantly from one 
stool to the next. We therefore compared the variability, 
of the OG measured by each method in intra-individual 
stool collections from 34 patients. We found that the OG1 l 
measurements varied significantly more than OG2 values 
(p = 0.0004) (see Statistical Appendix, note 3).
The reason for the greater variability in OG1 measurments 
is presumably due to varying degrees of changes in 
osmolality caused by differing activities of bacterial 
metabolic processes.
e) In cases of osmotic diarrhoea, it would be expected 
that a relationship between the severity of diarroea and 
OG would exist (112). We therefore measured the 
correlation of the severity of diarrhoea (expressed as 
PWC) with the OG1 and OG2 values in our patients with pure 
osmotic diarrhoea (see Statistical Appendix, note 2) . The 
regression graphs (figures 2.10 and 2.11) illustrate 
clearly that the correlation of PWC with OG2 (r = 0.81) 
was considerably better than PWC with OG1 (r = 0.25) again 
suggesting the OG2 measurement to be superior.
f) For any test to have clinical applicability it must be 
practicable and potential sources of error must be 
controllable. During the course of this study we
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experienced practical difficulties in freezing samples 
immediately after their collection. Since patients cannot 
defaecate 'on demand', co-operation in collecting and 
freezing stool samples was required. Nursing staff and/or 
patients were informed of the importance of freezing 
samples immediately and a portable freezer was 
conveniently located for this purpose. With out-patients, 
the freezer was delivered to the patients home and 
responsibility for immediate freezing of the sample, 
rested with the patient. With in-patients, nursing staff 
were often responsible for freezing the sample. In spite 
of the instructions given, some stool samples had very 
high osmolalities (sometimes in excess of 500mosmol/kg) 
because of uninhibited bacterial activity. Thus it was 
evident that stools were not always frozen immediately.
In this regard the use of 0G1 to express the osmotic gap 
was concluded to be impracticable since samples were not 
always properly collected. Furthermore a procedure for 
assessing the quality of collection was difficult to 
implement.
* * * * * *
For these six reasons we based the following conclusions 
regarding the clinical value of osmotic gap measurements 
on the use of 0G2 calculations.
Since only sodium and potassium, which are stable in stool 
homogenates (102, 109), require to be measured to
calculate OG2, the opportunity arose of including OG2
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results on stool samples that had previously been 
collected. It is routine practice in the Gastroenterology 
Laboratory, to store frozen aliquots of stool homogenates. 
It was possible therefore to calculate OG2 on those 
homogenates which had been prepared without the addition 
of water. To ensure that sodium and potassium results 
were accurate, seven stools which had known electrolyte 
concentrations were also thawed and re-analysed. The 
repeat results of sodium and potassium concentrations were 
in very close agreement to the original values which had 
been measured up to two years previously.
VALUE OF MEASURING THE OSMOTIC GAP
Before assessing the clinical usefulness of measuring 0G2, 
reference ranges in secretory and osmotic diarrhoea were 
determined. These reference figures could only be 
determined using samples from patients with diarrhoeas 
known to be either secretory or osmotic in nature. 
Although the mechanisms of many diarrhoeal conditions are 
not fully established, certain pathologies are well 
recognised as causing secretory or osmotic diarrhoea (112) 
and so only patients with these conditions, which are 
listed in table 2.6, were recruited.
Over the course of the study five cases of pure secretory 
diarrhoea and nine cases of pure osmotic diarrhoea were 
recruited. Of the patients with secretory diarrhoea the 
diagnoses were tubular villous adenoma in two, abuse of 
phenolphthalein in two and carcinoid syndrome. All
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Secretory Diarrhoea Osmotic Diarrhoea
Hormonal Saline Laxative Induced
VIPoma Magnesium sulphate
Carcinoid Magnesium hydroxide
Medullary Carcinoma Carbohydrate malabsorption
of thyroid Lactose intolerance
Villous adenoma Lactulose ingestion
Drug-Induced
Phenololphthalein
Bisacodyl
Anthraquinones
Ricinoleic acid
Cytotec
Infectious
Choi era
E. coll
Idiopathic
Table 2.6 - Recognised causes of secretory and osmotic
diarrhoea.
osmotic diarrhoeas were artificially induced, seven with 
magnesium hydroxide, and one each with magnesium sulphate 
and lactulose.
Fifteen stools were collected from the five patients with 
secretory diarrhoea and nineteen from the ten patients 
with osmotic diarrhoea. The summary statistics are
documented in table 2.7.
Analyte Osmotic
Diarrhoea
Secretory
Diarrhoea
P
Osmolality 
Sodium 
Potassium 
Chloride 
OG 1 
OG 2
311 ± 38.7 
8.3 ± 15.1 
20.4 ± 16.3 
18.3 ± 4.9
253.8 ± 40.6
233.9 ± 48.8
342 ± 59.5 
104.1 ± 18.8 
48.8 ± 25.6 
36.7 ± 10.2 
6.8 ± 74.4 
-15.7 ± 35.1
ns
p < 0.0001
p = 0.0005
p = 0.0002 
p = 0.0001 
p < 0.0001
Table 2.7 - Comparison of analytes and osmotic gaps in 
osmotic and secretory diarrhoeas (mean ± sd).
There was no apparent statistically significant difference 
between the osmolalitites of the two groups, but the
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sodium, potassium and chloride concentrations were all 
significantly higher in patients with secretory diarrhoea. 
As expected there was a highly significant difference in 
the OGs of the two groups whether these were calculated 
using equation 1 or 2 (ie. OG1 or OG2)
When OG1 results were plotted there was an overlap between 
patients with secretory and osmotic diarrhoea because of 
high osmotic gaps in two patients with secretory diarrhoea 
(figure 2.12). On both occasions the stool water 
osmolality was high (447 and 460mosmol/kg). In contrast, 
when OG2 results were plotted there was a clear 
discrimination between patients with osmotic diarrhoea and 
those with secretory diarrhoea (figure 2.12).
Using these data, provisional cut-off points were 
selected, an 0G2 value of over lOOmosmol/Kg being 
consistent with osmotic diarhoea and an 0G2 result of 
less than 30mosmol/Kg suggestive of secretory diarrhoea.
The only other study in which 0G2 results have been 
measured suggests that osmotic diarrhoea is associated 
with 0G2 values of greater than 50mosmbl/Kg, while 0G2 
results of less than 20 are disregarded (112) . It is 
possible that with further experience our cut-off values 
of less than 30mosmol/Kg for secretory diarrhoea and 
greater than lOOmosmol/Kg for osmotic diarrhoea, may be 
raised or lowered respectively. The range for secretory 
diarrhoea is also consistent with 0G2 figures of -10 ± 5 
(sem) that were calculated using data from a study in
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Figure 2.12 - Comparison of OG results in 
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which secretory diarrhoea was induced in healthy subjects 
by VIP infusion (124).
Several of the OG2 results gave negative values. This 
seemingly anomalous finding is readily explained: simple
doubling of the sum of potassium and sodium concentrations 
results in an overestimate because of incomplete 
ionisation of electrolytes, and the presence of divalent 
anions.
Before OG2 measurements can be employed usefully in a 
clinical setting, it is important that it is known which 
conditions give rise to osmotic diarrhoea and which cause 
secretory diarrhoea. At the present time the cause of 
diarrhoea in many different illnesses is not definitely 
known and is limited to the list compiled in table 2.6. 
Perusal of this list will show that most of these 
conditions are relatively uncommon in this country. It is 
clearly advantageous to know in what category other more 
commonly encountered diarrhoea states can be classified. 
For this reason we measured the 0G2 in several groups of 
pathology; chronic pancreatitis, coeliac disease, small 
bowel Crohn's disease, infectious disease, post gastric 
surgery, bile acid induced diarrhoea, ulcerative colitis, 
Crohn's colitis, and alcohol induced diarrhoea. Figure 
2.13 shows the 0G2 results found in these groups.
The large range of 0G2 results in most of the disease 
categories is probably indicative of the heterogeneity of 
each group and the multifactorial nature of its cause.
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For example, the diarrhoea of Crohn's disease may be 
attributable to a variety of mechanisms, for example 
exudation, active disease, carbohydrate malabsorption, 
malabsorption of bile acids or fatty acids etc.
Figure 2.13 also demonstrates that within each pathology 
group, diarrhoea was associated with 0G2 values in the 
secretory ( < 30mosmol/kg) and osmotic ( > lOOmosmol/kg) 
range. Table 2.8 lists the various pathologies associated 
with secretory and osmotic OG2 results encountered during 
this research.
Secretory Diarrhoea Osmotic Diarrhoea
Phenolphthalein ingestion 
Irritable bowel syndrome 
Seminoma 
Systemic lupus 
Alcohol abuse 
Campylobacter enteritis 
Small bowel overgrowth 
Villous adenoma 
Carcinoid syndrome 
Chronic pancreatitis 
Coeliac disease 
Small bowel Crohn's disease 
Salmonella
Post vagotomy diarrhoea 
Ulcerative colitis 
Radiation enteritis 
Chronic pancreatitis 
Bile acid induced diarrhoea 
Crohn's colitis
Coeliac disease 
Irritable bowel syndrome 
Small bowel Crohn's disease 
Dumping syndrome 
Salmonella
Insulin dependent diabetes 
Crohn's colitis 
Bile acid induced diarrhoea 
Ulcerative colitis
Table 2.8 - Pathologies associated with either secretory 
or osmotic diarrhoea on the basis of 0G2 results.
With such a large list of possibilites, to which can also 
be added the diseases listed in table 2.6, the measurement 
of 0G2 is unlikely to provide; any j further diagnostic 
information in cases of chronic idiopathic diarrhoea.
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Figure 2.13 - OG2 results in various pathologies 
associated with diarrhoea
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The clinical value of measuring OG2 was also assessed 
retrospectively in twenty-six patients who presented with 
chronic diarrhoea of unknown cause. The results and the
subsequent diagnoses are listed in table 2.9.
Patient OG2 Diagnosis
1 24,16,22,10 Idiopathic, ?IBS
2 112 Malabsorption, unknown cause
3 201,144,121,52 Alcohol-induced
4 86,-2 Malabsorption, chronic 
pancreatitis
5 16,122,108,156 Crohn's disease
6 14 Malabsorption, unknown cause
7 50,28,-14,20, malabsorption, unknown cause
8 14,92,14 IBS
9 -10,-56,-64,-46, Carcinoid syndrome
10 O > 00 to o Phenolphthalein abuser
11 134 Idiopathic
12 122,102,140,170 Malabsorption coeliac disease
13 46 Alcohol induced
14 40
15 30
16 0 Malabsorption, unknown cause
17 52, 76 Malabsorption, coeliac
18 18,52 ? Post infectitious IBS, 
? Alcohol-induced
19 2 Small bowel overgrowth
20 108 ? Alcohol-induced
21 -30 Tubular villous adenoma
22 192 Malabsorption, unknown cause
23 26 IBS
24 22 Phenolphthalein abuser
25 -4 Tubular villous adenoma
Table 2.9 - 0G2 results in patients with diarrhoea.
In six patients (numbers 3, 4, 5, 7, 8, and 18) in whom
more than one stool had been analysed, the intra­
individual results varied such that no classification into 
secretory or osmotic diarrhoea could be made. In a 
further three (numbers 13, 14, 17) OG2 results fell
between 30 and 100 and so again no classification could be
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made. Eleven patients (numbers 1, 6# 9, 10, 15, 16, 19,
21, 23, 24 and 25) had results of 30 or less suggestive of 
secretory diarrhoea. Two of these patients had
malabsorption, two had possible irritable bowel syndrome 
and one had small bowel overgrowth secondary to systemic 
sclerosis. The OG2 results would have been of no value in 
the first two instances since both malabsorption and IBS 
can be associated with secretory or osmotic diarrhoea. 
Similarly the mechanism of diarrhoea in patients with 
small bowel overgrowth is dependent on the cause and is 
multifactorial in nature (125). Hence a knowledge of the 
OG2 would not have been informative in this patient.
The other five patients with secretory diarrhoea were the 
patients mentioned earlier with known secretory diarrhoea 
caused by laxative abuse, carcinoid syndrome, or villous 
adenoma. In these cases the OG2 could have played a minor 
role in the differential diagnosis of diarrhoea. However, 
in the case of the two laxative abusers, more specific and 
simpler alternative tests are available. The patient with 
carcinoid syndrome was also readily diagnosed following 
urinary estimation of 5-hydroxyindole acetic acid 
concentrations and so did not pose a particularly 
difficult diagnostic problem. Similarly the diagnosis of 
villous adenoma in two patients was not difficult, the 
condition being recognised after sigmoidoscopy and 
histology.
Of the five patients with osmotic diarrhoea on the basis 
of high OG2 results (numbers 2, 11, 12, 20, and 22), three
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had malabsorption (two of unknown cause and one secondary 
to coeliac disease), and one had probably alcohol-induced
diarrhoea. In one case a diagnosis was not made.
Several conclusions can be reached regarding the clinical 
value of 0G2 measurements. a) There is a large intra­
individual variability in the results in many patients 
with diarrhoea. Consequently, diarrhoea cannot be
classified as being secretory from a single result of less 
than 30. Similarly osmotic diarrhoea cannot be diagnosed 
on the basis of a single OG2 result greater than 100. 
Instead, a series of OG2 results from the same patient is
necessary. A possible exception to this is when a very
low value (e.g. less than -50mosmol/kg) is found.
b) Even when diarrhoea is classified as being osmotic or 
secretory using OG2 results, the search for the eventual 
diagnosis is not advanced significantly because of the 
long list of possible differential diagnoses (see table 
2.8).
c) The diagnosis of the cause of diarrhoea can often be 
made following simpler and more specific tests than OG2.
d) The only apparent clinical place for measuring a single 
OG2 result is in order to exclude a diagnosis. For 
example a result of greater than 30 would exclude 
secretory diarrhoea, while a result of less than 100 would 
exclude osmotic diarrhoea.
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CONTRIBUTION OF OTHER ELECTROLYTES TO THE OSMOTIC GAP
In order to determine what significance calcium, magnesium 
and ammonium had in contributing to the composition of 
cationic electrolytes, these components were also 
measured. Unfortunately it was not practicable to. measure 
ammonium because its concentration increases rapidly 
unless samples are processed immediately and the analysis 
done within a few days (see page 81).
The results of calcium and magnesium measurements are 
tabulated in 32 patients along with the contribution to 
the osmotic gap that these electrolytes would have made 
(table 2.10). Their contribution to the osmotic gap was 
calculated by doubling the sum of the magnesium and 
calcium concentrations. (This may in fact underestimate 
the OG if magesium is associated, as is likely, with two 
monovalent anions rather than one divalent anion.)
Although the average magnesium and calcium concentrations 
are relatively small there is a very large range. 
Consequently the contribution to the osmotic gap in some 
cases may exceed 100. It is probable that elevated
Magnesium
Concentration
Calcium
Concentration
Osmotic gap 
(2 x [Ca + Kg])
Mean
sd
Range
6.5 
15.6 
0.2 - 55
4 
6.1 
0.1 - 21
25 
35.3 
0.6 - 128
Table 2.10 - Concentrations of magnesium and calcium in 
stool water in diarrhoea, and their contribution to the
osmotic gap.
concentrations of calcium and magnesium in the stool water
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are factors of dietary intake and/or absorptive capacity. 
When the group was subdivided into patients with and 
without malabsorption the average contribution to the OG 
was 44 (range of 2.4 - 112) in the malabsorption group, 
and 32 (range of 2 - 128) in patients with normal
absorptive capacity. Hence the presence of high
concentrations of calcium and magnesium in stool water 
cannot be attributed solely to those patients with 
malabsorption. There was no significant difference 
between these results (see Statistical Appendix, note 1) 
implying that variations in diet are more important in 
deciding the amount of calcium and magnesium excreted. 
This conclusion is supported by results showing that the 
concentrations of these substances decrease when patients 
are fasted (118).
None of the 32 patients, abused magnesium laxatives and so 
there were no cases of diarrhoea induced solely by these. 
However, it is likely that high magnesium and/or calcium 
concentrations may be a contributary cause of diarrhoea in 
some patients. The measurement of 0G2 in these cases would 
correctly reveal a high osmotic gap. On the other hand, 
lower concentrations of magnesium and calcium (e.g. in the 
order of 30 - 60) would be unlikely to play a significant 
role in the cause of diarrhoea, yet large enough to 
produce an erroneously high 0G2 result.
These conclusions were reached without measuring ammonium 
and unfortunately there is no published data on ammonium
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concentrations in stool water obtained from diarrhoea 
specimens. Two ammonium results were available from this 
study; 23mmol/l in a patient with carcinoid syndrome and 
23mmol/l in a patient with moderate malabsorption of 
unknown aetiology. Therefore it is likely that ammonium 
concentrations, as with calcium and magesium 
concentrations, should be considered when calculating the 
osmotic gap.
MEASUREMENT OF K/NA RATIOS
A total of ten patients with diarrhoea due to a colonic 
pathology were identified; two with Campylobacter
enteritis, four with ulcerative colitis, three with
Crohn's disease confined to the colon, and one each with 
Shigella sonnei infection and tubular villous adenoma. 
Recruiting patients with a purely ileal cause of diarrhoea 
was more difficult. Although there were several patients 
with small bowel lesions and a healthy colon (patients 
with Crohn's disease affecting only the ileum, or patients 
with coeliac disease), their diarrhoea was probably 
related, at least in part, to the effects of malabsorbed
fatty acids and bile acids on the colon. As a group of
patients with ileal diarrhoea we used five patients with 
salmonella. The diarrhoea in these patients is due to the 
effect of the toxin on the small bowel (112) . As an 
additional comparative group, sixty-seven stool 
supernatants from thirty patients with diarrhoea due to a 
mixed ileal/colonic dysfunction were used. The patients 
in this group consisted of six with malabsorption,
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fourteen with Crohn's disease affecting colon and ileum, 
and one each with carcinoid syndrome, dumping syndrome and 
alcohol induced diarrhoea. A fourth group consisted of 
forty stool supernatants from ten patients with bile acid 
induced diarrhoea. This last group should also have 
colonic diarrhoea.
The summary statistics of each group are shown in table
2.11.
Cause of diarrhoea median sem inter quartile 
range
Mixed ileal/colonic 0.75 0.15 0.57 - 1.33
Colonic 0.66 0.15 0.4 - 1.05
Ileal 0.31 0.34 0.24 - 1.11
BAID 0.8 0.25 0.52 - 1.3
Table 2.11 - Summary statistics of K/Na ratios in various
diarrhoea groups.
Figure 2.14 shows the distribution of the K/Na ratios in 
each group. No statistical significance was found between 
the groups.
The intra-individual variability of K/Na ratios in stool 
water collected consecutively from the same patient, was 
also studied. For the K/Na to be of potential value, the 
results should not vary significantly. Seven stool 
samples were collected from a patient with Crohn's colitis 
and the K/Na ratios were found to vary from 0.36 to 2.43. 
A similar wide spread of K/Na ratios was also found in 
stool supernatants prepared from consecutively collected 
stools from patients with a mixed ileal/colonic cause of 
diarrhoea or with BAID (eg. 0.32 - 5.76, 0.44 - 8. 1).
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This offers clear evidence that the calculation of K/Na
ratios provides no information regarding the site of
diarrhoea between small and large bowel. Other workers 
have suggested, however, that it may be of value in
classifying patients with inflammatory bowel disease 
affecting the colon. In patients with ulcerative
proctitis the ratio is significantly higher (3.6) compared 
with patients with chronic ulcerative colitis (0.55) or
Crohns' colitis (0.9) (99).
The main concept of using K/Na ratios an a clinical aid, 
was based on the notion that the main colonic mechanism 
governing the luminal concentrations of these electrolytes 
is a simple exchange of the two. Evidence has accumulated 
in the 1980s that another major factor controlling 
potassium fluxes in the colon is the body’s potassium 
stores. In the rat, at least, colonic perfusion studies 
have shown that a high dietary potassium intake stimulates 
the secretion of this ion in the colon (126). Conversely; 
when animals are fed a potassium-deficient diet, active 
potassium absorption in the colon helps to maintain 
homeostasis (127). Consequently the concentration of 
potassium in stool water is, in part, decided by dietary 
intake. Therefore, a patient with a colonic cause of 
diarrhoea, would be expected to have a high K/Na ratio if 
his body stores of potassium were replete.
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INTRODUCTION
'Bleed him and purge him; if he dies bury him'
(Spanish proverb)
HISTORICAL ASPECTS OF LAXATIVE USE
The use of purgatives in medicine has been documented since 
ancient times. Several herbal laxatives are listed in 
Eber's Papyrus - a pharmacopoeia dating from ancient 
Egyptian times (ca 1570 BC) . The use of purgation as a 
therapeutic mode for a wide variety of medical conditions 
has been attributed to Melampus who was a Greek shepherd- 
cum-healer. He successfully treated the daughters of 
Proteus, the King of Argos, for hysterical monomania using 
hellebore, a herb which he observed caused diarrhoea in his 
goats. Along with bloodletting, purgation has been a 
mainstay in medical therapy since these times and until 
surprisingly recently. The philosophy behind the use of 
purging has been encapsulated by Moses ben Maimen a twelfth 
century physician....
'man should always strive to have his intestines 
relaxed all the days of his life and that bowel 
function should approximate diarrhoea. This is a 
fundamental in medicine namely whenever the stool 
is withheld or extruded with difficulty grave 
illnesses result'.
The belief that regular bowel movements were essential to 
remove dangerous 'humors' from the intestine has persisted
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until this century. As recently as 1918 Dr. Arbuthnot Lane 
advocated taxation for a wide range of conditions: high and 
low blood pressure, asthma, neuritis, depression, 
rheumatism, goitre, tuberculosis and cancer; even flat feet 
and loss of feminine contours (129). The following 
extracts from a prestigious medical textbook written in 
the 1920's also suggest that the use of laxatives was 
widespread at that time...
’Diarrhoea very frequently results from the habit 
of taking aperients, either in excess of what is 
required for the correction of chronic 
constipation, or even when the bowels left to 
themselves would act quite normally. Thus many of 
the symptoms often ascribed to constipation are 
really due to the diarrhoea caused by purgatives, 
as it results in the absorption of excess of 
poisons from the too fluid faeces. f
’The most common cause of chronic catarrhal 
colitis~ is the habitual use of purgatives which 
are frequently taken even in the absence of 
constipation.' (130)
(* Obsolete terminology for irritable bowel syndrome.)
Medical thinking regarding the use of laxatives has changed 
through this century and now their prescribed use is 
reserved for the cautious treatment of severe constipation 
or as a bowel washout prior to intestinal surgery, barium 
radiology or colonoscopy (131).
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Nevertheless laxatives are easily purchased over the 
counter and consequently are freely available for ingestion 
by those so inclined. Certainly they constitute a 
considerable source of income for the pharmaceutical 
industry. In 1975 $130 million were spent on laxatives 
bought over the counter in USA (132). Similarly the 
proprietary sales of laxatives in Great Britain in 1988 
were £15 million (133). More insight into the usage of 
laxatives by the general public has been drawn from 
questionnaire studies. For example the use of laxatives in 
a GP population was found to be 6.4% of patients in their 
twenties and increased to 39% of patients in their fifties 
(134). In a Swiss study 18% (15% women and 3% men) of 
ambulatory patients admitted to regular laxative use (135). 
In this country 22% of healthy people interviewed took 
regular laxatives other than bran and 6% took laxatives at 
least twice per week (136). The motives for this habit are 
probably related to the individuals' concept of bowel 
normality, but aperients are also used as slimming aids. A 
questionnaire given to 1728 fifteen year old Americans, 
revealed that a considerable number took laxatives to 
control their weight: 1.1% of females and 0.2% of males
took laxatives several times per week and 6.1% of females 
and 4.1% of males used laxatives at least monthly (137).
There is further evidence suggesting that laxatives are 
widely used. In 1937 of 1000 patients who presented to’ a 
medical clinic with gastrointestinal symptoms
phenolphthalein was found in the faeces of 177 (138); in a
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study published in 1958 the authors managed to amass a
series of 887 patients with melanosis coli, a 
discolouration of the rectum caused by regular intake of 
anthraquinone laxatives (139).
ABUSE OF LAXATIVES
Although chronic laxative use is undoubtedly common, this 
practice does not usually cause significant pathology. 
However, since the 1930s an increasing number of reports 
have appeared which represent an extreme in the use of 
laxatives and can be considered as laxative abuse. 
Laxative abuse is now a well recognised clinical term which 
can be simply defined as a disease process which has been 
induced by the ingestion of laxatives.
There is no justifiable clinical reason for prescribing
large, frequent doses of laxatives and so it is likely that
the abused laxatives are purchased by the patient over the
counter. As table 3.1 shows there is a sizeable choice.
Laxative abuse is subdivisable into four distinct 
categories which are based partly on the motives for 
ingestion. 1) Control of bowel habit; 2) In emotionally 
or psychiatrically disturbed patients who may be seeking 
attention or sympathy by inducing illness; 3) Weight 
control by anorexia nervosa and bulimia nervosa patients; 
4) Child abuse.
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LAXATIVE PROPRIETARY DRUG
PHENOLPHTHALEIN Boldomint, Carters Little Pills, 
Ex-lax, Fam-Lax, Feen-a-Mint,
Juno Juniper Tablets, Kest, Nylax 
Reguletts, Sure-Lax.
BISACODYL Nylax.
SENNOSIDE California Syrup of Figs, 
Eucarbon, Nylax, Sennokot, 
Boots Senna Tablets.
ALOIN Beecham's Pills, Carter's Little 
Pills, Nylax.
CASCARA California Syrup of Figs, Nylax,
FRANGULA Normacol,
MAGNESIUM SALTS Andrews Liver Salts, Kest, 
Kruschen Salts, Milk of 
Magnesia, Mil-par, Epsom Salts
SULPHATE SALTS Juno Juniper Tablets, Kruschen 
Salts, Epsom Salts, Glaubers 
Salts
Table 3.1 - Laxatives Available Over the Counter
1. Laxative Abuse as a Means of Controlling Bowel Habit
The overzealous use of laxatives for the purpose of 
treating constipation, or perhaps more correctly inducing 
regular loose motions, can result in pathology. The 
patient typically presents with symptoms of muscular 
weakness and malaise and investigations demonstrate 
hypokalaemia and sometimes hypocalcaemia (140, 141, 142,
143, 144, 145). Paradoxically they sometimes present with 
severe constipation caused by a colon which has become 
spastic from long-term laxative ingestion. These patients 
seem to have an unusual concept of what constitutes normal 
bowel frequency. Consequently they do not necessarily
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complain of diarrhoea despite the fact that typically they 
pass several loose motions per day. Clearly the treatment 
is to stop taking laxatives and the outcome then is usually 
successful.
It is probable that in Westernised societies the incidence 
of this form of laxative abuse is decreasing as traditional 
cultures and medical knowledge change. It is difficult to 
imagine that the advertisement in figure 3.1 could have an 
impact today. The situation in other cultures may be 
different, however. In India, for example, there is still 
a degree of paranoia about bowel frequency and laxatives 
and enemas remain in vogue (146).
2. Laxative Abuse as a Means of Inducing Illness
This group of laxative abusers usually present with 
diarrhoea and/or abdominal pain and less often muscular 
weakness and weight loss. Most investigations are normal 
although hypokalaemia or low-normal potassium may be 
present. There may be some degree of steatorrhoea or 
protein-losing enteropathy, and osteomalacia has also been 
reported (147, 148). The condition is sometimes
erroneously diagnosed as irritable bowel syndrome and there 
are some similarities in that the patient has diarrhoea, is 
typically not unwell, and is often of a nervous or anxious 
disposition. However, some patients have been extensively 
investigated, having multiple invasive tests and even 
laparotomy (149, 150, 151, 152). If the patient is asked
about the use of laxatives there is usually a prompt
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Figure
Lazing around— or off with a bound?
Mother—when your child seems 
irritable—even finds play too much 
trouble, constipation may be the 
cause. If so, it’s time for Ex-Lax Chocolate. 
Ex-Lax is the nice-tasting laxative that 
gives thorough relief the gentle way. I t’s 
the safe, easy way to help children over 
constipation troubles.
Adults to o ! Yes, Ex-Lax will give you 
thorough relief and the comfort of natural 
regularity. Buy Ex-Lax at your chemist. 
Only 11 |d . or economy size, 2/3d. for three 
times as much.
REMEMBER EX- LAX
and forget Constipation!
j 5 j ' ' ' > ... t •*
2.1 - Advertisement from May edition of Women's 
Weekly, 1952.
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denial. As a result the diagnosis is difficult to make and 
requires either a search of the patients' belongings or 
chemical identification of the drug in urine or stool.
This type of laxative abuse is more common in women and is 
a form of Munchausen syndrome where the patient is hoping 
for a gain - perhaps of attention or sympathy - by inducing 
illness. The patients are frequently anxious or nervous 
individuals and the case notes often include a passing 
reference to an unusual psyche or bizarre personality. 
Confronting a patient with a positive finding invariably 
elicits a strong denial. On persisting, some patients do 
reluctantly admit to the fact, enabling some form of 
psychiatric treatment to be initiated. Nevertheless, many 
continue to deny purgative abuse. In either case the 
response to treatment is poor and even if the purgative 
habit is stopped the patients' psychiatric condition may 
present itself in another form.
The extent of this form of laxative abuse is not known 
although Fordtran found it to be the main diagnosis in 
patients referred to his unit with extensively investigated 
chronic idiopathic diarrhoea (111). Another study concluded 
that the incidence of this type of laxative abuse may be 
more common than is generally believed (148).
3. Laxative Abuse for Weight Control
Purgatives are sometimes used, along with diuretics, as 
slimming aids, and advertisements for laxatives sometimes 
appear in slimming magazines. Their use has been reported
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in patients with anorexia nervosa and bulimia nervosa 
(153) . Again the laxative abuse may be surreptitious (154) 
although it is common for these patients to be quite open 
about the habit (155).
4. Child Abuse by the Administration of Laxatives
Perhaps the saddest form of laxative abuse is Munchausen 
syndrome by proxy when parents, seemingly quite devoted, 
administer laxatives to their children (156).
In the last three categories laxatives are taken, or given, 
surreptitiously. If it was not for the fact that 
phenolphthalein, one of the more popular laxatives, turns a 
bright violet colour in an alkaline medium, these syndromes 
might well be unrecognised. The discovery of laxative 
abuse in patients presenting with diarrhoea and in children 
was initially quite fortuitous. French et al
'accidentally' diagnosed the syndrome in two patients when 
their stool samples were alkalinised during the van de 
Kamer procedure for faecal fat estimation (157). Similarly 
the reported cases of laxative abuse in children were 
recognised only because of the pink-staining of nappies or 
bed-clothes (156, 158).
DIAGNOSIS OF LAXATIVE ABUSE
This study is concerned mainly with the surreptitious 
laxative abuse associated with induction of illness and 
control of weight. Since the patients' ingestion of the
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laxatives is usually secret, simple questioning of the 
patient may not be informative. Instead a more devious 
approach is required such as searching the patients' 
belongings or by a chemical test. The former method has 
ethical and indeed legal implications (159,160) and the 
search has to be done while the patient is in hospital. In 
addition, a negative search does not necessarily exclude 
laxative abuse. A Dutch group has established an
effective, albeit rather complex, thin layer chromatography 
method for the detection of most over-the-counter laxatives
(161) and this method has been recently simplified (162) . 
By thin layer chromatographic methods, the so-called 
colonic stimulant laxatives such as phenolphthalein,
bisacodyl, sennosides, cascara and aloin are detectable,
but saline laxatives like magnesium sulphate and sodium 
sulphate are not. Of the two hundred or so case reports 
published on laxative abuse only five describe saline
laxative abuse (110, 115, 118, 163, 164) and in three of
these, colonic stimulant laxatives were also taken. The 
reason for the relative paucity of such reports may be that 
saline laxatives are not as frequently abused. (They are 
certainly less palatable than irritant laxatives.) An 
alternative possibility is that the diagnosis of saline 
laxative abuse is easy to miss. Saline laxatives are 
indistinguishable from endogenous constituents and so 
interpretation of a measurement can only be made by 
comparison with reference ranges from normal subjects and 
laxative abusers. At present such reference ranges have 
not been established although cut-off points for magnesium
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in urine and stool water have been suggested (149, 165) .
PHARMACOLOGY OF LAXATIVES
It is useful to have some knowledge of how laxatives work 
in order to diagnose their surreptitious use.
1. Anthraquinones
The anthraquinone group of laxatives include the main 
vegetable purgatives such as cascara, senna, aloes, and 
frangula. The anthraquinones occur naturally either as the 
free molecules, as dianthrones, or more commonly as 
glycosides. Glucose is the predominant sugar residue 
forming either O-glycosides at positions 8 and/or 10 or 3 
C-glycosides at position 10 (166). The anthraquinone
glycosides are not digested by the alpha-glycosidases in 
the small intestine and so they pass through the small 
bowel virtually unchanged. Any free anthraquinones are 
absorbed and then excreted into the urine or bile as 
glucuronides. Once in the colon, the glycosides cannot 
induce taxation directly but must initially be hydrolysed 
to the free form (see figure 3.2) by bacterial enzymes. 
Thus in neomycin-treated animals little laxative effect is 
seen. The purgative action is thought to be caused by a 
local effect on the intramural nerves resulting in 
peristalsis (167). It has also been demonstrated that free 
anthraquinones cause sodium and water secretion (168, 169). 
Only the free anthraquinone can be absorbed and this is 
metabolised and excreted by the kidney as a glucuronide 
conjugate, (see figure 3.3, page 134)
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OH
R1 R2
-COOH RHEIN -H
-CH^OH ALOE-EMODIN -H
-CH3 FRANGULA-EMODIN -OH
-ch3 CHRYSOPHANOL -H
-ch3 PHYSCION -och3
-H DANTHRON -H
Figure 3.2. - The Chemical Structure of Anthraqinone
Laxatives.
2. Diphenylraethanes
Phenolphthalein, bisacodyl and oxyphenisatin are the main 
laxatives in this group although the last has been 
withdrawn from the market because of liver toxicity. They 
are structurally similar (see figure 3.4) and probably 
effect taxation by the same mechanism. They are absorbed
OH
OH
Phenolphthalein
Bisacodyl
Figure 3.4 - The Chemical Structure of Diphenylmethane
Laxatives.
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Anthraquinone 
Glycoside, Free 
Anthraquinone
Hepatic
Metabolism
Absorption Free ^ 
-Anthraquinone
Rhein and 
Anthraquinone 
Glucuronide
Anthraquinone
Glycosides
UrineBacterial
Metabolism
Free 
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I
I
Free Anthraquinones 
Rhein
*
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Figure 3.3 - Metabolism of Anthraquinones
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from the intestine and excreted in the bile as glucuronide 
conjugates. They seem to have little effect systemically 
since obstruction of the bile duct prevents their action. 
There is a direct action on the colonic smooth muscle 
causing peristalsis and in addition there is secretion of 
sodium and water, mediated by inhibition of Na/K-ATPase, 
and the stimulation of prostaglandin E2 and cyclic AMP 
production (168).
3. Saline Laxatives
This group of laxatives which are also called osmotic 
laxatives, are thought to draw fluid into the lumen of the 
intestine by an osmotic effect. Certainly magnesium, 
sulphate and phosphate, of which the saline laxatives are 
comprised, are poorly absorbed and so increase the 
osmolality in the gut lumen. An alternative theory, 
however, has been proposed by Harvey and Read, who 
suggested that magnesium sulphate stimulates the release of 
cholecystokinin which in turn causes increased peristalsis 
and intestinal hurry (171).
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OBJECTIVES
1. DEVELOPMENT OF A SUITABLE SCREENING METHOD FOR
LAXATIVES.
At present the screening methods for laxative abuse are 
qualitative only. It was intended to develop a high 
performance liquid chromatography method so that laxatives 
could be quantitated. This would enable future study of 
the pharmacokinetics of the colonic irritant drugs as well 
as providing a laxative screening technique.
2. DETERMINATION OF THE SPECIFICITY OF THE LAXATIVE
SCREEN.
Since anthraquinone laxatives are derived from plants, a 
false positive laxative screen might occur if a patient 
consumes a vegetable containing such compounds. The 
patients' denial of laxative ingestion would be quite 
appropriate in such a circumstance. Nevertheless a denial 
would be in keeping with laxative abuse and would probably 
be taken as such. Clearly it is essential that the 
specificity or false positive rate of the test is known. 
In order to determine this, possible dietary sources of 
anthraquinones in foods associated with diarrhoea (such as 
rhubarb, liquorice, chillies, prunes, and figs) were 
investigated. Urine samples taken after consumption of 
these foodstuffs were screened for the presence of 
laxatives.
The possibility of false positive results caused by drug 
interference has already been considered and of 73
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commonly prescribed drugs none were found to interfere 
with the TLC method (161) . It is possible that other 
drugs not tested in this study may interfere. Rather than 
attempt to exclude all drugs exhaustively by performing 
TLC on each, drugs known to be structurally similar to 
laxatives were tested. Thus, drugs such as chrysarobin, 
dithranol, podophyllum, daunorubicin and doxorubicin which 
have anthraquinone moieties, were analysed.
3. -TO ESTABLISH METHODS FOR MEASURING FAECAL MAGNESIUM AND
SULPHATE CONCENTRATIONS.
Magnesium and sulphate are present in most over-the- 
counter saline laxatives. These substances can be 
measured readily in plasma and urine but their measurement 
in faeces, especially sulphate, poses particular 
difficulties. Methods were developed for their
measurement in stool using atomic absorption 
spectrophotometry for magnesium, and high performance 
liquid chromatography for sulphate.
4. TO DETERMINE REFERENCE RANGES IN THE APPROPRIATE 
SPECIMEN FOR THE DIAGNOSIS OF SALINE LAXATIVE ABUSE.
Magnesium and sulphate are normal body components and so 
reference ranges must initially be established before 
saline laxative abuse can be diagnosed. In addition it is 
not known what sample, stool or urine, is most appropriate 
to use. These aspects were investigated in a group of 
volunteers in whom diarrhoea was induced by ingestion of 
saline laxatives.
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5. TO DETERMINE THE EXTENT OF LAXATIVE ABUSE.
The diagnosis of laxative induced diarrhoea can only be 
made reliably by a chemical test which is not routinely 
available at most hospitals. As a result it is possible 
that the diagnosis of laxative abuse may be missed. Some 
idea of this eventuality can be made by calculating the 
prevalence of laxative abuse. However, it would be 
logistically difficult to measure the incidence in a 
random population unless it were fairly common. For this 
reason the incidence in a selected population, patients 
presenting to a Gastroenterology Clinic with diarrhoea, 
was studied.
Another way of gaining information on the possible 
underdiagnosis of laxative abuse is to investigate the 
requesting pattern for laxative screening tests in the 
areas where this test is available. For this purpose 
requesting patterns in Scotland were studied.
6. ACCUMULATION OF A SERIES OF LAXATIVE ABUSERS FOR 
CLINICAL AND THERAPEUTIC INVESTIGATION.
After establishing a laxative screening method a service 
was offered to Biochemistry and Gastroenterology 
departments throughout the West of Scotland. It was hoped 
that sufficient cases would be diagnosed to build up a 
series of patients on whom more information about the 
natural history of the condition could be gleaned. In 
addition a unified approach to the psychiatric management 
could be adopted in order to determine the effectiveness 
of this form of therapy.
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7. TO STUDY THE MECHANISM OF DIARRHOEA CAUSED BY SALINE
LAXATIVES.
Two postulates on the mechanism of saline laxative action 
have been proposed: secretion of water into the gut by an 
osmotic effect or release of cholecystokinin with 
consequent peristalsis. This was studied by measuring the 
osmotic gap in stool, and plasma cholecystokinin 
concentration in samples obtained from volunteers in whom 
diarrhoea was induced by ingestion of saline laxatives.
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MATERIALS AND METHODS
PREPARATION OF ANTHRAQUINONES
Anthraquinones were initially prepared as standards by 
oxidative hydrolysis of their glycosidic form using ferric 
chloride in concentrated hydrochloric acid (172). It was 
later found that the recovery of anthraquinones could be 
considerably improved by oxidising with 4% periodic acid. 
The final method was as follows. lOOmg of anthraquinone 
glycoside and 25ml of water was added to a stoppered test 
tube and boiled for 15 minutes. The supernatant was 
transferred to a second tube and 5ml of 4% periodic acid 
was added and the mixture boiled for 5 minutes. A volume 
of 1ml of concentrated hydrochloric acid was added and the 
anthraquinones extracted into 3 x 20ml of ether. 
Glycosides used were sennoside A, sennoside B, rhein 
glycoside (gifted by Reckitt and Colman, Dansom Lane, 
Hull), aloin (gifted by Parke Davis and Co, Pontypool, 
Gwent) and frangula (gifted by Norgine Ltd, Headington, 
Oxford).
The following commercially available substances were also 
used: emodin, chrysophanic acid, rhein (Aldrich Chemical
Co, Gillingham, Dorset), bisacodyl (gifted by Dr Karl 
Thomae GMBH), sodium picosulphate (gifted by WB 
Pharmaceuticals, Bracknell, Berkshire), oxyphenisatin 
(gifted by Sterling Winthrop Group Ltd, Aldwych, London), 
phenolphthalein (British Drug Houses, Poole) and danthron 
(gifted by Riker Laboratories, Loughborough,
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Leicestershire).
To determine the specificity of the laxative method, 
dietary constituents which are sometimes associated with 
diarrhoea (rhubarb, prunes, figs, liquorice, and chilli) 
were analysed. Lyophilised aliquots of lOOmg were 
oxidatively hydrolysed by the above method prior to TLC 
analysis.
Two groups of drugs were also studied: those with a
structural similarity to anthraquinone laxatives 
(chrysarobin, dithranol, podophyllum, adriamycin, 
plicamycin, dactinomycin, and methotrexate) and the drugs 
taken by patients who gave a positive laxative screen. 
Minimum patient doses were extracted into 
chloroform/isopropanol (9:1) and separated by thin layer 
chromatography (TLC).
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
High performance liquid chromatography (HPLC) of laxatives 
was performed using an isocratic system consisting of an 
Altex 110A pump, Altex Sample Injector, Hitachi 100-10 
ultra-violet/visible spectrophotometer, Altex 155-00 
analytical flow cell (path length 1cm, cell volume 20jil), 
24 x 0.5cm metal column packed with 5|im microparticulate 
octadecasilane (ODS, Shandon Southern Products, Astmoor, 
Runcorn), and a 5 x 0.5cm guard cell with similar packing. 
Chemicals used were HPLC grade methanol and HPLC grade 
acetonitrile (Rathburn Chemicals Ltd, Walkerburn, 
Peeblesshire) and cetyl trimethyl ammonium bromide (CTMAB
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Aldrich Chemical Co, Gillingham, Dorset). Mobile phases 
were degassed prior to use by vacuum and filtered through 
membrane filters (GVWP filters from Millipore).
The conditions of the HPLC method developed are shown in 
table 3.2.
Mobile Phase 25% methanol, 25% Acetonitrile 0.0075% 
CTMAB and 50% 0.2M acetate buffer pH 5.8
Flow Rate 0.5ml/min
Detection UV absorbance at 254nm
Column 5 \im ODS
Volume, 20^1
Table 3.2 - HPLC Conditions for Separation of Colonic
Stimulant Laxatives.
EXTRACTION OF LAXATIVES
Purification of laxatives is an essential preliminary step 
prior to their analysis in urine and faeces by HPLC. 
Commercially available columns were used in the 
development of a solid phase extraction system. Type W 
columns (Du Pont,) and XOD columns (Analytichem,) were 
tested. The basic method was as follows. Columns were 
activated by flushing with 1ml of methanol followed by 1ml 
of water. To 10ml of urine was added 1ml of acetate 
buffer (0.2mol/l, pH 4.5) and 50|il of glucuronidase (Sigma 
Chemical Co) and this was heated for 2 hours at 60°C. A 
volume of 4ml of solution was placed on the top of the 
column which was spun at 1800rpm for ten minutes and then
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washed with 2ml of water. Laxatives were eluted from the 
column with either chloroform:isopropanol (9:1) or 
methanol.
Urine and stools from subjects who had ingested laxatives, 
or from positive patient material were used. On some 
occasions normal samples were spiked with laxative to 
produce a final concentration of 250mg/l to 500mg/l. In 
these cases similar concentrations in mobile phase were 
also prepared so that recoveries could be calculated. 
When chloroform/isopropanol (9/1) was used to elute 
columns the recoveries from type W columns were 90% for 
phenolphthalein, 15% for rhein and 30% for picosulphate. 
Using XOD columns the recoveries were 80%, 0% and 30%
respectively. The recovery of bisacodyl could not be 
accurately measured since a negative urine gave a peak 
corresponding to the Rf of bisacodyl. When methanol was 
used as the eluting solvent the recoveries were 80%, 50%, 
and 0% from type W columns for phenolphthalein, rhein and 
picosulphate respectively and 70%, 80%, and 0% from XOD
columns.
Using an aqueous standard it was found that most 
picosulphate passed through the column without being 
retained by the solid phase. By making the standard 
solution 0.5g/l with CTMAB, almost all was retained on the 
columns and could be eluted with methanol. Unfortunately 
when the sample was injected on to the HPLC column the Rf 
values were prolonged because of the additional injected 
CTMAB. When a standard picosulphate solution was prepared
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using lower CTMAB concentrations (100 and 250mg/l) only a 
small amount was retained on the column.
THIN LAYER CHROMATOGRAPHY
Laxatives were detected in urine by an adapted TLC method
(162). Briefly, to 20ml of urine was added 2ml of acetate 
buffer (pH 5.0) and 50\l1 of p-glucuronidase. After 
overnight incubation at room temperature or two hour 
incubation at 60°C, the laxatives were extracted into 20ml 
of chloroform:isopropanol (9:1). The lower solvent layer 
was dried and then redissolved in 100|il chloroform before 
applying a suitable volume (5 - 50^1) to the TLC plate 
(LHP-KF plates, Whatman Laboratory Sales). The laxatives 
were initially separated using the published solvent 
system of chloroform:acetone (4:1). However, it was found 
that pure rhein remained at the origin rather than having 
a mobility of 0.5 as reported. In addition a patient 
sample which was positive for rhein (patient CL who took 
Sennokot) gave a mobility of 0.04. To avoid potential 
confusion, an alternative solvent system was used: 4-
methyl-2-pentanone:chloroform:acetic acid (5:2:1). To 
visualise the laxatives the plate was sprayed with 5M 
sodium hydroxide and then heated at 100°C for 10 minutes. 
TLC was also employed as a confirmatory method by using a 
solvent system of hexane:toluene:glacial acetic acid 
(3:1:1).
MEASUREMENT OF FAECAL MAGNESIUM 
Magnesium in faecal homogenate or faecal lyophylate was
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easily measured by atomic absorption spectrophotometry
following digestion and dilution of the samples. The 
magnesium concentrations were measured using the 
conventional 265nm magnesium peak as well as the less 
sensitive 202nm peak. The reason for using the latter
wavelength was to obviate the necessity of the second 
dilution step.
The precision of duplicate assays was measured using each 
of the two wavelengths and were acceptable for a faecal 
assay, as shown in table 3.3. In addition the correlation 
of the two methods was good (rs = 0.979, Y202 = 1.02X265 + 
0.23). (See Statistical Appendix, note 4.)
Although there was little to choose between the two 
methods the 265nm wavelength method was marginally 
preferred because the baseline was steadier and the 
precision slightly better. The magnesium results which 
follow are based on the method using a wavelength of
265nm.
Magnesium 
at 265nm
Magnesium 
at 202nm
Number of Pairs 31 29
Mean (mmol/Kg) 22.9 31.1
Standard Deviation 1.8 2.9
Coefficient of Variation 7.9% 9.4%
Table 3.3 - Precision of two Magnesium Methods
* * * * * *
In brief, the following methods were developed for 
measurement of magnesium in the various stool samples.
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Magnesium in Homogenate: About 500mg of faecal homogenate
or 50mg of lyophilised stool (weighed accurately) was 
added to a 50ml graduated stoppered test tube. To this 
was added 5ml of concentrated nitric acid and 1ml of
concentrated sulphuric acid. The tube was capped lightly, 
slowly heated to 150°C/ and refluxed for one hour. The 
cap was removed and nitric acid evaporated off. After 
cooling, 0.5% lanthanum chloride was added to the 50ml 
mark. A seventy-fold dilution was then made with 0.5% 
lanthanum chloride and the magnesium was measured at 265nm 
by atomic absorption spectrophotometry. Alternatively to 
avoid the need for the dilution step the sensitivity of
the method could be diminished by using the minor 
magnesium peak at 202nm. Each sample was measured in
duplicate.
Magnesium in Faecal Supernatant: Concentrated
hydrochloric acid was added to freshly prepared stool, 
supernatant (50|il to 1000[il) to ensure that magnesium did 
not precipitate out of solution. The supernatant was
initially diluted 1:20 (or 1:100 if a high result was 
expected) and then 1:70 with 0.5% lanthanum chloride,
before aspirating into the atomic absorption
spectrophotometer.
EFFECT OF STANDING ON MAGNESIUM CONCENTRATION
It is well recognised that pH falls in stool samples left 
at room temperature. Since magnesium is more soluble in 
acid conditions it seemed likely that the magnesium
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concentration in stool supernatant might increase in 
samples left at room temperature. To test this
supposition five stool samples were aliquotted and left at 
room temperature for 24 hours before being centrifuged. 
The results illustrated in table 3.4 show that the
magnesium concentration in supernatant increased 
significantly in samples that were not processed
timeously.
Magnesium Concentration Percentage
Increase0 Hours 24 Hours
Stool 1 101 147 46%
Stool 2 134 147 10%
Stool 3 140 173 24%
Stool 4 20 22 10%
Stool 5 20 27 35%
Table 3.4 - Effect of Incubation at 25°C on Concentration 
of Magnesium in Supernatant.
MEASUREMENT OF FAECAL SULPHATE.
Some time was spent in developing an assay for measuring 
sulphate in faecal water in order to cater for the 
diagnostic possibility of sodium sulphate laxative abuse. 
Two spectrophotometric methods and an HPLC method (173) 
were tested for the measurement of faecal sulphate. 
Sulphate was measured using the reversed-phase ion-pair 
HPLC system described previously (see page 75). The 
conditions employed in this HPLC system are outlined in 
table 3.5.
A published spectrophotometric method for sulphate (174) 
subsequently modified by Wrong et al (101) for measurement 
of faecal sulphate was established. When the recovery of
1 4 7
Chapter 3 - diagnosis of Laxative Induced Diarrhoea
Mobile Phase 0.065% TBAH adjusted to pH 8.0 with KHP
Flow Rate 1.5ml/min
Detection UV absorbance at 280nm
Column 5 |im ODS
Volume 20|il
Table 3.5 - Conditions for HPLC of Sulphate.
sulphate in faecal water was measured, highly variable 
results were found. Wrong et al used as standards, 
solutions of sulphate which had not been pretreated in the 
same way as stool water (by decolourisation with activated 
charcoal, and passing through a cation exchange column to 
remove interfering cations). We found that when standards 
were treated in the same way as samples, a obvious linear 
response was no longer found: instead there was little
apparent trend.
In view of these findings which could be attributable to 
very poor precision this method was abandoned.
A second spectrophotometric method using sodium 
rhodizonate as chromophore was also tested (175). Again 
the precision of this method was very poor and the 
addition of phosphate, at concentrations found in stool 
water, produced significant interference. This method was 
also abandoned.
* * * * * *
The main problem encountered in these methodologies was
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the strong stool colouration which interfered with the 
spectrophotometric end-point. Attempts to decolourise the 
stool with charcoal helped but were not curative. In view 
of the success of the enzymatic method which was developed 
for measuring faecal ammonium (page 78) , this approach, 
perhaps using the enzyme aryl sulphatase, might prove 
successful in the measurement of sulphate. The advantage 
of an enzymatic method in this situation is that a change 
in optical density is monitored, making the intensity of 
background colour immaterial.
The prevalence of sodium sulphate induced diarrhoea is 
probably very low: sodium sulphate is unpalatable and OTC
sales are minimal (information provided by 
Intercontinental Medical Statistics Ltd, Hanover House, 
Lyon Rd, Harrow, Middlesex); sales are less than magnesium 
based laxatives which are themselves probably abused very 
rarely. For these reasons it was considered inexpedient 
to invest further effort in the development of a sulphate 
assay.
INDUCTION OF DIARRHOEA BY SALINE LAXATIVES
After an overnight fast six healthy volunteers were given 
an oral dose of 5.86g magnesium hydroxide in 100ml of 
water.
Stool was collected for the next 36 hours into separate 
plastic containers and stored immediately in a freezer. 
Blood samples were collected into 10ml heparin tubes 
containing 200/iV of Trasylol (20,000 units/ml) at 0, 30 and
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60 minutes. Aliquots of 1ml were lyophilised and 
cholecystokinin measured by radioimmunoassay (Professor S 
Bloom, Hammersmith Hospital, London). Magnesium was 
measured in plasma and in a 24 hour urine collection by 
atomic absorption spectrophotometry.
Stool samples were semi-thawed and homogenised without
addition of water. An aliquot was centrifuged at 14000rpm 
and the supernatant produced was filtered through paper 
filter discs (AP25 pre-filters from Millipore). The
supernatant was frozen until analysed or refrigerated if 
the assays were performed on the same day. The following 
analyses were made on the faecal supernatant: magnesium
by the method described above; osmolality using a freezing 
point depression osmometer; sodium and potassium by flame 
photometry; chloride using a silver electrode chloride
meter.
Sulphate induced diarrhoea was induced in two healthy 
subjects by the oral administration of 13.2g of anhydrous 
soldium sulphate or 35g of magnesium sulphate (MgS04.7H20) 
as Epsom Salts.
It was intended to measure the daily output of magnesium 
using an non-absorbable stool marker such as cuprous 
thiocyanate (176) in order to make appropriate
corrections. Unfortunately new legislation prohibiting 
human consumption of non-BP chemicals, such as stool 
markers, was introduced at the time that this study was 
carried out and so this could not be done.
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As control samples stool and urine collections were 
obtained from patients being investigated for diarrhoea.
Ethical permission for this part of the study was granted 
by the Ethical Committee of the Greater Glasgow Health 
Board, East 1.
PATIENTS
The casenotes of out-patients due to attend the 
Gastroenterology clinic were screened in order to select 
those patients who were a) GP referrals for the 
investigation of diarrhoea, or b) existing patients who 
were being investigated for chronic diarrhoea of unknown 
origin. The patients were asked to return a random urine 
specimen (collected at a time when they had diarrhoea) at 
their next appointment or to provide a urine sample during 
the clinic. These urines were screened for colonic 
stimulant laxatives by the TLC method.
LAXATIVE SCREENING SERVICE
The laxative screening service was offered in writing to
all Gastroenterologists and Biochemists in the following
hospitals:
Royal Infirmary, Glasgow;
Victoria Infirmary, Glasgow;
Western Infirmary, Glasgow;
Southern General Hospital, Glasgow;
Stobhill Hospital, Glasgow;
Royal Alexandra Hospital, Paisley;
Royal Hospital for Sick Children, Glasgow; 
Falkirk and District Royal Infirmary; 
Dumfries and Galloway Royal Infirmary; 
Vale of Leven Hospital, Dumbarton; 
Stirling Infirmary;
Inverclyde Hospital, Greenock;
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Crosshouse Hospital, Kilmarnock; 
Monklands DGH, Airdrie;
Law Hospital.
These are the principal hospitals in six of the health 
boards in Scotland (Greater Glasgow, Argyll and Clyde, 
Forth Valley, Lanarkshire, Ayrshire and Arran, and 
Dumfries and Galloway), covering approximately 52%
(2,751,600 at June 1987) of the countrys' population
(177). In addition, all physicians within the Royal 
Infirmary, Glasgow were invited to use the laxative 
screening service.
TELEPHONE SURVEY
The main biochemistry laboratories throughout Scotland 
were contacted by telephone and the following information 
gleaned from an appropriate source: whether the
laboratory provided a routine laxative screening service; 
if so the annual request rate.
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RESULTS AND DISCUSSION
METHODOLOGICAL ASPECTS
HPLC of Stimulant Laxatives
HPLC was initially chosen as a way of detecting laxatives 
to enable their quantitation and so facilitate possible 
future pharmacokinetic studies. An HPLC method was 
readily established such that colonic stimulant laxatives 
could be reliably measured from standard solutions.
Using the HPLC system as described (page 141) it was 
possible to separate the colonic stimulant laxatives 
tested from a standard solution. They were eluted in the 
order of bisacodyl, oxyphensitin, phenolphthalein, 
picosulphate, rhein, and danthron. The retention times 
and precisions of standard solutions of each laxatives are 
shown in table 3.6.
Laxative Retention Time 
(Minutes)
Precision
(CV)
Bisacodyl 4.6 2.8%
Oxyphenisatin 5.2 1.1%
Phenolphthalein 6.4 2.2%
Picosulphate 12.1 11.8%
Rhein 14.0 3.8%
Danthron 38.0 4.7%
Table 3.6. - Retention times and Precisions for Laxative
Assay
The retention times could be readily adjusted by simple 
modification of the mobile phase: increasing the
proportion of non-polar solvent resulted in shorter 
retention times, and vice versa. Picosulphate was most
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sensitive to alterations in the acetonitrile concentration 
followed by rhein, danthron, aloin, phenolphthalein, 
oxyphenisatin and bisacodyl. Similarly, picosulphate was 
highly sensitive to changes in the ratio of methanol 
followed by oxyphenisatin, phenolphthalein and bisacodyl. 
The retention times of rhein and picosulphate, and to a 
lesser extent aloin and danthron, varied in proportion to 
the CTMAB concentration. Since ion-pairing played no part
in the separation of phenolphthalein, bisacodyl and
oxyphenisatin, their retention times were unaffected by 
alterations in CTMAB conceentration. The retention times 
of all laxatives were prolonged by increasing the
methanol:acetonitrile ratio.
The detector response was linear up to a concentration of 
(at least) lmmol/1 for phenolphthalein, bisacodyl, and
oxyphenisatin and up to 0.7mmol/l for picosulphate, rhein 
and danthron.
However, it was clear that in order to measure laxative 
concentrations in urine and faecal homogenates a 'clean­
up' procedure was required. By using liquid/liquid and 
solid phase extraction procedures a purified extract was 
obtained and, although the laxative recovery was good, 
there remained a number of extra chromatographic peaks 
which were caused by impurities. Two possible solutions 
to this problem were considered; the use of other solid 
phase extraction columns in an attempt to purify the 
sample further, or replacement of the non-specific UV 
detector with a more specific detection system.
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There have been recent commercial improvements in the area 
of solid phase extraction with newer and more specific 
matrices being developed. There are about twenty- 
different materials now available and, although the choice 
can be narrowed down to a handful by chemical 
considerations, final selection of the optimum column 
often requires individual evaluation of each.
UV detection is versatile but unfortunately very non­
specific. Consequently several UV absorbing species in 
the urine and stool samples interfered with the laxative 
method. A possible alternative spectrophotometric method 
is alkalinisation of the eluent and measurement of the 
more specific reddish chromophores spectrophotometrically. 
Alkalinisation can be achieved either by post-column 
addition of base or by use of an alkaline mobile phase and 
a resin column which can withstand the conditions of 
elevated pH. Unfortunately financial and temporal
constraints did not allow either of these possibilites to 
be explored.
In retrospect, TLC is a superior method to HPLC for the 
detection of drugs. With the latter, the presence of some 
spurious extra peaks made it difficult to be entirely 
confident that a peak of an appropriate Rf value was 
indeed a laxative. If HPLC had been used to detect 
laxatives a confirmatory method such as TLC would have 
been essential. In addition, HPLC is a more
'temperamental' technique requiring fastidious attention 
to detail. In brief, HPLC is useful when quantitation
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rather than identification is required while TLC is the 
preferable method in the converse situation.
TLC of Stimulant Laxatives
TLC was chosen as the most appropriate screening method 
for detection of laxatives because of the problems in 
their measurement by HPLC. Figures 3.5 and 3.6 show 
chromatographs of typical separations using the main 
solvent system of 4-methyl-2-pentanone:-chloroform:acetic 
acid (5:2:1) and the confirmatory method using 
hexane:toluene:acetic acid (3:1:1). The colours produced 
and their Rf values are shown in tables 3.7 and 3.8.
In the first screening procedure published, by a Dutch 
group (161), two separate TLC separations using different 
solvent systems were required in order to achieve adequate 
resolution. However, Morton demonstrated that all
laxatives can be satifactorily separated by employing a 
single, and simpler, solvent system (chloroform:acetone - 
4:1) (162). This method was initially chosen for the
present study and proved to be effective for separating 
all laxatives with the exception of rhein. The reported 
Rf for rhein was 0.5, but in our hands the pure rhein 
standard did.not migrate from the origin, while a positive 
rhein control had a slow mobility (Rf = 0.04). The reason 
for this difference could not be accounted for, especially 
since both sources of rhein gave similar mobilities using 
the Dutch system and the one finally chosen for this study 
(4-methyl-2-pentanone:chloroform: acetic acid - 5:2:1).
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Solvent front origin
phenolphthalein +ve 
chrysophanol standard 
rhein +ve
bisacodyl standard
phenolphthalein/rhein +ve 
rhein standard
phenolphthalein +ve
chrysophanol standard
-ve urine
phenolphthalein standard 
rhein +ve
aloe-eiodin standard 
phenolphthalein +ve 
oxyphenisatin standard
Figure 3.5 - Typical thin layer chromatograph of laxatives 
using main solvent system (methyl pentanone- 
:chlororform:acetic acid).
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Solvent front origin
/
/
phenolphthalein +ve 
chrysophanol standard 
rhein +ve
bisacodyl standard
phenoiphthalein/rhein +ve 
rhein standard
phenolphthalein +ve
chrysophanol standard
-ve urine
phenolphthalein standard 
rhein +ve
aloe-eiiodin standard 
phenolphthalein + ve 
oxyphenisatin standard
Figure 3.6 - Typical thin layer chromatograph of laxatives 
using confirmatory solvent system (hexane:t o l u e n e :acetic
a c i d ) .
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Laxative Rf Light Alkali Heating
Bisacodyl
Biscodyl
0.68 - - Blue/purple
Metabolite 0.39 — - Blue/purple
Phenolphthalein
Phenolphthalein
0.89 Violet Violet
metabolite 0.86 — Blue/purple Blue/purple
Rhein 0.81 Yellow Orange Orange
Emodin 0.93 Yellow Purple Purple
0.86 Yellow Red/brown Red/Brown
Chrysophanol 0.93 Yellow Pink/purple Pink/purple
Danthron 1.0 Yellow Orange Orange
Oxyphenisatin 0.46-0.98 - - Pink/purple
Frangula 0.92 Yellow Pink/purple Pink/purple
Table 3.7 - Mobilities and colour reactions of colonic 
stimulant laxatives separated by TLC (methyl 
pentanone:chloroform:acetic acid).
Laxative Rf Light Alkali Heating
Bisacodyl 0.14 - - Blue/purple
Biscodyl
Metabolite 0.0 — - Blue/purple
Phenolphthalein 0.04 - Violet Violet*
Phenolphthalein
metabolite 0.04 - Blue/purple Blue/purple
Rhein 0.53 Yellow Orange Orange
Emodin 0.44 Yellow Purple Purple
0. Yellow Red/brown Red/Brown
Chrysophanol 0.73 Yellow Pink/purple Pink/purple
Danthron 0.7 Yellow Orange Orange
Oxyphenisatin in
T—1O1oo - - Pink/purple
Frangula 0.83 Yellow Pink/purple Pink/purple
Table 3.8 - Mobilities and colour reactions of colonic 
stimulant laxatives separated by confirmatory TLC method 
(hexane:toluene:acetic acid).
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It was felt that the unexplained difference in movement of 
standard and sample rhein could cause confusion and this 
was later shown to be the case. A colleague in Edinburgh 
using the chloroform:acetone solvent system contacted me 
for assurance that a result he had obtained was not due to 
the presence of a laxative. The substance in question 
gave a colour reaction typical of rhein but had a 
different mobility from the standard (0.04 compared to 0). 
When the run was repeated in the Gastroenterology 
laboratory in the Royal Infirmary similar results were 
found. Although the sample spot was distinct from the 
standard it had the same Rf as the positive control. When 
either of the solvent systems quoted in the present study 
were used, the band in question was readily identified as 
rhein.
This episode revealed one of the arguments for providing a 
regional service for detection of laxatives, namely the 
availability of experience. Another potential hazard in 
using TLC is that by applying too much urine extract to 
the plate, ironically perhaps in the hope of not missing 
a positive response, the presence of a laxative can be 
concealed. In addition, the phenolphthalein colour, while 
being very vivid and characteristic, fades quite rapidly 
and in inexperienced hands may well be missed.
With the low numbers of laxative screens requested at 
present, it is not a sensible use of hospital resources to 
duplicate an infrequently used test in each laboratory. 
Even with this laboratory acting as a regional centre for
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the detection of laxatives the low request rate has
resulted in most requests being analysed individually.
Predictive Value of TLC Laxative Screening
The predictive value of the TLC laxative screening test in 
terms of sensitivity and specificity cannot be accurately 
evaluated in the absence of a definitive method for
identification such as mass spectrometry. With respect to 
the sensitivity of laxative screening, it was impossible 
to determine how many, if any, laxative abusers were
missed. However, de Wolff et al have provided some 
insight into the sensitivity of the test by performing TLC 
on urine extracts obtained at different times after 
ingestion of the lowest commercially available dose of 
each laxative (161). They found that all the laxatives 
were detectable in urine up to 18 hours, and in most cases 
up to 32 hours, after ingestion. In a second similar 
study (164) positive results were found for all urine 
samples from sixteen patients who were taking laxatives in 
doses ranging from one to six tablets per day. This 
second study also concluded that the method was 
sufficiently sensitive to detect bisacodyl, 
phenolphthalein or anthraquinone at least 32 hours after 
ingestion of a single dose (178).
It is also possible to miss a laxative abuser if the urine 
sample is collected at a time when the patient has not 
been taking laxatives. In Bytzers' study (164) four of 
seven patients with laxative induced diarrhoea were taking
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laxatives intermittently and so if a single urine sample 
had been collected false negatives might have resulted. 
In contrast, if the patient has diarrhoea at the time that 
the sample is collected then one sample will suffice. 
Although in the present study one urine was usually 
collected, this was done at a time when the patient was 
complaining of diarrhoea.
It is particularly important that a laxative screening 
test is specific, since a false positive could result in a 
patient being misdiagnosed as a laxative abuser. While 
the patient would, quite appropriately, deny taking 
laxatives, the clinician would take such a denial as being 
in keeping with the diagnosis. The specificity cannot be 
determined in the conventional way by comparison with a 
gold standard method since none exists. Although complete 
assurance cannot be given regarding the specificity of the 
laxative screening test, de Wolff and colleagues have 
tried to exclude the possibility of false positive results 
by demonstrating the absence of substances which might 
give a positive response. Hence they performed the screen 
on 73 commonly prescribed non-laxative drugs, none of 
which gave positive results. (161).
Two possible sources of anthraquinone substances which 
could result in false positive results have so far escaped 
investigation. All of the purgative substances that have 
been used through the history of medicine were derived 
from plants, indeed the anthraquinone laxatives still sold 
today are obtained on a commercial scale from plants
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rather than being synthesised. It is quite plausible 
then, that dietary sources of anthraquinones might be 
detected in the urine. In addition anthraquinones and 
some chemically related substances have therapeutic 
qualities other than taxation. Examples are drugs such as 
dithranol, podophyllum, and chrysarobin for the treatment 
of skin conditions, and mithramycin, daunomycin, and 
adriamycin as antibiotics. The possibility of these drugs 
interfering is strengthened by the observation that some 
colour the urine red similarly to some laxatives.
These two potential causes of false positive results were 
investigated in this study.
Of the foods analysed only rhubarb contained a substance 
which produced a characteristic although faint colouration 
corresponding to chrysophanol. Using the confirmatory TLC 
method the Rf of the rhubarb band was 0.51 in comparison 
to chrysophanol whose Rf was 0.73. Urine samples from 
four volunteers who had taken 85g (a generous helping) of 
rhubarb eight hours before, were all negative.
In contrast, several of the drugs gave positive responses 
by TLC (table 3.9) although only one, dithranol, gave an
Drug Rf by TLC 
screen
Rf by confirm­
atory method
Colour
Plicamycin 0.02 0.0 Yellow
Podophyllum 0.85 0.0 Yellow
Doxorubicin 0.0 0.0 Blue
Dithranol 0.92 0 to 1 o <_n Brown/purple
Dactinomycin 0.46 0.07 Yellow
Table 3.9 - Laxative screen of potentially interferent
drugs.
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Rf and colour reaction that was likely to cause confusion.
Whenever a positive laxative result was produced, the 
other medications that the patient was taking were also 
obtained and tested by TLC. All of the following drugs 
which were tested to exclude a possible interference gave 
a negative result: metochlopramide, imodium, paracetamol, 
codeine, frusemide, hydrochlorthiazide, bendrofluazide, 
bumetanide, amiloride, triamterine, cyclopenthiazide 
amitryptiline, ibuprofen, rifampicin, isoniazid, nitraze­
pam, ponstan, and hydroflumethazide.
In contrast to the anthraquinones it is unlikely that the 
presence of phenolphthalein in the urine could be caused 
by anything other than laxative ingestion. Phenol­
phthalein is not a naturally occurring substance, neither 
is it a food additive (although at the turn of the century 
it was tested as a red colouring for wine) and so would 
not be expected to be consumed as a normal constituent of 
the diet.
Diagnosis of Saline Laxative Abuse
Saline laxative abuse is more difficult to identify 
because the constituent ions of these substances are 
normally found in body fluids. Consequently appropriate 
reference ranges in a suitable sample must be determined 
initially. The first diagnostic consideration then, is to 
decide the sample in which saline laxative ions should be 
measured. In order to facilitate this objective, 
diarrhoea was induced in seven healthy volunteers by oral
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administration of magnesium hydroxide, and in two further 
volunteers by magnesium sulphate and anhydrous sodium 
sulphate. These doses provoked borborygmus in all 
subjects followed by 1 - 4 loose bowel motions after four 
hours.
Plasma magnesium concentrations did not vary significantly 
before or 30 and 60 minutes after oral administration 
(figure 3.7). Urinary excretion of magnesium is shown in 
figure 3.8 compared with 24 hour concentrations in seven 
patients with diarrhoea and the normal 24 hour value 
quoted by the Clinical Biochemistry Laboratory.
Magnesium was measured in seventeen stools collected by 
the seven volunteers and in 60 stool collections from 39 
diarrhoea controls. The concentrations of magnesium in 
the stool homogenate, lyophylate, and supernatant, are 
shown (figures 3.9, 3.10, 3.11).
There is an obvious difference in the magnesium 
concentrations between the two groups in all stool samples 
and the 24 hour urine collections. However, in only the 
stool supernatant is there a complete separation between 
the two groups: in the magnesium group the minimum
magnesium concentration is 65 mmol/1 (mean = 123, sem = 
6.1) and in the control group the maximum magnesium 
concentration is 26mmol/l (mean = 9.1, sem = 0.77).
Previous studies have suggested the measurement of 
magnesium in urine, stool homogenate or stool water (149,
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Figure 3.7 - Plasma magnesium concentrations 
following oral magnesium hydroxide.
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Figure 3.8 - Urine magnesium output in magnesium group 
compared to control group.
1 6 6
M
ag
ne
si
um
M
ag
ne
si
um
 
Co
nc
en
tra
tio
n 
(m
m
ol
/g
 
we
t 
w
ei
gh
t) 
(m
mo
l/g
 
dry
 
st
oo
l)
Chapter 3 - diagnosis of Laxative Induced diarrhoea
0.3 -|
0.2 -
10
Magnesium
group Controls
Figure 3.9 - Magnesium concentration in homogenate of 
magnesium group compared with controls
3
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Figure 3.10 - Magnesium concentration in stool lyophylate of 
magnesium group compared with controls.
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Figure 3.11 - Magnesium concentration in supernatant 
compared in magnesium and control groups
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163, 164, 165). Although our findings show that a urinary 
output of more than 7mmol/d may be consistent with saline 
laxative induced diarrhoea, it cannot be considered as 
diagnostic (see figure 3.8, page 166). Similarly the 
measurement of magnesium in the faecal homogenate, 
expressed either with respect to the wet weight or the dry 
weight of the sample, cannot be used to diagnose magnesium 
salt laxative abuse (see figures 3.9 and 3.10, page 167).
This is not surprising since the faecal output of
magnesium is a factor of dietary magnesium intake and 
percentage absorption of magnesium. Since about 60 - 70% 
of magnesium consumed normally escapes absorption (179), a 
high dietary magnesium intake will give elevated outputs 
of faecal magnesium. Malabsorption syndromes, of which 
hypomagnesaemia is a common consequence, would also be 
expected to be associated with an increased faecal output 
of magnesium. Unfortunately the daily output of magnesium 
could not be assessed in this study because of the legal 
problems of using a non-absorbable stool marker (see page 
150).
The present work demonstrates that the measurement of 
magnesium in the stool water gives the only clear
separation of subjects with magnesium induced diarrhoea
from controls (see figure 3.11).
The next diagnostic consideration was to determine the 
concentration of magnesium in stool water that separates 
cases of magnesium induced diarrhoea from other diarrhoeal 
illnesses. Results from this study show that the maximum
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stool water magnesium concentration in the control group 
was 26mmol/l (mean = 9.1mmol/l, sem = 0.77) compared with 
a minimum concentration of 65mmol/l (mean = 123mmol/l, sem 
=6.1) in the magnesium-induced diarrhoea group. On the 
basis of these results 30mmol/l would be a suitable cut­
off concentration.
Morris and Turnberg (163) suggested a cut-off figure of 
20mmol/l but gave no scientific reason to support this 
choice. Some previous studies have used 49mmol/l as the 
upper limit of normal, this being the maximum faecal
dialysate concentration found in healthy individuals 
(101). However, the validity of using the in vivo 
dialysis procedure to prepare stool water has been 
questioned (see page 58) . In addition, rather than use 
healthy subjects as a control group, it is more 
appropriate to recruit patients with non-laxative causes 
of diarrhoea.
Our control results were considerably higher than those 
from a study by Fortran et al in which the range of 
magnesium in a diarrhoea control group was 0.1 
11.3mmol/l (mean = 2.1, sem = 0.6). They suggested a cut­
off concentration of only 12mmol/l (112). However, in 
their study only a relatively small number of patients 
with undefined causes of diarrhoea were used to obtain 
this figure. In our control series some patients were 
specifically selected because they had fat malabsorption. 
In these patients a combination of decreased absorption of 
magnesium and increased solubility, because of lower stool
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pH, would be expected to give higher faecal water 
concentrations. This may explain why our results were 
higher.
It is worthwhile remembering that the volunteers used in 
the present study were given a single dose of purgative 
and so the resultant diarrhoea might not be entirely 
typical of magnesium laxative abuse. It is also possible 
that the diarrhoea was more severe than patients with 
purgative abuse. One volunteer, however, had only minimal 
diarrhoea with a faecal water magnesium concentration of 
65mmol/l which was still quite distinct from the control 
group (less than 26mmol/l).
Five cases of magnesium induced diarrhoea have been
reported and the stool water magnesium concentrations were 
measured in all. Results of 166, 58 and 21mmol/l were
found by Morris and Turnberg in three successive daily 
stools from a patient with magnesium induced diarrhoea
(163) . The last result of 21mmol/l can be excluded from 
consideration because the patient added water to this
stool in an attempt to mislead clinicians. In another 
case report, elevated magnesium concentrations of 148 and 
41mmol/l were noted before and after fasting (110) . In 
the other three studies stool water magnesium of
140mmol/l, 120mmol/l and 31mmol/l were noted in patients 
with magnesium induced diarrhoea (115, 118, 164).
Although by our criteria the last result is borderline, 
the diagnosis was probably correct since the patient was 
also abusing bisacodyl (164).
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Our work also demonstrates the importance of freezing 
stools until analysis or processing them immediately since 
the magnesium concentration can rise significantly in 
stools which are left at room temperature.
Predictive Value of Saline Laxative Measurements
Less can be said about the predictive value of measuring 
saline laxatives. The severity of diarrhoea correlated 
with the magnesium concentration suggesting that these 
purgatives act by an osmotic effect. Consequently it is 
highly improbable that a patient with saline laxative 
induced diarrhoea could have a normal concentration of the 
salt in the stool water. Hence there is little 
likelihood, assuming the result is technically correct, of 
producing false negative results. On the other hand, the 
constituents of saline laxatives are normal body ions and 
so a false positive result is perhaps feasible, albeit 
unlikely. Consequently in patients with only a slightly 
elevated result it would be sensible to exclude a) 
malabsorption as a possible cause of a high result, and b) 
a dietary idiosyncrasy which might result in a high intake 
of magnesium, (such as an addiction to dried fruit, brazil 
nuts or winkles!).
Mechanism of Diarrhoea
The faecal supernatant electrolyte concentrations of the 
subjects taking magnesium were measured and are shown in 
table 3.10.
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Faecal Analytes Median Interquartile
range
OG2 260 234 - 270
Magnesium (mmol/1) 134 114 - 140
PWC value 67% 46 - 73%
Sodium (mmol/1) 5 2 - 8
Potassium (mmol/1) 14 9 - 4 0
Chloride (mmol/1) 18 16 - 24
Bicarbonate (mmol/1) 152 141 - 170
pH 8.4 8.2 - 8.5
Table 3.10 - Concentrations of faecal electrolytes in 
supernatants in magnesium hydroxide induced diarrhoea.
The electrolyte composition of the supernatant was quite 
different from normal faecal fluid: magnesium and
bicarbonate concentrations were both considerably higher; 
the sodium, potassium, chloride and hydrogen ion 
concentrations were relatively low.
When the severity of diarrhoea, as assessed by the PWC
value (see page 75) was studied, no correlation with the
| was found
magnesium content of faecal fluid as had been expected (rs 
= -0.04, see Statistical Appendix, note 4). Of the
volunteers studied, six produced more than one diarrhoeal 
stool sample and so it was possible to assess the 
individual correlation of severity of diarrhoea with 
magnesium concentration (see Statistical Appendix, note 
5) . When the data was analysed in this way there was a 
correlation between PWC and magnesium concentrations (rs =
0.59), implying a direct porportional relationship. The 
disagreement in results produced by these two statistical 
approaches, suggests that the subjects had differing 
sensitivities to high concentrations of magnesium in the 
intestinal lumen.
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As was previously mentioned (page 102) there was a good
correlation between the OG2 and severity of diarrhoea (r =
0.81) suggesting that the diarrhoea is osmotic in nature. 
The faecal water in these patients has a very large 
osmotic gap which largely comprises magnesium and its
associated anions.
Cholecystokinin was measured and gave the results shown in 
figure 3.12. However, there was difficulty in
solubilising some of the lyophylates and so doubt was cast 
on the reliability of these results.
CLINICAL ASPECTS
Requesting Pattern
The laxative screening service was offered to 
Gastroenterologists and Biochemists in the main hospitals 
of six Scottish Health Boards, covering a population of 
2.7 million. None of the regions previously had ready 
access to such a facility.
Over a two year period, sixteen requests for the screen 
were made, three of which originated from hospitals other 
than those originally notified. The breakdown of the 
figures is given in table 3.11.
Of the sixteen requests made, ten (63%) were for 
investigation of unexplained diarrhoea, three (19%) in 
patients with eating disorders, and the remaining three 
for investigation of infantile diarrhoea, red urine, and 
of long-standing unexplained hypokalaemia.
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Figure 3.12 - Plasma cholecystokinin following 
magnesium hydroxide ingestion
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Hospital Source No.
Glasgow Royal Infirmary 
Royal Hospital for
Gastroenterologist ' 2
Sick Children Physician 1
Raigmore Hospital, Inverness Psychiatrist 2
If GP 1
Lewis Hospital, Stornoway Psychiatrist 1
Monklands DGH, Airdrie Physician 1
Falkirk Royal Infirmary Gastroenterologist 3
Stobhill Hospital, Glasgow 
Royal Alexandra Hosptial,
Gastroenterologist 1
Paisley Physician 1
Western Infirmary, Glasgow Gastroenterology 3
Table 3.11 - Requesting Pattern for Laxative Screen over a
Two Year Period
Over the same two year period none of the physicians 
within the Glasgow Royal Infirmary who were informed made 
use of the facility.
Despite the apparent clinical usefulness of this screening 
test it was surprisingly infrequently used, as reflected 
by the request rate of eight per annum. In addition many 
of the requests came from the same sources (frequently 
Falkirk and Inverness) where there was presumably more 
awareness of laxative induced diarrhoea (LID) as a 
diagnostic possibility.
This low rate of requests prompted the telephone survey in 
order to determine the pattern of laxative screen 
requesting throughout Scotland. This exercise revealed a 
similar request rate with a total of only about twenty 
laxative screens being performed annually in Scotland.
Two laboratories were found to have carried out tests for 
phenolphthalein in the past but did not provide a 
comprehensive service. A full screening service, using
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TLC, was only available in two other centres.
Prior to 1987 only one centre in Scotland (Wolffson 
Gastrointestinal Laboratory in Edinburgh's Western General 
Hospital) offered a laxative screening service. . It is of 
interest that of the three screening services that have 
been initiated since then, only one of these was in 
response to a request from clinicians (at Raigmore 
Hospital in Inverness, whose samples are now analysed in 
the Gastroenterology Laboratory at Glasgow Royal 
Infirmary). The other two were instigated by Biochemists 
as research projects.
Prevalence of Laxative Induced Darrhoea
One of our principal objectives of the study was to the 
determine the prevalence of laxative abuse. However, it 
was clearly impracticable to screen the general population 
to this end. Consequently the prevalence of laxative 
abuse was estimated in a sub-population who were 
unselected apart from having diarrhoea and being referred 
to the Gastroenterology Department of Glasgow Royal 
Infirmary for its investigation. We discovered in 4% (2
of 49) of patients presenting with diarrhoea, that the 
complaint was self-induced.
It is interesting to gauge the incidence of laxative 
induced diarrhoea in Scotland using this statistic. 
Almost 7,000 new patients were seen at Scottish 
Gastroenterology outpatients clinics in 1989 (information 
provided by Information and Statistics Division, Scottish
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Health Services Common Services Agency, Trinity Park 
House, South Trinity Rd, Edinburgh). Since about a third 
of new patients seen present with diarrhoea (181) the 
prevalence of LID in Scotland can be extrapolated to be 
approximately 82 cases per year.
The prevalence of LID was also measured in patients who 
were already being investigated for chronic diarrhoea of 
unknown cause or on whom the diagnosis was not definite. 
Many of these patients had complained of diarrhoea for 
many years. In 20% of these patients (2 of 10) laxatives 
were detected in the urine. This figure is broadly 
comparable with the frequency of laxative abuse in 
unselected patients who were referred to specialist 
Gastroenterology Centres with long-standing diarrhoea: 26% 
by Fordtran et al (111) and 13% by Lodefoged et al (118).
It was entirely coincidental that a diagnosis of LID was 
happened upon in two further patients who were also being 
investigated for chronic diarrhoea. Both had been taking 
phenolphthalein and during alkalinisation of stool samples 
the characteristic colour of this laxative was noticed.
It has been widely, assumed that LID is relatively 
uncommon. Although most publications of laxative abuse 
are in the form of single case reports a few series of 
patients have been accumulated. However, in each case 
several years have been taken to amass these. For example 
Cummings' series of seven patients were diagnosed over a 
period of five years with some of these having been
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investigated for much longer (149). Fordtrans' group 
found that laxative abuse was the commonest diagnosis, at 
7 of 27 (15%), in patients referred to them for
investigation of chronic idiopathic diarrhoea (111) . 
These patients who were highly selected having previously 
been investigated elsewhere, were gathered over a period 
of six years. Fordtran et al extended this study by 
determining the diagnosis in 87 subsequent patients who 
were referred from other physicians for investigation of 
chronic diarrhoea (180). Of these patients, 20 (23%) were 
surreptiously ingesting drugs, predominantly laxatives. 
In a similar study performed over a five year period, 3 of 
23 (13%) with chronic diarrhoea were found to be laxative
abusers (118). The largest documented series was obtained 
retrospectively with 17 LID patients being uncovered 
during a five year period from a large referral centre 
with 1000 beds (150).
It is difficult to extrapolate the real prevalence of LID 
from these reports. In some studies highly selected 
groups of patients with severe chronic diarrhoea were 
recruited, while in others only patients suspected of 
laxative ingestion were studied. None examined the 
prevalence in unselected patients with diarrhoea. A more 
recent study has given more insight into the prevalence of 
LID (164): of 200 unselected patients attending a
Gastroenterology department 54 had diarrhoea of which 47 
were screened for ingestion of laxatives (including 
magnesium laxatives). Of these, seven gave positive
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results putting the prevalence at 15% in this population. 
It is possible that this figure is an underestimate since 
four patients with diarrhoea refused to be included in the 
study when they were informed (surprisingly) that their 
excretions would be analysed for laxatives.
While the relatively high prevalence rate of 4% in our 
study was unexpected, we were further surprised at the 15% 
figure quoted by the Danish group. The discrepancy 
between the two studies is large considering that the 
design of the investigations was broadly similar. 
However, one important difference was the way that the two 
studies tried to avoid missing the diagnosis in patients 
who only took laxatives intermittently. In the study by 
Bytzer et al several urines from each patient were usually 
collected (on average two per patient) . Although we only 
requested one urine sample per patient we asked that it be 
taken at a time when diarrhoea was occurring. Since we 
put the onus on patient co-operation in this respect, it 
is possible that our result may be underestimated. 
Nevertheless, it was felt that this was probably not the 
main factor: using their figures it was calculated that
two out of the seven laxative abusers might have been 
missed had they collected only one urine. This would 
still put the prevalence in their study at 11%. Other 
factors, possibly cultural differences, between the two 
populations could be involved.
It was interesting that in the Danish study the type of 
laxatives ingested were anthraquinones in 71% (5 of 7
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patients) and bisacodyl in 29% (2 of 7 patients), while in 
our experience phenolphthalein is the laxative most 
usually taken at 86% (6 of 7 patients) followed by
anthraquinone at 14% (1 of 7 patients) with no patients 
taking bisacodyl. This preference for phenolphthalein was 
also found in America (180). This may be due to a 
combination of different preferences between the two 
populations and differing availabilities of 'over the 
counter' laxative preparations. On the other hand the 
high prevalence found by Bytzers' group could also be 
explained by false positive results, which are more likely 
to be encountered with anthraquinone laxatives.
Case Histories
During the two year course of this study nine patients 
were discovered to be taking laxatives, seven of whom were 
being investigated or followed up in a Gastroenterolgy 
clinic for diarrhoea.
A brief case history of each of the nine diagnosed cases 
of laxative abuse follows.
1. MD, a 64 year old lady, presented to the 
Gastroenterology clinic with a two month history of 
diarrhoea, abdominal pain, insomnia, fluid retention, and 
general pruritis amongst other complaints. She was 
anxious, highly-strung, and hyperactive with a poor 
appetite. After several investigations a diagnosis of 
irritable bowel syndrome was made and she was treated with 
amitryptiline and ibuprofen and was regularly seen at the
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outpatient clinic.
About a year and a half after her initial presentation she 
was admitted for investigation of weight loss in the 
presence of continuing diarrhoea and abdominal pain. A 
three day stool was collected for analysis of faecal fat. 
During the alkalinisation step of this assay the sample 
turned a purple colour which was subsequently shown by TLC 
to be phenolphthalein. She emphatically denied taking 
this despite several further positive urine analyses.
Her symptoms remained and she was continued to be seen and 
investigated at the Gastroenterology clinic for several 
months but was eventually discharged.
2. IH, a 50 year old woman, had made numerous prior 
visits to Gynaecology, Orthopaedic, Surgical, Psychiatric 
and General Medical clinics over an eighteen year period. 
In 1972 she was initially investigated in Gynaecology 
clinics for lower abdominal pain which was thought to be 
related to. her menstrual cycle. After sterilisation she 
complained of pain in the lower back, right iliac fossa, 
and right thigh. Investigations revealed little and she
was treated|symptomatically .
I ;
Since then she frequently complained of pain which was 
variously located in the back, thigh, head, right iliac 
fossa, and upper abdomen. A large functional component 
was suspected especially since she had many emotional 
difficulties and at different times suffered from 
depression, anxiety, insomnia, lethargy, and poor
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appetite. She was taking many medications for these 
ailments and at one time had been prescribed danthron for 
the treatment of constipation.
Over the years more tangible diagnoses were found and 
treated accordingly: thyroidectomy for simple cystic
adenomata; bilateral oophorectomy for polycystic ovaries; 
hysterectomy because of dysmenorrhoea; and cholecystectomy 
for gall stones.
In 1978 following one of many check-ups she was found to 
have hypokalaemia (K-4- = 1.6) and had predictable symptoms 
of muscular weakness, tiredness and lack of energy. She 
also complained of vomiting and this was thought to be a 
contributory factor to her low serum potassium, along with 
inadequate nutrition and a suspicion of laxative abuse. 
Although she had admitted to taking laxatives in the past 
this was contemporarily denied. Other members of her 
family, however, confirmed that she took sennoside 
laxatives and on occasions she also admitted to the 
intermittent use of laxatives to control her constipation.
Latterly she complained of urinary incontinence which was 
though to be voluntary, and polyuria which was caused by 
massive intake of fluids especially Cola which she 
consumed in quantities of several litres each day.
The subsequent laboratory confirmation of laxative intake 
(on these occasions phenolphthalein was detected) served 
to corroborate clinical suspicions but this information 
did not elicit any therapeutic benefit. This lady's
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medical and psychiatric problems continue unabated and she 
remains a frustrating clinical challenge.
3. CL, a 41 year old casualty sister/ presented with 
diarrhoea of two years duration dating from the birth of 
her last child. She had suffered from post-partum 
depression and also developed a phobia about going out. 
The presence of melanosis coli was noted at sigmoidoscopy 
but she denied taking laxatives. When informed about the 
association of melanosis coli and laxative use she 
explained that her mother had given her laxatives as a 
child because of a 'lazy bowel7.
Despite this story laxative abuse was still suspected 
because of her unusual personality, and a laxative screen 
was positive for rhein. Initially she again denied taking 
purgatives but eventually admitted to taking Senokot. She 
was referred to a psychiatrist for management.
4. MK had already been undergoing long-term treatment of 
fluid retention syndrome or idiopathic oedema, a condition 
which other family members also suffered. She was a 
difficult patient with an unstable and emotional 
personality and could be very manipulative and hysterical. 
During a period of poor psychiatric status she had been 
admitted with nausea, vomiting, and diarrhoea and was 
found to have hypokalaemia and hypochloraemic alkalosis. 
A butterfat test demonstrated that she had malabsorption 
and a three day stool collection was made for measurement 
of di-antitrypsin clearance. While the glassware was
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being cleaned of faecal contamination using an alkaline 
detergent, a strong purple colour typical of 
phenolphthalein, was noticed. The presence of phenol­
phthalein was confirmed by TLC.
When confronted with this finding she vigorously denied 
taking laxatives to the extent that her physician was 
persuaded to accept her story and subsequently made a 
diagnosis of irritable bowel syndrome. A few months later 
her diarrhoea spontaneously resolved. Shortly after she
presented with breast pain and urge frequency of 
micturition.
5. GH had been diagnosed with coeliac disease in 1966 but 
had not taken a gluten-free diet because of financial 
restraints. He presented in 1983 with epigastric 
discomfort and a variety of non-specific gastrointestinal 
problems including loose motions but had no symptoms 
strongly suggestive of continuing coeliac disease. He was 
described as having a bizarre personality, claimed to have 
stigmata, and had a previous psychiatric referral.
A urine sample was taken as part of the study to determine 
the prevalence of laxative-induced diarrhoea and this, and 
further samples, were positive for phenolphthalein. He 
repeatedly denied taking laxatives and has been treated 
symptomatically since.
6. LF, an 18 year old girl who was thought to be suffering 
from anorexia nervosa, presented to her family doctor 
concerned that she might be passing blood because of red
1 8 5
Chapter 3 - Diagnosis of Laxative Induced Diarrhoea
colouration of her urine. No blood was detected by dip­
stick analysis and her astute GP thought that she might be 
taking phenolphthalein. The patient denied this during her 
initial GP visit but when the laxative screen detected 
phenolphthalein and she was asked again, she readily 
admitted taking Sure Lax laxative tablets in an attempt to 
control her weight.
7. GS, a strange 55 year old man, had a laxative screen 
when he presented to the clinic with a six month history 
of diarrhoea and abdominal pain. This was positive for 
phenolphthalein and he admitted that he had taken 
laxatives. This man was considered to have a low 
intellectual capacity and a short time later he again 
presented to the clinic complaining of diarrhoea. A 
laxative screen was not requested.
8. KO, a Ugandan girl of Asian descent, presented in 1981 
with a six week history of constant diarrhoea, vague upper 
abdominal pain, nausea and vomiting. She was a very 
nervous individual and after several investigations and 
unsuccessful treatments with lactose-free and high-fibre 
diets she was diagnosed as having irritable bowel 
syndrome.
She continued to be seen at the Gastroenterology clinic 
for the next two years but because of continuing diarrhoea 
and abdominal pain, as well as weight loss and slight 
anaemia, she was admitted for investigation. She was thin 
on admission and several investigations, including Mantoux
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test, were negative. A presumptive diagnosis of Crohn's 
disease was made but response to sulphosalazine and 
steroids was poor. Subsequent colonoscopy was normal and
she was readmitted for laparotomy which excluded Crohn's 
disease.
isoniazid and rifampicin was started with some improvement
intermittent courses of treatment for tuberculosis but 
continued to have diarrhoea and abdominal pain. In 1989 
she was seen at the Rheumatology clinic because of 
arthropathy and neurological problems and was diagnosed
sample was collected as part of this study and this gave a 
strongly positive result for phenolphthalein. She denied 
laxative intake and despite many subsequent positive urine 
tests and prompts, continues to disclaim this.
9. HP presented as a very pleasant 34 year old lady for 
investigation of abdominal pain. Past medical history 
revealed that she had been troubled with constipation 
since the birth of her second child. She was found to 
have iron-deficiency anaemia caused by a combination of 
gastric erosions and heavy periods. She developed watery 
diarrhoea defaecating about five times every three or four 
days. Initially she was thought to be suffering from 
irritable bowel syndrome but a previous finding of 
amyloidosis made intestinal amyloidosis a diagnostic 
possibility. A urine sample collected as a routine part
Despite negative tests 1 tuberculosis a trial of
in symptoms. For the next six years she had many
with osteomalacia. In the same year a routine urine
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of this project was strongly positive for phenolphthalein. 
On her next two clinic appointments she denied self­
induced diarrhoea or that laxatives could have been 
ingested accidentally. However, she subsequently made a 
tentative admission conceding that she had taken laxatives 
prior to her present appointment and also in the past in 
order to contol constipation. The cause of the latter was 
thought to be pelvic floor damage during childbirth or 
descending perineum syndrome. On referral for surgical 
assessment she was found to have a normal proctogram but a 
very slow transit constipation only defaecating every 10 - 
14 days when laxatives were avoided. At present she is 
considering colectomy.
* * * * * *
Table 3.12 summarises some of the more relevant findings 
in the seven patients who had laxative induced diarrhoea.
Patient Time to 
Diagnosis
Denial of 
Laxative
Diagnosis
Suspected
Steato-
rrhoea
Diagnosis
MD 18 months YES NO MILD IBS
CL 1 month YES/NO YES ? ?LID/?IBS
MK 6 months YES NO MILD IBS
GH 6 months YES NO ? IBS
GS 9 months NO YES NO ?IBS/?LID
KO 8 years YES NO MODERATE IBS/Crohns
/TB
HP 9 months YES/NO NO NO ?IBS/
?Amyloid
Table 3.12 - Summary of findings in patients with laxative
induced diarrhoea.
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Rate of Missed Diagnosis of Laxative Induced Diarrhoea
An important incidental finding of this study was that in 
five of the seven LID patients (71%) the diagnosis was 
clinically unsuspected. This figure accords with Bytzer 
et al's report (164) in which the diagnosis was 
unsuspected in four of seven (57%). In particular we 
found that the diagnosis was often mistaken for irritable 
bowel syndrome (IBS): of our seven patients a diagnosis of 
IBS had been made in three and was, or had been, 
considered in four others (table 3.12).
IBS is one of the most common conditions seen by
Gastroenterologists: of 2000 consecutive outpatients
attending a Gastroenterology clinic, an eventual diagnosis 
of idiopathic painless diarrhoea was made in 214 (10.7%)
and a further 998 (45%) were diagnosed with IBS (abdominal
pain and altered bowel habit) (181). In view of the 
incidence of IBS and possibility of LID being mistaken for 
IBS, it would be prudent to perform a laxative screen on 
these patients. Indeed, since IBS is considered to be a 
diagnosis of exclusion, it is mandatory to perform a
laxative screen before the diagnosis can be confidently 
made.
LID has been well documented over the years as a clinical 
entity and textbooks invariably warn of the possibility of 
surreptitious ingestion of laxatives in patients with 
chronic diarrhoea. Nevertheless, as the low request rate 
for laxative screens testifies, there seems to be little 
clinical awareness of the condition. In contrast,
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requests in this country for VIP measurement are 
relatively common in the diagnostic workup of patients 
with chronic idiopathic diarrhoea, yet the incidence of 
VIPoma is rare. For example, of the patients referred to 
Fordtran's unit for investigation of diarrhoea (111) the 
possibility of VIPoma had been suggested in most patients 
by the referring physicians (None of these patients was 
eventually diagnosed as such.)
It is interesting to speculate the reason that LID is 
infrequently considered as a diagnosis. Typically, 
patients with LID, and indeed IBS, are not unwell but tend 
to be nervous or anxious and are often quite demanding. 
They are often referred to as 'heart-sink' patients 
because of the feeling they invoke as the doctor sees them 
entering his consulting room. In the eyes of the 
clinician, the demands of such patients with an apparently 
functional illness may outweigh the severity of their 
symptoms. Consequently they may not command as much 
respect, interest, or sympathy as would a more severely 
ill patient with organic disease. Such a reaction is 
understandable in view of frequent understaffing and the 
consequent time constraints on doctors in typically busy 
outpatient clinics.
★ ★ * ★ * ★
Another unforeseen situation in this study was a 
reluctance by the doctor to accept the laboratory finding 
of laxative ingestion. This happened on one occasion when
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the physician, caught between laboratory evidence of 
laxative abuse and his patients' denial, accepted the 
latter, presumably assuming that the laboratory test was 
erroneous.
Screening for Laxative Induced Diarrhoea
It has been suggested that it may be a worthwhile exercise 
to screen for laxatives in all patients presenting to 
Gastroenterology clinics with diarrhoea. For example de 
Wolff advised that 'the cost of the laboratory screen is 
negligible in comparison with the cost of hospital 
admission or other advanced diagnostic tests' (182). The
criteria for instigating screening procedures can be
itemised as follows. i) For treatment to be effective the 
disease should be diagnosed early so that initiation of 
therapy is prompt. While this is true of most diseases 
screened, such as cervical and breast cancer, congenital
hypothyroidism, phenylketonuria etc, early diagnosis is 
not crucial for the well-being of patients with LID, 
especially since response to treatment is relatively poor, 
ii) The disease should not be readily diagnosed
clinically. In the case of LID the only effective way to 
make the diagnosis is by a chemical test. iii) The
benefits of a screening procedure should outweigh the cost 
associated with it. In the case of laxative induced 
diarrhoea this is the most telling argument in favour of
screening and indeed the main benefit is financial.
Bytzer et al demonstrated that the cost of a screen
(186DKK) was about one hundred times less than the money
1 9 1
Chapter 3 - Diagnosis of Laxative Induced Diarrhoea
actually spent on potentially preventable costs (18,931DKK 
per patient). In total, the cost of their screening 
exercise was 20,790DKK compared to 132/519DKK/ the costs 
of outpatient and inpatient visits and investigative tests 
that were considered in retrospect to be irrelevant (164). 
Had the cost of inappropriate treatment also been 
considered these financial arguments would be even more 
persuading.
It is important to exclude LID so that further unnecessary 
tests, with corresponding financial and health-care 
implications, can be avoided. One patient (KO, page 186) 
in this series highlights this: over an eight year period 
she had, in retrospect, many irrelevant investigations, 
including laparotomy and had been variously treated as 
having IBS for two years, Crohn's disease for several 
months, and intestinal tuberculaosis for six years. 
Whereas this patients' initial condition was mainly 
psychiatric, she now has medical problems in the form of 
osteomalacia.
There is less justification in screening for saline 
laxative abuse: the prevalence is relatively low and such 
patients, who also usually take colonic stimulant 
laxatives, would probably be detected by the TLC screen.
Potential Aids in the Diagnosis of Laxative Induced
Diarrhoea
Apart from diarrhoea there are a number of signs and
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symptoms which may also be part of the clinical picture of 
LID: abdominal discomfort, weight loss, nausea and
vomiting, hypokalaemia with resultant muscular weakness 
and lassitude, melanosis coli, and steatorrhoea.
Although the diagnosis of LID can only reliably be made by 
a chemical test, it was thought that 'at risk" patients 
might be identifiable by a study of their clinical 
details. For this reason the following symptoms, signs 
and other clinical factors which were thought to be 
potentially helpful were chosen: abdominal pain,
hypokalaemia, nausea and vomiting, previous psychiatric 
referral, weight loss, loss of appetite and non-specific 
psychological symptoms. These factors were selected 
because of their apparent frequency in our seven cases of 
LID. The inclusion of the relatively unscientific term of 
non-specific psychological symptoms was considered useful 
and included symptoms such as depression, anxiety, 
insomnia, phobia, and hysteria, and clinical observations 
such as unusual personality. Table 3.13 compares the 
incidence of these factors in LID and other patients whose
Symptoms
LID Diarrhoea
Controls Probability
Abdominal Pain 75% 73% ns
Hypokalaemia 38% 0% p = 0.014
Nausea & Vomiting 50% 18% ns
Psychiatric Referral 38% 18% ns
Weight Loss 88% 35% p = 0.015
Poor Appetite 50% 24% ns
Non-Specific Psychol­
ogical symptoms 88% 35% p = 0.015
Table 3.13 - Frequency of potentially useful diagnostic 
factors in patients with laxative induced diarrhoea and 
other diarrhoea patients.
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diarrhoea was not caused by laxatives. When analysed 
statistically (see Statistical Appendix, note 6) three 
factors were significantly more common in the group of 
patients with LID, the presence of hypokalaemia, weight 
loss and non-specific pyschological symptoms.
Bytzer et al also found that psychiatric disorders were 
more common in LID (164). Therefore it is particularly 
important that LID is excluded in patients with 
psychiatric disorders and those with psychologically 
related symptoms such as anxiety, nervousness, insomnia, 
and/or depression.
Other Relevant Clinical Findings in Laxative Induced
Diarrhoea
The reported association with steatorrhoea (159) was found 
in three patients of the four in which faecal fat was 
measured, with the fat malabsorption being severe enough 
in one case to cause osteomalacia (KO, page 186) . 
Hypocalcaemia has been documented previously in patients 
with LID (183, 184, 185, 186) but only once has
osteomalacia been reported (183), being induced following 
twenty years of phenolphthalein intake. Simply by 
avoiding laxative intake this documented patient improved 
radiologically, biochemically and symptomatically.
Melanosis coli, a brown discolouration of the colonic 
mucosa caused by anthracenes, was found in the one patient 
who took sennokot, an anthraquinone laxative. When she 
was informed of the association of melanosis coli and
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laxative intake she claimed that she had been given 
laxatives as a child by her mother. However, this
explanation was misleading since melanosis coli is known 
to disappear within a year after discontinuation of 
anthraquinones (139).
It is widely held that the diarrhoea induced by laxatives 
is severe (159, 165) and individual reports often quote
patients with gross diarrhoea; for example, Read et al 
found the average daily stool weight to be over one litre 
(1.11, range = 325 - 2561g/day) (111). However, in most
of our patients in whom stool weights were measured the
diarrhoea was not copious (mean = 331g/day ± 53, n = 4)
The motive that drives patients to self-induce diarrhoea 
is difficult to understand although a desire to induce 
sympathy from family or friends or to gain attention has 
been demonstrated in some individuals (159). Consequently 
the condition can be considered to be a form of 
Munchausens syndrome. Since many patients (86% in this 
study) deny taking laxatives they will clearly not 
volunteer their reasons, even if rational motives exist. 
In most of these patients, however, there seem to be 
complex underlying psychological factors of relevance. 
Table 3.14 documents some personal circumstances of our 
patients with co-existing psychological conditions which 
may be pertinent. Anxiety, depression, insomnia and 
emotional lability are frequently present. It is possible
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that with an underlying psychiatric condition, the 
existence of unmanageable personal or social circumstances 
may have been the prompt for inducing disease. However, 
this possibility could not be reliably demonstrated in any 
of our patients. Two of the LID patients in this study 
were underweight and anorexia nervosa was a diagnostic 
possibility although this had not been established.
It is particularly relevant that some of our patients had 
other medical manifestations of a psychiatric illness. 
One of the LID patients in this study (MK, page 184) had a 
primary diagnosis of fluid retention syndrome or 
idiopathic oedema (10), and another (MD, page 181) had 
symptoms consistent with this condition.
The psychiatric make-up of patients with 10 has several 
parallels to those with LID, with psychological symptoms 
such as lability of mood, hysteria, phobia, anxiety and 
depression. Indeed, it has been postulated that the 
pathogenesis of this disorder may be related to diuretic 
and/or laxative abuse (187). There is a strong local 
interest in 10 (Dr M Dunnigan, Stobhill Hospital) and this 
enabled a co-operative study to be performed, of the 
possible role of diuretic and laxatives in the 
pathogenesis of 10. Preliminary results of this
investigation have revealed that laxative abuse is 
unlikely to be a factor. Of 100 urines from patients with 
10, laxatives were found in only four, of whom only one was 
abusing laxatives.
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Treatment of Laxative Induced Diarrhoea
In the treatment of LID one of the first considerations is 
whether the patient should be confronted with the 
laboratory findings of laxative ingestion. In most 
published studies this has usually been done although some 
psychiatrists doubt its value. All of the patients in our 
series were confronted with the results of the laxative 
screen but only one readily admitted to taking laxatives, 
with two others eventually admitting after further
questioning at subsequent consultations. If patients 
initially deny laxative intake then it is less likely that 
they will admit to this at a later date. Indeed the more 
that a patient is questioned about laxative ingestion the 
more vehement their denial may become. Slugg and Carey 
believe that heated confrontations can be avoided by 
explaining in a non-judgmental manner, the result of the 
test and what it means (150) . An alternative approach is 
to play down the central issue of laxative ingestion and 
to control the atmosphere and direction of the
consultation such that the patient is not embarrassed to 
admit to taking laxatives. If this fails then an
alternative tactic is to avoid confronting the patient 
with laboratory evidence of laxative ingestion but rather 
make it tacitly evident in conversation that it is known 
that laxatives have been taken and so give the impression 
that the diagnosis has been accepted.
Unless a patient admits to taking laxatives it is 
difficult to persuade him/her to accept a psychiatric
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referral. This is considered to be a central aspect of
management. Medical management may, nevertheless, still 
be required if the patient has electrolyte abnormalities, 
or other organic illnesses, such as cathartic colon 
induced by long-term laxative intake. An additional 
clinical problem is the development of oedema which may
occur when the patient stops laxative intake. This is
thought to be caused by secondary hyperaldosteronism 
induced by sodium depletion (188). The latter has been 
well documented in these patients and is controlled by
limiting fluid intake (189).
If psychiatric referral is not accepted by the patient the 
outcome is generally poor: the patient may continue to
attend the clinic for symptomatic treatment or discharge 
themselves from the clinic and present with the same or 
other symptoms elsewhere. Alternatively the patient may 
stop taking laxatives and perhaps present with another 
medical problem which is secondary to their underlying 
mental condition.
Ultimately in most cases of LID the clinical outcome is 
unsatisfactory. This was the case in most of the patients 
detected in this study. However, despite this
unfavourable conclusion LID should still be considered, if 
for no other reason than to avoid subsequent needless 
investigations.
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INTRODUCTION
Malabsorption of dietary nutrients is a non-specific 
finding in a wide range of gastrointestinal diseases. 
Whereas malabsorbed carbohydrates and proteins are 
metabolised by colonic bacteria, malabsorbed fat passes 
through the gut relatively unchanged resulting in 
steatorrhoea, the excretion of excess fat in the stool. 
Tests for the diagnosis of malabsorption usually focus on 
the ability of the intestine to absorb fat, rather than 
carbohydrate, protein or any other nutrient. The
physiology of fat absorption is complex, requiring the 
normal functioning of liver and pancreas as well as 
intestine and so a test of malabsorption can be used as a 
broad screening test which reflects the function of these 
organs. Consequently it is useful to have a full 
understanding of the normal physiology of fat absorption.
PHYSIOLOGY OF FAT ABSORPTION
Westernised societies have a fat intake of approximately 
50-100g, most of which is in the form of triglycerides. 
The digestion of fat begins in the duodenum, where its 
presence stimulates the release of secretin and 
cholecystokinin-pancreozymin (CCK-PZ) from epithelial cells 
and also inhibits the further emptying of gastric contents 
into the duodenum. Secretin causes the pancreas to secrete 
bicarbonate which neutralises the gastric chyme to pH 6.0 - 
6.5, the optimum for most digestive enzymes. CCK-PZ acts 
upon the pancreas to release digestive enzymes and also
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stimulates gallbladder contraction and relaxation of the 
sphincter of Oddi.
Triglyceride digestion requires the presence of pancreatic 
lipase which hydrolyses the ester bond at positions 1 and 3 
of triglycerides releasing p-monoglycerides and free fatty 
acids. The efficiency of lipase action is greatly improved 
by the presence of bile salts and lecithin, which are 
normal components of bile. These substances act as 
surfactants reducing the surface tension at fat/water 
interfaces. Pancreatic colipase is a cofactor of MW 10,000 
which binds to the interfaces of bile salts and lipids and 
is necessary for the efficient action of lipase. Other 
pancreatic enzymes which play a role in fat digestion are 
phospholipase, which hydrolyses phospholipids within 
micelles, and cholesterol esterase, which digests 
cholesterol esters.
The second phase of absorption involves the delivery of the 
products of lipase digestion - monoglycerides and fatty 
acids - to the mucosal cells. These digested fats being 
insoluble in water are not readily absorbed but their 
solubility is increased by their association with bile 
salts to form micelles. Digested fats form the centre of 
micelles, and bile salts which are amphipathic (ie have 
hydrophobic and hydrophilic areas) surround this core.
In micellar form, fats can more readily penetrate the two 
layers which cover mucosal cells (the unstirred water 
layer, and mucous coat layer) so gaining access to the
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absorptive villi. In free form, the non-polar fatty acids 
and monoglycerides would find these layers relatively 
impermeable. For micelle formation the concentration of 
aqueous bile salts must exceed a specific value (the 
critical micellar concentration) of around 4mmol/l (190). 
In the normal duodenum and jejunum, bile salt 
concentrations of 3 - 12mmol/l ensure that micelle
formation is rapid.
Once delivered to the microvillus membrane the fats are 
absorbed into epithelial cells where triglycerides are 
reformed and then incorporated with specific proteins into 
chylomicra. These proteins (apoB, apoA-1 and apoA-IV) are 
produced in mucosal cells and are required for the 
production of normal chlyomicra.
The intraluminal breakdown of micelles results in the 
release of bile salts into solution again. Although there 
is some passive absorption in the upper intestine of bile 
salts, mainly monohydroxy and dihydroxy bile salts, most 
bile salts are absorbed in the terminal ileum by an active 
process. A small proportion of bile salts will escape 
absorption in the small bowel and are rapidly deconjugated 
and 7oc-dehydroxylated by anaerobic bacteria of the colon. 
Despite the secretion of large amounts of bile salts into 
the intestine, the efficient enterohepatic circulation, 
together with some jejunal and colonic absorption, ensures 
that the faecal loss of bile salts is limited to about 
500mg daily.
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The final stage of fat assimilation is the release of 
chylomicra into the lamina propria and their transport 
through the lymphatic system and thoracic duct to the 
circulatory system.
PATHOPHYSIOLOGY OF FAT ABSORPTION
The physiology of fat assimilation is summarised 
diagramatically in figure 4.1. Disease can disturb this 
physiology in the following ways giving rise to 
malabsorption.
1. Decreased mucosal release of CCK-PZ and secretin eg. in 
conditions where the duodenum is by-passed, such as 
Billroth II anastamosis and gastroenterostomy.
2. Decreased amounts of lipolytic enzymes eg. chronic 
pancreatitis or obstruction of ducts (pancreatic 
carcinoma).
3. Inactivation of lipase due to low duodenal pH eg. 
Zollinger- Ellison syndrome (low pH also causes 
precipitation of bile salts and damage to mucosal cells).
4. Decreased hepatic release of bile acids eg. chronic 
hepatic disease causing poor uptake of bile acids from 
portal circulation, and decreased de novo synthesis.
5. Decreased delivery of bile acids to the duodenum eg. 
biliary obstruction.
6. Depleted bile salt pool eg. impaired reabsorption of
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stomach
liver
(bile salt/formation)
Mucosal cells 
(CCK-PZ release)
CCK*
pancreas 
(lipase formation)Fat + bile salt
micelles
chylomicron
formation
10
lymphatic uptake
terminal ileum 
(bile salt reabsorption)
colon
Figure 4.1 - Physiology of fat absorption. Numbers refer 
to sites of pathophysiological mechanisms in fat 
malabsorption (see text).
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bile acids due to terminal ileal disease such as Crohn's 
disease, radiation enteritis or terminal ileal resection.
7. Intraluminal deconjugation of bile salts eg. small bowel 
overgrowth, which can be caused by blind loop; scleroderma; 
diabetic nephropathy etc.
8. Damaged mucosal cells eg. coeliac disease, giardiasis 
or Crohn's disease. (There may also be impaired release of 
CCK-PZ and secretin.)
9. Impaired formation of chylomicra eg. abetalipoprotein- 
aemia.
10. Decreased lymphatic uptake eg. infiltration of lamina 
propria with macrophages or obstruction of lymph ducts as 
in lymphangiectasia and lymphoma.
METHODS OF DIAGNOSING MALABSORPTION
1. Faecal Fat
Several methods have been devised for the diagnosis of 
malabsorption, but the test which is still considered to be 
the 'gold standard' is the measurement of faecal fat.
It might be expected that the amount of fat in the stool is 
at least partially decided by the fat intake from the diet. 
This subject has received considerable attention. When the 
dietary intake is reduced to negligible amounts in normal 
subjects there is still a faecal excretion of about 3g/day, 
which presumably represents normal endogenous losses - loss 
of mucosal cells and bacterial lipids. When fat intake is
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varied in quantity (50, 100, and 150g/day) or type, there
is little change in the amount of fat excreted (191). Even 
with an intake up to 200g/day there is little change in the 
faecal fat (192). With a normal Western diet, which 
contains about 50 - lOOg of fat each day, the faecal fat is 
normally less than 6g/day and the efficiency of fat 
absorption is greater than 97%. However, in patients with 
abnormalities of fat absorption, an increase in fat intake 
is, not surprisingly, reflected by an increase in faecal 
fat (193, 194).
Consequently when fat balance studies are performed it is 
important to know the fat intake within fairly broad 
limits. A common problem in estimating fat intake is that 
GI patients are not infrequently anorexic, or find eating 
fatty foods nauseating. Feedback from the nurses and 
dietitians is required to correct for incomplete fat intake 
and such corrections are based on judged, rather than 
measured, estimates.
A timed stool collection is required for faecal fat 
determination and this poses potential problems. Because 
the bowels cannot be evacuated at will and individuals 
defaecate about once each day, it is difficult to collect 
an accurately timed collection over a short period of time 
(unless perhaps the patient has diarrhoea and requires to 
defaecate more than about five times per day) . This 
problem can be solved by collecting samples for long 
periods of time - three to five day collections are 
considered to be the minimum - or by monitoring the
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excretion of a non-absorbed marker such as chromium 
sesquioxide or cupric isothiocyanate. The former approach 
makes the test much less appealing for the nursing staff 
and patient, as well as laboratory staff. The complete co­
operation of nurse and patient is needed for accurate 
collections and against the background of an unpleasant 
test this may be difficult to obtain. Personal experience 
has shown that the completeness of the collection (as 
gauged by the recovery of non-absorbed isotopic markers) 
varies considerably from ward to ward. Although the 
daytime ward sister may be convinced of the completeness of 
collection, she has limited control over other shifts of 
nursing staff.
The use of a non-absorbed marker does not necessarily solve 
the problems of a timed stool collection. An additional 
assay contributes its own degree of imprecision, 
measurement of a marker may not be a valid procedure in 
patients with diarrhoea, and new legislation limits the 
oral intake of non-BP substances such as these markers.
The most 'popular' technique for the laboratory 
determination of faecal fat is the van de Kamer method, in 
which the fatty acids are measured by titration after the 
sample has been homogenised (195). Another commonly used 
method is the extraction of fat from the stool into a 
solvent which is then evaporated leaving fat which can be 
measured by weight (196). The van de Kamer method does not 
measure non-acidic fats and so results are slightly lower 
than gravimetric methods. Both types of method are manual
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and time-consuming and, being unpopular, are often left to 
junior laboratory staff. No external quality control 
scheme is in operation for faecal fat determination and 
personal experience has shown that many laboratories do not 
employ internal quality control schemes. This laboratory 
employs the van de Kamer method but sends a duplicate 
sample to the routine Biochemistry laboratory for 
measurement by gravimetry. Results commonly referred to as 
'fliers' have occurred with some regularity and presumably 
reflect poorly controlled laboratory practices.
2. Triolein Breath Test
In 1962 an American group proposed a novel approach for the 
diagnosis of fat malabsorption. Their method simply 
involved measuring :L4C-carbon dioxide in the breath 
following the oral adminstration of a triglyceride -
trioctanoate - labelled with 14C in the carboxy group.
After digestion and absorption the fatty acid moiety is
metabolised with the production of 14C02, which is exhaled 
and can easily be measured. The breath 14C02 would be
expected to be low in malabsorption and higher in normal 
controls and their work confirmed this theory (19 7)
This ingenious concept obviates the unpleasantness of stool 
collections and, not surprisingly, has been widely studied. 
The original methods for collecting and analysing breath 
samples were cumbersome and involved sophisticated 
equipment, but Abt and Schuchling simplified this by 
trapping C02 in a hyamine hydroxide solution followed by
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liquid scintillation counting (198). Another important 
modification has been the use of other more preferable
triglycerides. Trioctanoate, being a medium chain
triglyceride is absorbable directly without the need for 
bile acid involvement, chylomicron formation, or lymphatic 
transport, and is less appropriate as a test fat.
Tripalmitate was considered to be a more appropriate choice 
since it is the commonest triglyceride consumed and tests 
all physiological aspects of fat absorption. Although some 
trials have been encouraging (199, 200, 201) several have
demonstrated an unacceptably high overlap of controls and 
malabsorbers (202, 203, 204)
In an important paper by Newcomer et al from Hofmann's
laboratory, the three triglycerides - trioctanoate,
tripalmitate, and trioleate - were used as fat probes and 
were compared with faecal fat analysis (203). Using faecal 
fat as the gold standard, the triolein breath test had a
sensitivity of 100% and a specificity of 96%, while using
the other two triglycerides produced excellent sensitivity 
but poor specificity. Since this publication there has 
been considerable interest in the triolein breath test, 
which has now been evaluated several times (205, 206, 207, 
208, 209, 210, 211). These studies, however, show a
considerable divergence of opinion as to the clinical
usefulness of this test, as illustrated in Table 4.1.
One possible reason for these discrepancies is the design
and analysis of the studies. There is no foolproof 'gold
standard' test for malabsorption with which to compare the
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results of the breath test. In the absence of a more 
suitable test. faecal fat measurement, despite its well 
known pitfalls, was mainly used for comparisons. Another 
alternative used was the classification of patients into 
those who on clinical, laboratory and radiological grounds 
might be expected to have malabsorption. Neither system of 
assessment can be considered ideal.
Most of the reports used predictive values for evaluating 
the data, but quoting sensitivity and specificity alone can 
be misleading. A small change in the reference range of 
the 'gold standard' (table 4.1 shows that there is a wide 
variation in what level of faecal fat is considered normal) 
can have a sizeable effect on the rate of false positives 
and negatives. The choice of control population also 
varied from healthy volunteers to irritable bowel disease 
and from GI patients to non-GI patients. It is unfortunate 
that few studies correlated the breath test with faecal 
fat, as this is a better way of evaluating a new test. The 
calculated correlation coefficients are shown in Table
4.1. (Those from Pedersons' study have been excluded for 
reasons quoted below.) It is interesting that there is no 
correlation in a study which quotes good predictive values 
(208) and a good correlation in a study which shows much 
poorer predictive values (210).
Another important factor that has varied between studies is 
the calorific load given with the 14C-triolein. It is 
known that the rate of fat metabolism is dependent on the 
availability of other energy sources (212, 213) . By
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increasing the calorific load given (either as carbohydrate 
or fat) the peak of breath 14COs is generally found to be 
delayed and reduced in height. For this reason Pederson's 
study is probably invalid, since a large fat and 
carbohydrate load was given and the breath was not 
collected for a sufficient length of time (only six hours) 
(211).
In general, most studies achieved good discrimination 
between fat absorbers and malabsorbers, however, the 
ability to diagnose mild cases of malabsorption has been 
questioned (210).
In order to calculate the breath test accurately the 
excretion rate of carbon dioxide must be measured. The 
instrumentation required for this is not widely available 
however, and so it is usual to assume that carbon dioxide 
output is normal - 9mmoles of carbon dioxide per Kg per 
hour. This data was derived from thirteen healthy fasting 
males, aged twenty-one to eighty-one, twelve of whom were 
aged less than twenty. (214) The average value was 8.7mmol 
COz/Kg/Hour, but there was a considerable range from 7.1 -
12.1. Interestingly, the eighty-one year old had the lowest 
output of C02 and this would be in accord with the general 
understanding that metabolic rate decreases with age. A 
more recent study has looked specifically at the effect of 
caloric intake, comparable to that used in breath tests, on 
the carbon dioxide output (215). At an intake of 200Kcal 
there was a small rise in carbon dioxide production, which 
increased to 30% with a calorie intake of 750Kcal. This
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effect of calorie intake on the endogenous carbon dioxide 
output has a two-fold effect on 14C-breath tests: 14C02 is 
diluted in a greater amount of endogenous CO2 , and the 
production of the 14C02 itself is greater. The endogenous 
carbon dioxide output was measured in normal fasting 
subjects and agreed fairly well with the earlier study 
(from 6 - 1 1  mmol/Kg/hour with an average of 8.0 - 8.2). 
No difference was found between healthy controls and 
patients with malabsorption. If an assumed value of 
9mmol/kg/hour had been used in the calculation (in this 
case the test was the 14C-glycocholic acid breath test) one 
of the twelve results would have been misclassified.
The excretion of 14COz in the breath is affected by 
respiratory function as well as the rate of fat metabolism, 
availability of other energy sources, and basal metabolic 
rate. Consequently the test is considered to be unsuitable 
for febrile and overweight patients and those with 
respiratory, liver, and various metabolic illnesses (216, 
217). In two studies on patients with liver disease the 
false positive rates were 33% and 50% (218, 219) . Such
exclusion criteria clearly limit the applicability of the 
test, and in one study on patients with suspected 
malabsorption 46% of the patients had at least one of these 
conditions (211).
A further important aspect of the test is that fat 
absorption is assessed over a brief period of time, usually 
during the morning. This may have implications in patients 
with a small bile acid pool. The test is usually performed
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after a period of fasting during which time the bile acid 
pool, although diminished, is concentrated in the gall 
bladder. Consequently, there may be sufficient secretion 
of bile acids to produce a normal triolein breath test 
despite the possibility that under non-fasting conditions 
malabsorption may be occurring.
3. Dual Isotope Tests
A less common approach to the assessment of absorption 
involves the use of two radioisotopes which are 
administered orally. One radioisotope, usually r e ­
labelled triolein, is absorbable and the other is a non­
absorbable marker. The ratio of isotopes excreted in a 
stool sample is compared with the ratio administered 
orally. If there is no in the stool (ie. ratio = 0)
then there is 100% absorption and if the excreted ratio is 
the same as that administered then there is 0% absorption. 
Because a ratio is being measured a random stool sample 
alone is required.
The two non-absorbed markers which have been used for this 
method are 51Cr-chloride which is water-soluble, and the 
fat-soluble 3H-triether. Morgan and Hofmann, using rats 
with steatorrhoea induced by cholestyramine, showed a good 
correlation between percentage absorption by the dual 
isotope method (using 3H-triether) and faecal fat (r = 
0.89, 0.96, and 0.87 for three consecutive days) (220).
The evaluation of this method in man was continued in our 
Gastroenterology Laboratory. Gerskowitch et al
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demonstrated that 3H-triether is almost completely 
recoverable from the gastrointestinal tract and does not 
separate from the oil phase (221). Nelson et al showed the 
dual isotope test to be reproducible with little day to day 
variation. Absorption in normal subjects was within a 
narrow range of 96.4% - 100%, while patients with
steatorrhoea caused by pancreatic or small intestinal 
disease had percentage absorptions ranging from 0% to 90% 
(222) . Lembcke et al used the same two fats but labelled 
with ^-emitting isotopes and found a good correlation with 
faecal fat (r = 0.813), with a sensitivity of 87.5% and 
specificity of 81.8% (223)
Pederson tested 5a-Cr-chloride as a non-absorbable marker 
and, although there are theoretical objections to its use 
since it is water-soluble, good results were obtained, 
showing a significant correlation with faecal fat (r =
0.82) (224).
On theoretical grounds, this type of approach suffers none 
of the problems of the faecal fat test. As with the 
triolein breath test it assesses fat absorption over a 
brief time period, but the problems associated with this 
(see page 215 - 216) can be easily avoided by starting the 
test in the afternoon. One aesthetic objection to this 
test is that a stool collection is necessary, but results 
can be calculated using a small untimed stool which does 
not require homogenisation.
2 1 7
Chapter 4 - Diagnosis of Steatorrhoea
4. Other Tests
In addition to the tests already discusssed the following 
alternative techniques for diagnosing malabsorption have 
been used. These have not achieved widespread application, 
however, mainly because subsequent evaluation has shown 
them to be suspect.
i) Faecal Microscopy: Microscopy of the stool for fat and 
meat fibres is a qualitative method which is still used as 
the sole test for malabsorption in some centres. The test 
is highly operator-dependent. To achieve the optimum 
quality of results the test should be performed by the same 
individual who has a clear protocol for analysis and 
interpretation (225). In severe steatorrhoea the test 
gives good results, but when the degree of malabsorption is 
moderate, the sensitivity falls and has been reported to be 
as low as 14% (226) .
ii) Serum Turbidity: After a fatty meal the turbidity of
blood increases and this increase has been used as an index 
of the efficiency of absorption. Although Osman et al 
(227) showed a clear descrimination between normal controls 
and malabsorbers, the latter group had pancreatic 
insufficiency in which there is gross steatorrhoea. When 
the Effectiveness of the technique is studied more 
realistically, by including patients with less severe 
malabsorption, there is a large overlap between normal and 
abnormal groups (205, 228) .
iii) Urinary Oxalate: The intestinal absorption of
oxalate, and consequently urinary oxalate excretion, is
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increased in the presence of malabsorption. It is thought 
that an increased concentration of intraluminal fats 
results in the formation of calcium-fatty acid soaps. 
Consequently, there is competition between fatty acids and 
oxalate for calcium, resulting in the release of oxalate 
making it more available for colonic absorption. 
Hyperoxaluria is often found in subjects with malabsorption 
and initially the measurement of urinary oxalate following 
an oral load of oxalate seemed to be a promising 
alternative to faecal fat determination (229, 230) .
However, the test requires a carefully controlled intake of 
fat as well as oxalate and current routine methods for 
measuring oxalate are poor. In addition a later study has 
demonstrated a poor correlation (r = 0.03) between daily 
urinary oxalate and faecal fat excretion (207).
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OBJECTIVES
The dual isotope fat absorption test using 3H-triether as 
non-absorbable marker has been developed in this 
laboratory and is now used as a routine test of fat 
absorption in this hospital. However, 3H-triether is not 
a routine item which can be readily purchased from 
radioisotope companies and in 1987 our stocks, which were 
custom-prepared by Amersham, were becoming depleted. 
Consequently a decision had to be made whether to reinvest 
in another batch of the isotope or to switch over to an 
alternative test of fat absorption. The main disadvantage 
of the former approach was the cost involved since one-off 
custom preparation of isotopes is an expensive procedure 
(1987 cost of c£4, 000/mCi) . With regard to an alternative 
fat absorption method there were two which seemed to have 
potential, although both had possible drawbacks. The 
simplicity of the triolein breath test was appealing but, 
as has been outlined above, the results of various 
evaluations of this technique are conflicting. The second 
possibility was to continue to use a dual isotope fat 
absorption test but replacing 3H-triether with 51CrCl3 as 
the nonabsorbed marker. Our main misgiving in using 
sxCrCl3 was that it is water soluble and therefore might 
not satisfy all the criteria required for a nonabsorbed 
marker. In particular we were concerned that the test 
isotope (14C-triolein) and 53-CrC13 would move through the 
gut at different rates due to their different solubility 
properties.
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We decided to solve this dilemma by comparing both of 
these tests with our dual isotope method which we felt 
could more justifiably claim to be the 'gold standard' 
test than the measurement of faecal fat (see pages 216 - 
217) . The practical aspects of the triolein breath test 
and the two dual isotope tests are very similar. With 
simple modifications it was feasible to perform the three 
tests simultaneously. Consequently we were in the 
fortuitous position of being able to use our remaining 
stocks of 3H-triether to compare the two fat absorption 
tests with our existing dual isotope technique.
The individual objectives were as follows.
1. To improve our existing methods for extracting and 
quantitating 3H and 14C.
2. To modify our existing dual isotope method to ensure 
that 53-Cr could also be counted.
3. To assess the validity of using slCrCl3 . as a 
nonabsorbable marker.
4. To compare the results of the triolein breath test with 
the dual isotope and faecal fat methods.
5. To measure the endogenous production of carbon dioxide 
in order to determine the validity of using an assumed 
value.
6. To determine the necessity of collecting specifically 
end-expired breath to calculate the triolein breath test
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result.
7. To assess whether the triolein breath test gave valid 
results on the patient groups which are usually excluded, 
ie. febrile patients and those with metabolic and 
respiratory illnesses.
8. To investigate the possibility of measuring PAT-3H on 
single untimed stools.
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MATERIALS AJSTD METHODS
EXISTING METHOD FOR MEASURING PERCENTAGE ABSORPTION OF 
TRIOLEIN BY THE DUAL ISOTOPE TECHNIQUE.
The two isotopes used in the existing dual isotope fat 
absorption method were glycerol tri [ 1-:L4C] oleate and 
tritiated glycerol triether (Radiochemical Centre, 
Amersham). The latter was prepared by catalytic reduction 
of 1-(9-cis-hexadecyl)2,3-didodecyl glycerol with tritium 
(231). The isotopes - 400kBq of ^C-triolein and 2000kBq 
of 3H-triether - were administered orally within gelatin 
capsules and a small aliquot was retained as standard. A 
20g fat load in the form of double cream (42g) was taken at 
the same time.
After administration of the isotope capsules, faeces were 
collected over a three day period and homogenised, with the 
addition of water if necessary. Approximately 40ml of 
stool homogenate was added to a round-bottomed flask 
followed by a fourfold volume of chloroform:methanol (2:1) 
and this was refluxed for six hours. The chloroform layer 
was separated by overnight filtration and the radioactivity 
in dried aliquots (of 50, 100, and 200jrl) measured by a
Packard liquid scintillation counter. The window settings 
of the counter were adjusted to 0 - 12keV for 3H and 12 - 
156keV for 14C. Correction for quenching was achieved 
using commercially available quench standards (Canberra 
Packard Ltd, England). The percentage absorption of 
triolein using 3H-triether as nonabsorbable marker (PAT-3H)
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was calculated from the ingested and excreted isotope 
ratios as follows.
Percentage Absorption
= 1 [3H/14Clngested] X 10
Tritium and 14C are 3-emitting radioisotopes (ie. they 
decay by the release of 3-particles) but the energy of 
these particles is not sufficient to be measured directly. 
The technique of liquid scintillation counting enables the 
quantitation of radioactivity by initially converting the 
energy of radiation to light energy. The substance to be 
measured is dissolved in a solution containing scintillant 
molecules. When 3-particles impinge upon these molecules, 
photons of light are released whose intensity is 
proportional to the energy of the 3-particle. In the case 
of 14C, photons of energy up to 156KeV are produced whereas 
tritium emissions are weaker being up to 18KeV.
Any process which interferes with the production or 
transmission of light is referred to as quenching. In 
practice two types of quenching exist. With chemical 
quenching the efficiency of energy transfer from the 3- 
particle to the scintillant is decreased. This can be 
caused by the presence of solvent molecules in the 
scintillation fluid. Colour quenching is the subsequent 
absorption of light energy that has been produced by the
MODIFICATIONS TO THE METHOD OF QUENCH CORRECTION.
Background
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scintillant. Any colour, particularly yellow, in the 
scintillation fluid will cause this. The result of both 
forms of quenching is that the intensity of light energy is 
decreased. The amount of quenching in each sample can be 
measured and appropriate corrections to the dpm made, by 
comparison with commercially available quench standards. 
When stool extracts are dissolved in scintillation fluid 
the solution becomes a strong yellow or golden colour 
making quench correction essential. During the measurement 
of PAT-3H it was normal practice to measure the 3H/14C 
ratio in each of three duplicated aliquots containing 
different volumes of dried chloroform extract (50, 100 and 
200|il) . However, it was noticed that there was a frequent 
effect of the chloroform volume used on the measured 
ratio; in general, the dpm/ml (ie. radioactivity per ml of 
dried chloroform) of both 3H and 14C, decreased with 
increasing volumes of chloroform extract. This trend was 
more pronounced with highly quenched (coloured) samples. 
On first thought it seemed likely that the chemical quench 
standards did not correct accurately for samples with 
colour quenching. Another possibility was that there was a 
fault in the dual label programme in the p-counter for 
calculating 3H and X4C.
Experiment to Determine the Effect of Colour Quenching on
3H and X4C Counts.
In order to investigate this observation more fully, the 
following experiment was set up. To three sets of ten p- 
counting vials were added equal volumes of 3H-triether
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containing about 500, 5000, and 50,000dpm. Scintillation
fluid was added and the 3H was measured using commercially 
available quench standards. The window settings on the 
counter were adjusted to measure 3H only (ie. single-label 
programme). There was some variation of dpm measured 
between the ten vials, and so eight vials whose dpm agreed 
best were selected from each set. The scintillation fluid 
was then transferred to a second set of eight glass p- 
counting vials containing 0, 50, 100, 250, 500, 1000, 1500, 
and 2000|il of dried chloroform extract from a stool sample 
which contained no radioactivity. The radioactivity in 
each vial was then counted again using both single-label 
and dual-label programmes (for 3H in the presence of X4C).
This experiment was repeated using X4C-triolein which was 
again counted using single-label (14C only) and dual-label 
programmes (for X4C in the presence of 3H).
The 3H dpm results obtained were similar for the single­
label and dual-label programmes. The same was true of X4C 
dpm. This demonstrated that the dual-label programme was 
producing valid results.
The effect of quenching - calculated as the quench index 
parameter (QIP) - on the three levels of 3H dpm is shown in 
figure 4.2. (The QIP has an inverse relationship to the 
degree of quenching.)
This experiment demonstrated that as the colour quenching 
increased (ie. QIP decreases) the 3H dpm decreases. This 
effect was seen at the three levels of 3H dpm investigated.
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No effect of colour quenching on 14C dpm was found.
It was clear that with no correction for colour quenching 
the results of PAT-3H were inaccurate. It seemed that this 
problem could be solved in one of two ways; correction of 
quenching using colour quench standards, or decolourisation 
of the samples.
Use of Colour Quench Standards to Correct for Quenching
In order to correct for colour quenching a set of colour 
quench standards was prepared as follows. Similar amounts 
of 3H-triether (about 100,000dpm) was added to each of 
fifteen glass p-counting vials. Eight vials whose dpm 
varied the least were chosen from the fifteen and an 
average dpm value was calculated. The contents of these 
vials were then transferred to a second set of eight p- 
counting vials containing differing volumes of dried 
chloroform extract obtained from a stool containing no 
radioactivity. The quench curves produced are shown in 
figures 4.3 - 4.6 along with quench curves obtained from 
chemically quenched standards. It is evident that the two 
ways of correcting quenching produce quite different 
curves. This substantiated the conclusion that a chemical 
quench curve is not suitable for colour quench correction.
With this lack of success of colour quench correction, 
attempts were then made to avoid the problem by 
decolourising the faecal chloroform extracts.
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Decolourisation of Chloroform Extract By Bleaching
The addition of hydrogen peroxide has been employed to 
decolourise samples prior to liquid scintillation counting. 
However, when this method was applied to decolourise faecal 
extracts, results were disappointing. It was found that 
small volumes (0.5ml) of hydrogen peroxide were ineffective 
in decolourising faecal chloroform extracts. By using 1ml 
of hydrogen peroxide decolourisation was still incomplete 
and in addition the 3H and 14C dpm increased by an average 
of 11.2% and 8.4% respectively.
Decolourisation of Chloroform Extract By Irradiation
The characteristic colour of stools is caused by pigments 
derived from bilirubin such as stercobilin and urobilin. 
(Hence patients with complete biliary obstruction excrete 
stools which are nearly white in colour.) It was 
speculated that these pigments could be destroyed by 
exposure to ultaviolet light in a manner analogous to the 
treatment of jaundiced neonates.
This simple procedure proved to be effective in 
decolourising dried chloroform extracts, with an overnight 
exposure being sufficient for all but the most strongly 
coloured samples.
To determine whether the commercially available chemical 
quench standards gave satisfactory results with 
decolourised samples the following experiment was 
performed.
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Similar 3H and 14C counts (about 100,000dpm of each) were 
measured into seven 3-counting vials, scintillation fluid 
was added, and the dpm measured. To a second set of seven 
vials were added different volumes (0, 0.25, 0.5, 1.0, 1.5, 
2.0, and 2.5ml) of chloroform extract from a stool 
containing no radioactivity. The samples were then 
evaporated and decolourised. The contents of the first set 
of tubes was then transferred to the second set and the 
counts measured. Compared with the sample containing no 
chloroform extract, there was no significant percentage 
difference for either 3H (100.6%) or 14C (99.4%).
With the use of chemical quench correction' 3H and 14C 
results were achieved which did not vary with the volume of 
chloroform extract used. It was found at a later stage 
that overnight exposure to light from an ordinary tungsten 
lamp was as effective as using a UV lamp. Longer exposure 
times were sometimes required to decolourise highly 
coloured faecal extracts or if large chloroform volumes 
were used. However, as long as the QIP was greater than 
500, there was no effect on either 3H or 14C dpm.
MODIFIED METHOD FOR MEASURING PERCENTAGE TRIOLEIN
ABSORPTION
It was apparent that at least one modification to the 
extraction procedure described above would be required. 
Ratios of 3H/14C can be used to calculate the PAT-3H result 
because the triolein and triether are similarly extracted 
into chloroform. However, with the use of 51CrCl3 as non­
absorbable marker a ratio could no longer be used since
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slCrCl3 - being water-soluble - does not extract into the 
chloroform with the 14C-triolein. Consequently, to
calculate the percentage absorption of triolein using 
51CrCl3 as non-absorbable marker (PAT-51Cr), the absolute 
amount of 14C-triolein excreted had to be measured. In 
order | to measure this accurately, no losses of chloroform 
due to evaporation (as would occur during the filtration 
step) could be tolerated. It was considered that the 
separation of chloroform from the aqueous phase could 
alternatively be achieved by centrifugation. Since the 
refluxed stool could be centrifuged in a contained system 
losses due to evaporation might be minimised.
The final modified method for measuring the percentage 
triolein absorption is as follows. For two days prior to 
the test and during the three days of the stool collection, 
the patient ate a high fat diet containing 70 - lOOg/day of 
fat. Dietary fat intake was calculated in those patients 
who were unable to tolerate this diet. After an overnight 
fast the patient swallowed the gelatin capsules containing 
14C-triolein and 3H-triether. The capsules were washed 
down with 20g of fat in the form of double cream and 
lOOOkBq of slCrCl3 dissolved in 50ml of water. Two 100^1 
aliquots of slCrCl3 solution were retained as standards. 
This protocol, which is broadly similar to that of Newcomer 
et al (203), was chosen so that comparative results would 
be available to facilitate the interpretation of the 
triolein breath test results.
A three day stool sample was usually collected into three
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containers each covering a 24 hour period. In some cases 
individual stool samples were collected over the three day- 
period. After homogenisation, an aliquot of 3 - 6g was 
transferred to a round-bottomed flask. A volume of 25ml of 
0.9% saline and 37.5ml of chloroform:methanol (2:1) was 
added and the flask weighed. After refluxing for one hour 
(it was found that decreasing the reflux time from six 
hours to one hour gave similar results) the flask was 
cooled and reweighed. The refluxate was transferred to a 
stoppered test tube and centrifuged (lOOOrpm for five 
minutes) to separate the chloroform and aqueous layers. 
Volumes of 0.5, 1.0, and 1.5ml of the lower chloroform
layer were transferred by Pasteur pipette to 3-counting 
glass vials. When the chloroform had evaporated the dried 
extract was exposed to light until decolourised. The dried 
extract was then dissolved in 10ml of liquid scintillant 
(Pico Fluor 40, from Canberra Packard Ltd) and the 14C and 
3H radioactivity was measured using the dual-label counting 
facility of a Packard Liquid Scintillation Counter. 
Quenching was measured and corrections made using 
commercially available chemically quenched standards. The 
faecal fat excretion was measured by the van de Kamer 
method (195) and sometimes also by a standard titrimetric 
method (196) .
Four aliquots of homogenate of about 5g (accurately 
weighed) were transferred to gamma-counting vials and the 
dpm of 5:LCr was measured in a Packard gamma counter with 
window settings of 240 - 400keV. The PAT-3H was calculated
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as was described earlier (page 224) and the PAT-5:LCr was 
calculated in an analogous way as follows.
sa-CrCl3 excreted = (dpml + dpm2 + dpm3 + dpm4) x H
(W1 + W2 + W3 + W4)
where H = weight of homogenate and W = weight of aliquots
counted
14C excreted = dpm/ml x 25 x H
W
(The 37.5ml of chloroform/methanol (2:1) used produced a 
chloroform subnatant of 25ml)
PAT—slCr = 1 — [51Cr/14Cxngested] x 100%/
/[51Cr/14 Cexcreted]
ASSESSMENT OF THE MODIFIED PROCEDURE
Assessing for Completeness of Chloroform Recovery
To ensure that there was no loss of chloroform at the 
refluxing stage the weight of sample was measured before 
and after this step. The average loss of chloroform was 
0.49g (sem = 0.028, n = 11). This is equivalent to a
volume of 0.33ml and percentage loss of 1.3% which was 
considered to be acceptable.
Effect of slCrCl3 on the Measurement of 3H and 14C dpm
Although 5:LCr is a gamma-emitting isotope it will also 
produce readings on a liquid scintillation counter. It was 
important therefore that the 51CrCl3 was not extracted into 
the chloroform layer. To assess this, two stool samples 
containing all three isotopes were extracted in the normal
2 3 5
Chapter 4 - Diagnosis of Steatorrhoea
way and aliquots of the aqueous supernatant, solid 
interphase, and chloroform subnatant were measured in a 
gamma counter.
s±Cr was found predominantly in the solid interphase with 
some in the aqueous supernatant. No 53-Cr was detectable in 
the chloroform layer. On the first twenty patient tests 
performed, the chloroform layer was measured in a gamma 
counter. Again no 51Cr was measurable. it was
consequently concluded that 3H and 14C could be confidently 
measured in the chloroform layer without contamination from 
51Cr.
Assessing the Recovery of 14C and 3H During Extraction
The recovery of 3H and 14C was assessed as follows. 
Aliquots of eleven stool samples were transferred to round- 
bottomed flasks and about 8kBq each of 3H-triether and 14C- 
triolein in ether was added. The ether was evaporated off 
and the samples extracted and counted normally. As 
standard, a similar amount of each isotope was added to a 
clean flask and diluted with 25ml of chloroform. The 
recoveries of 3H-triether and ;L4C-triolein were good at 
104.7% (sem = 3.7) and 98.4% (sem = 3.1) respectively.
Reproducibility of the Extraction Procedure
The extraction procedure was performed in duplicate on the 
first twenty-five patient tests. Results of precision at 
differing ranges of PAT-3H are shown in table 4.2. 
Because of the nature of the equation used to calculate
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PAT—3H the precision varies with different degrees of 
malabsorption. Thus, when absorption is approaching 100% 
large differences in the 3H/14C ratio produce relatively 
small changes in the percentage absorption. When the 
percentage absorption is low the converse is the case.
PAT—3H 
Range
n Mean Standard
Deviation
Coefficient 
of Correlation
90 - 100% 8 97.8% 0.78 0.80%
75 - 90% 12 83.3% 3.3 3.9%
< 20% 5 9.6% 2.2 23%
Table 4.2 - Precision of PAT-3H at Differing Degrees of
Malabsorption
In general the test showed good precision. Fortunately the 
poorer precision found at very low levels of absorption has 
no clinical implications.
Comparison with Biological Oxidation
The technique of biological oxidation enables 14C and 3H to 
be counted without prior extraction. The sample is 
oxidised on a metal coil at high temperature over a stream
of oxygen. Tritium is trapped in an enclosed system as
steam while 14C isotopes are oxidised to 14C-carbon dioxide 
which is trapped separately on Carbosorb (Canberra Packard 
Ltd, England). In this way 14C and 3H were separated from 
each other and collected directly into scintillation fluid 
in a comparatively pure form. This would have been a
preferable method for counting 14C and 3H in the
calculation of PAT-3H. Unfortunately biological oxidisers
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are expensive and not routinely available. However, access 
to one in the Department of Medicine of the Western
Infirmary in Glasgow was obtained for the purposes of 
evaluating the above extraction procedure.
A Packard Biological Oxidiser using a platinum coil at 
700°C was used. Tritium in the form of water was collected 
into Monophase-40 scintillation fluid and 14C-carbon
dioxide was trapped on Carbosorb and washed into 
Permafluor-5 scintillation fluid (Canberra Packard Ltd, 
England).
Stool samples were spiked with small quantities of 3H-tri- 
ether and 14C-triolein; the mean recovery was found to be 
104.9% and 98.4% respectively but individual results varied 
widely. The precision in duplicate stool samples was also 
measured: the standard deviation was 6.9 and the
coefficient of variation 10%.
A total of fifteen stool samples was analysed by both 
methods and their degree of correlation is shown in figure 
4.7 (see Statistical Appendix, note 4). The correlation
coefficient, at 0.92, was not ideal but was considered to 
be partially due to the performance of the biological 
oxidation method which in practice gave poor 
reproducibility (CV = 10%) and highly variable recoveries.
Accuracy of 3H and 14C counting
It was important that both radioisotopes, particularly 14C, 
were accurately counted by liquid scintillation counting.
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Figure 4.7 - PAT -3H results: biological 
oxidation vs extraction.
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When PAT—3H results approach 100% the 14C dpm is very low 
therefore even a small spillover from the 3H channel to the 
14C channel would result in the results being 
underestimated. This experiment was designed to study the 
mutual effect of the two radioisotopes on the accuracy of 
counting.
Known amounts of pure 3H-triether and 14C-triolein were 
added to p-counting vials to produce levels of dpm 
typically encountered during the measurement of PAT-3H. 
Dpms used were 250 - 18,000 for 3H and 0 - 500 for 14C.
The results demonstrated that 3H could be accurately 
measured at all levels of 14C investigated. Conversely, 
although there was some spillover from the 3H to the 14C 
channel this was insufficient to alter the isotope ratio 
such that inaccurate PAT-3H resulted. PAT-3H results were 
calculated (using a value of 5 for the isotope ratio of the 
standard) in order to determine whether any spillover was 
significant. The calculated and expected PAT-3H results 
are shown in table 4.3.
USE OF SINGLE UNTIMED STOOLS TO CALCULATE PAT-3H
One of the potential benefits of dual isotope fat 
absorption tests is the opportunity to use a single small 
untimed stool sample. Although this technique still 
requires the use of stool samples, the test would be more 
like a stool occult blood test with regards to patient and 
staff acceptability. However, Nelson et al showed that 
results could not always be produced since the stool
2 4 0
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3H dpm PAT-3H Results
Odpm 14C 25dpm 5 Odpm 10Odpm 25Odpm 50Odpm
250 98 100) 60 (59)
500 100 100) 79 (77) 56 (48)
750 100 100) 88 (87) 73 (71) 47 (46)
1000 97 100) 86 (87) 76 (74) 55 (53)
2000 97 100) 92 (94) 83 (88) 74 (75) 42 (38)
4000 100 100) 97 (97) 94 (94) 86 (87) 72 (68) 43 (37)
9000 99 100) 98 (99) 99 (97) 94 (95) 88 (87) 74 (73)
18000 99 100) 98 (99) 98 (99) 98 (97) 92 (93) 86 (85)
Table 4.3 - Calculated and expected PAT-3H results at 
different levels of 3H and 14C. (Expected results in
parentheses).
collected may not contain any isotope. They suggested 
therefore that the test could not be reliably carried out 
by collecting a single stool collection on either days one,
two, three or four (222)
It was speculated that rather than collecting a stool at a 
specific time after the start of the test, the time of 
stool collection could be altered (with a knowledge of the 
patients' bowel habit) to ensure that isotopes were 
present. This was investigated on thirty consecutive 
patients who attended the Gastroenterology Unit for an out­
patient PAT—3H test. They were initially questioned about 
their frequency of bowel movement to decide when the stool 
should be collected. In 18 patients with normal bowel 
movements or intermittent diarrhoea the first stool passed 
after 24 hours was collected, in eight with troublesome
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diarrhoea the first sample after 12 hours was collected, in 
one slightly constipated patient the first stool after two 
days was collected. Two patients failed to return the 
collection.
MEASUREMENT OF PERCENTAGE 14C-TRIOLEIN IN BREATH
At 0, 1, 2, 3, 4, 5, and 6 hours after the isotope capsules 
had been given, end-expiratory samples of breath were 
collected. Factors known to affect carbon dioxide 
production, such as smoking and exercise (232), were 
minimised. Patients exhaled normally and then blew via a 
drying tube into a carbon dioxide trapping solution (1ml of 
hyamine hydroxide - methyl benzethonium hydroxide - 1ml of 
methanol and 50[il of thymolphthalein as pH indicator) . 
This process was repeated until the solution changed from 
blue to colourless, indicating complete neutralisation of 
the hyamine hydroxide. Scintillation fluid was added and 
the sample left for four hours to allow any 
chemiluminescence to subside before measuring the 14C by 
liquid scintillation counting.
Hyamine hydroxide obtained commercially is approximately 
lmmol/1. The exact concentration was measured by titrating 
2ml with 100mmol/l hydrochloric acid using thymolphthalein 
as indicator.
It soon became obvious that some patients had difficulty in 
collecting end-expired breath. In such patients a mixture 
of end-expired and normal expired breath was usually 
collected. To determine whether these collections had an
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effect on the result, a number of patients who could 
collect end-expired breath in the proper way were also 
asked to provide normally expired breath, ie. normal 
exhalations rather than forced exhalations were collected.
At some point during the breath test, three or four two- 
minute samples of breath were collected into Douglas bags 
and the carbon dioxide and oxygen concentrations and total 
volume measured (Ventilation Monitor, PK Morgan, Chatham, 
Kent) . It was found that some patients tended to 
hyperventilate when breathing through the mouthpiece and so 
instructions were subsequently given to encourage the 
patient to relax and avoid hyperventilation. Whenever 
possible the patient read a book or newspaper, or watched 
television during collection of breath so that they were 
less aware of their breathing rate.
The respiratory quotient (r) was calculated using the 
equation:
r = %C0a
(20.9 - %Oa)
where 20.9 is the percentage of oxygen in air. High r 
values in these fasted and resting patients probably 
represented hyperventilation and so if r was found to be 
outwith the normal range of 0.7 - 0.9 this result was
excluded from consideration.
The patients' carbon dioxide output was measured by the
following equation.
Carbon dioxide Output %C02 x V x K x 60
(mmol/hour/Kg) = 22.4 x Wt
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where V = volume of breath excreted per minute, K = a 
factor to convert volume to conditions of standard 
temperature and pressure (STP), and Wt = the patient's 
weight in kg. Dividing by 22.4 converts litres of gas at 
STP to moles.
The percentage 14C-carbon dioxide excretion in the hourly 
breath samples was calculated as follows.
%14C excretion in breath = dpmbreath x CO x Wt x 100
C x dpm standard. X Ka. X K2
Where CO is the carbon dioxide output in mmol/hour/Kg, Wt = 
weight of patient, C = molarity of hyamine hydroxide 
solution, Ki = a factor (1.25) to compensate for the volume 
difference in p-scintillation vials between the standard 
solution and the 'breath solution', and K2 = the ratio of 
the weight of isotope administered and that retained as 
standard.
Results were expressed as the percentage of the total 14C 
isotope administered in the breath per hour. The 
cumulative 14C02 in the breath during the six hour period 
of the test was calculated as the sum of the average hourly 
outputs.
SEPARATION OF 3H—TRIETHER AND 14C-TRIOLEIN
Separation of the two radio-labelled fats was achieved by 
high performance thin layer chromatography (TLC) using 10cm 
x 10cm silica plates (LHP-K plates from Whatman Inc, 
England). When the method of Gerskowitch (221) was tested 
using the solvent system of hexane:ether (85:15), the
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triether standard ran with the solvent front (ie. Rf = 
1.0). Since this system would not allow the resolution of 
two bands with this mobility, the solvent system was 
changed. Triether did not move from the origin when hexane 
or methanol was used, but the addition of glacial acetic 
acid (100:5) resulted in a mobility of 0.23. The presence 
of ether increased the Rf further. The final solvent 
system of hexane:ether:glacial acetic acid (85:15:1.5) gave 
mobilities of 0.92 for triether (1,2,3-didodecyl triether, 
0.62 for triolein (glycerol trioleate, BDH, Poole), and 
0.35 for oleic acid (BDH).
Fat was detected as a yellow colour after TLC plates were 
sprayed with 0.05% 2',7'-dichlorofluorescein (Sigma
Chemical Co, Poole) in ethanol. Radioactivity was 
visualised after exposing the plates to photographic film 
(GBX-2, Kodak, England) for several days.
To quantitate the amount of radioactivity in TLC bands, 
silica corresponding to the band was scraped off and the 
ether-soluble extract counted by p-scintillation counting.
PURIFICATION OF 3H—TRIETHER
Tritiated triether was purified by a preparative thin layer 
chromatography method using the solvent system described 
above. The tritiated extract was spotted onto the TLC 
plate and after chromatographic separation, autoradiography 
was used to locate the radioactive bands (figure 4.8). The 
position of 3H-triether was determined by comparison with a 
chemical standard of 1,2,3-didodecyl triether. The silica
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corresponding to this was scraped from the plate and the 
3H-triether separated by dissolving in ether. This step 
was repeated, and the ether dried in a glass vial. The 3H- 
triether was solubilised in toluene and stored at 4°C.
STABILITY OF RADIOISOTOPES TO COLONIC BACTERIA
The following experiment was performed in order to 
investigate the stability of 14C-triolein and 3H-triether 
isotopes to colonic bacterial enzymes. A small volume of 
faecal homogenate (5 - lOg) and 25ml of 0.9% saline was 
added to a round-bottomed flask. 50kBq of 14C-triolein or 
3H-triether dissolved in ether was added and the solvent 
evaporated under a stream of nitrogen. After incubation at 
37°C overnight (approximately sixteen hours) the sample was 
refluxed and extracted as usual into chloroform. Stool was 
excluded from one flask to serve as a control. A volume of 
lOpl of chloroform was applied to a TLC plate and after 
chromatography the plate was autoradiographed.
The experimental design employed could not be used to
identify the presence of 14C-labelled gas production such
as 3-4C-carbon dioxide or 14C-methane. In order to
ascertain whether either of these breakdown products was
being generated, the experimental system was modified as
illustrated in figure 4.9. The round-bottomed flask was
made air-tight, and after incubation water was added to
displace the gas. This was then bubbled through a series
of tubes containing either hyamine hydroxide for thecapture
of carbon dioxide, or chloroform to trap methane. Since it
was not known what proportion of gas would be trapped in
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solution, a series of tubes was used so that the decrease 
in X4C could be monitored in order to gauge the recovery of 
14C-gas. When all the gas within the round-bottomed flask 
was displaced, the solutions were transferred to p-counting 
vials, scintillant added, and 14C counted.
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RESULTS AND DISCUSSION
Despite the development of a variety of techniques for 
detecting fat malabsorption, none stands out as the 
obvious routine method of choice and for assessment 
purposes there is no test which can be considered as
definitive.
The concept of dual isotope tests, although not widely 
employed, has a sound theoretical basis and should provide 
good results provided that the following criteria for a 
non-absorbable marker are satisfied. i) The non­
absorbable marker and absorbable test substance should be 
inseparable throughout the intestine except if the latter 
is absorbed. ii) The marker should be resistant to
digestion and colonic transformation. iii) The marker
should be easily and reliably measured, iv) The marker 
should be non-toxic, v) The marker should not be absorbed.
The present study provided an opportunity for further 
assessing some of these criteria.
INTRA-INDIVIDUAL VARIABILITY OF PAT~3H AND PAT-SiCR
RESULTS
The initial criterion, that non-absorbable marker and 
absorbable test substance should be inseparable, is one of 
the most difficult to ascertain. Initial in vitro studies 
have attempted to simulate the physiological situation in 
the gut and monitor the partitioning of test and non­
absorbable probes. However, the physiology of intestinal 
function is so complex that any assessment is incomplete
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without in vivo confirmation. On the other hand, since 
the test marker is absorbed to some extent it is difficult 
to assess the separability of non-absorbable marker from 
the test probe by in vivo experiments. Since neither 
probe is absorbed in the stomach, the potential for 
separation within the gastric lumen and during gastric 
emptying can be ascertained by in vivo studies. However, 
the only effective way of investigating the separability 
of the two probes in the entirety of the gastrointestinal 
tract is to determine if the two markers move through the 
intestine at the same rate. If the isotopes move at 
different speeds through the gut then the ratios in 
consecutive stools would change. This can be readily 
assessed by collecting individual stools from a subject 
who has taken the isotopes orally. If the relative 
movements of test and non-absorbable marker are similar 
then each faecal collection should give similar ratios. 
This investigation must be performed in subjects who have 
a degree of fat malabsorption so that some of the test fat 
(usually 14C-triolein) travels through the gut and is 
excreted.
To assess this, stool samples from each patient were 
collected separately and PAT-3H and PAT-5:LCr measured. We 
initially suspected that the intra-individual variability 
of the latter might be poor because 5;LCrCl3 is water 
soluble. However, quite unexpectedly the initial PAT-3H 
results, illustrated in table 4.4, showed very poor 
reproducibility between samples from the same patient. 
This imprecision was such that the calculation of
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Number Stool 1 Stool 2 Stool 3
1 97% 93% —
2 -20% 18% -
3 100% 100% -
4 99% 99% -
5 - 48% 89%
6 93% 99% 98%
7 43% 83% -
8 100% 100% 100%
Table 4.4 - Initial PAT-3H results showing intra­
individual variation.
PAT-3H using a random stool could have given erroneous 
results. In addition, one PAT-3H result (patient 2) was 
negative, ie. the 3H/14C ratio in the stool was lower than 
the standard. Various technical reasons for this 
anomalous result, such as counting errors or isotopic 
contamination, were excluded.
These two findings, of poor intra-individual precision and 
a negative result, could be explained on the basis that 
3H-triether and 14C-triolein were moving through the gut 
at different rates and/or that impurities of 3H or X4C 
were present. On patient number eight a urine sample was 
collected and this was found to contain about 5% of the 
ingested 3H. Since previous studies have shown that 3H- 
triether is not absorbed (220, 221) this suggested that 3H 
impurities were present.
It was decided that more extensive investigations into the 
nature of this problem was required before any further 
patient tests were carried out.
Autoradiography of Isotopes
In order to investigate the integrity of 3H-triether, TLC
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was performed followed by autoradiography of the 
chromatogram. This revealed that '3H-triether' ran not as 
a homogeneous band but as three predominant bands with Rf 
values of 0.0, 0.21, and 0.90 (figure 4.10). The bulk of 
the radioactivity, 61%, remained at the origin, with 20% 
at Rf 0.21 and only 15% at R± 0.9 corresponding to pure 
triether.
This experiment clearly demonstrated that a large 
proportion of 3H was present as other chemical forms. The 
3H which remained at the origin was much more polar than 
the tritiated form and so would be expected to a) move 
through the intestine at a different rate and b) be 
available for absorption. On both counts these initial 
PAT-3H results were invalid.
The tritiated radioisotope was stored and dispensed by the 
West of Scotland Radioisotope Dispensary in the Western 
Infirmary, Glasgow, in two separate vials. It was 
subsequently found that the second vial also contained 
tritiated breakdown products of the triether, although 
relatively more of the tritiated triether was intact 
(about 80%).
The triether molecule itself is chemically very stable and 
tritium isotope has a long half-life (12.26 years). 
However, the presence of an isotope as an integral part of 
the molecule was probably the cause of its degradation, 
with local radiation within the molecule causing radiation 
autolysis. The radioactivity had been stored in
concentrated form and so the decay due to irradiation was
2 5 6
Chapter 4 - D i a g n o s i s  of Steato r r h o e a
solvent front
3H-triether
R f = 0.9
Rf = 0.21
origin
Figure 4.10 - Autoradiograph of impure 3H-triether.
257
Chapter 4 - Diagnosis of Steatorrhoea
accentuated. For this reason the stocks are now stored in 
more dilute form.
There was a salutory lesson to be learnt from this 
episode. Over several years the test had become accepted 
as a routine procedure and 3H-triether was ordered when 
required from the West of Scotland Isotope Dispensary. 
The responsibility for the 3H-triether was therefore 
shared by two distinct departments but neither was 
carrying out quality assessment and nor was the isotope 
exposed to the stringent standards of a commercial 
concern. A quality control procedure had not been 
established at the early research stage and with the 
responsibility for the isotope being dichotomised, none 
had been implemented since. Hence there was incomplete 
control regarding the integrity of the isotope. This 
oversight was probably the result of the regard of the 
test evolving over a number of years, from an awareness 
within a tightly-controlled research setting, to the 
abstracted approval of routine.
When the problem had been identified, the 3H-triether was 
repurified by preparative TLC (see page 245). In addition, 
working practices were modified so that responsibility for 
the isotope was placed with only one department, the 
Gastroenterology Laboratory, and a quality assessment 
procedure was introduced to ensure that 3H-treither used 
for future tests was pure.
* * * * * *
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The stability of 3H-triether was also assessed over 
different time intervals by TLC/autoradiography. 50kBq 
aliquots of purified 3H-triether were stored in 5ml of 
toluene at -20°C, 4°C and room temperature (approximately 
23 ° C).
Results of this experiment revealed that 3H-triether 
appeared as a single band corresponding to pure glycerol 
triether at all the temperatures and times investigated. 
Thus the isotope was stable for up to at least two years 
at each of the temperatures used. Stocks of the 
radioisotope were subsequently stored at refrigerator 
temperature (4°G).
Amersham International report decomposition rates of less 
than 2% per annum for 14C-triolein when stored in toluene 
under nitrogen at -20°C. This recommendation was already 
being followed.
Once the initial problem of 3H-triether impurity had been 
remedied the intra-individual variability was studied 
afresh.
Variability of PAT-3H in Individual Stool Samples
PAT—3H was measured (using purified 3H-triether) in 108 
individually collected stool samples from 37 patients. 
Results of 100% were found in 15 patients. These results 
were excluded since the stools contained no 14C and so no 
information could be gleaned about the relative movement
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of 5:LCrCl3 and 14C-triolein through the intestine, the
main objective of this exercise. The variability of
results in individually collected stools from patients
with less than 100% absorption is recorded in table 4.5.
Patient
Number
Stool 1 Stool 2 Stool 3 Stool 4
1 100% 100% 99%
2 99% 99% (99%)
3 97% 93% 96% (96%)
4 100% (89%) (90%)
5 11% 39% 50%
6 79% 81%
7 (75%) 74%
8 96% 99%
9 11% 17% (39%)
10 98% 99% 97%
11 (31%) 38% 32% (45%)
12 23% 27%
13 98% 100% 100%
14 31% 32% 64% (66%)
15 99% (92%)
16 (92%) 69% 86%
17 (28%) 26% 28%
18 97% 100% (100%)
19 100% (100%) (99%)
20 74 (88%) (87%)
21 98% 100% (100%)
22 100% 100% (99%)
Table 4.5 - Intra-individual variability of PAT-3H in 
separately collected stools. (Bracketed figures are from 
stools with low recovery of 3H).
Inconsistent results were sometimes produced when the 
recovery of ingested tritium was low (<3%) . When this 
situation arose the 3H dpm were usually very low making it 
possible that the quantitation of 14C and 3H was 
technically imprecise. However, when small, known amounts 
of 3H and 14C were measured, the accuracy of counting was 
assessed revealing that both isotopes could be counted 
accurately even at low dpm (see pages 238 - 9).
Since the results were technically correct the cause of
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intra-individual variability was presumably due to the 
separation of the isotopes in the intestine. This only 
occurred when the recovery of 3H in the collection was low 
and so it was easily identified. Although these results 
are noted in the table they were excluded from subsequent 
consideration (see later discussion).
No overall statistical difference was found between 
results from consecutive stools (see Statistical Appendix, 
note 7) . Nevertheless it was apparent that some patients 
showed differences when PAT-3H results from individual 
stools were studied.
In five of the tests (numbers 5, 9, 11, 14, and 16), the
absorption increased with time indicating that 14C moved 
relatively faster through the intestine than 3H-triether.
This difference in results was only found in patients with 
gross malabsorption and so was of no clinical importance. 
The remaining 17 results on patients with other degrees of 
absorptive capacity were comparable from stool to stool.
Hoving et al performed a similar study to this in which 
malabsorption was induced in rats by biliary fistulae or 
intestinal ischaemia (233). They also demonstrated a 
similar trend in stools collected over four separate time 
periods following the oral infusion of radiolabelled 
triolein and triether. They found that there was little 
difference between results except when malabsorption was 
more severe in which case the faecal ratio increased, 
again indicating a relatively faster intestinal transit
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time of 14C-triolein.
Our results also concurred with those of Nelson et al (my 
predecessor in the Gastroenterology Laboratory, in GRI) 
who found no intra-individual variation in PAT-3H results 
except in one patient with severe malabsorption (222).
* * * * * *
When the recovery of 3H-triether from a stool was very low
(<3%), the isotope present probably represented either the
first or last traces of label to be excreted. Stools
collected between these two extremes gave reproducible
results. The probable reason for this situation can be
more easily explained diagrammatically. Figure 4.11
displays a representation of the relative amounts of each
label in the most distal part of the intestine. Both 3H
and 14C, despite being given as a bolus, do not traverse
the intestine in such a form but disperse considerably.
! is :
As a result it quite usual to recover significant 
percentages of 3H label in individual stools collected 
over a three day period. Similarly in cases of fat 
malabsorption 14C was usually recoverable in stools over a 
similar time period. Hence the diagram shows a broad 
distribution of isotopes by the time they reach the distal 
colon. The extent of this dispersion is dependent on the 
intestinal transit time and so patients with watery 
diarrhoea usually excrete the label within the first 12 to 
36 hours.
The distribution of triolein and triether approximately
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3H/14C ratios similar
high 3H/14C ratios low3H/14C ratios
Time
Figure 4.11 - Theoretical distribution of 
3H-triether and 14C-triolein in gut.
3H-triether
14C-trioiein
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overlap, although 14C-triolein moves slightly faster. 
Therefore, although the 3H/14C ratio is similar at most 
sampling times, at the extreme ends of the distribution 
larger discrepancies are apparent, with low ratios (ie. 
high PAT—3H results) at the leading end and high ratios 
(ie. low PAT—3H results) at the trailing end.
As a result any separation of the two isotopes will be 
accentuated in samples at either end of the distribution 
of isotopes. However, on the odd occasion when a stool 
containing the extreme end of isotope is collected it can 
be readily identified because of the low 3H-triether 
recovery and the result excluded.
* * * * * *
The inseparability of test and marker has previously been 
assessed indirectly by studying in vitro their relative 
solubilities in different media designed to resemble 
physiological situations. Thus Hofmann's group showed 
that when a two-phase medium was prepared - an oil phase 
of triolein or fatty acid and monoglyceride, and an 
aqueous micellar phase - the triether remained exclusively 
in the oil phase (234) . In vivo work also confirmed that 
triether remains in the oil phase layer: Gerskowitch
infused an emulsion containing 3H-triether and 14C- 
triolein into the stomach of humans, and collected gastric 
aspirate at regular intervals. The ratio of the two fats 
was similar in each of the gastric aspirates, suggesting 
that they remain in the same phase (221) .
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Some doubt was cast on these findings when Saunders et al 
found that when triether and linolenic acid were infused 
into the stomach the triether/linolenate ratio 
progressively diminished implying a more rapid gastric 
emptying of the triether (235). The same group also found 
that triethers separated from triglycerides in test meals 
in vitro.
Cortot et al repeated studies on gastric emptying at a 
later date again using an in vitro simulation of gastric 
contents and conditions, and an in vivo study using a 
duodeno-jejunal tube for aspirating luminal contents 
following the introduction of an homogenised meal into the 
stomach (236). This group concluded that triether is an 
ideal oil-phase marker and suggested that the conflicting 
results found by Saunders et al were due to the different 
triether labelling employed: the 3H was incorporated in
the glycerol moiety and was therefore available for 
exchange with hydrogen.
However, these in vivo studies are limited since they can 
only investigate the partitioning of non-absorbable and 
test substances in the stomach and duodenum. Because of 
absorption of the test substance beyond this no 
conclusions can be drawn about lipid partitioning 
distally.
Variability of PAT-5a-Cr in Individual Stool Samples
The intra-individual variability of PAT-5;LCr in 104 
individually collected stool samples from 38 patients was
2 6 5
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calculated as in the previous experiment. On this
occasion results of 100% were found in 49 samples from 17 
patients. The results of the other twenty-one patients
are tabulated as follows (table 4.6).
Number Stool 1 Stool 2 Stool 3 Stool 4
1 97% 100% (100%)
2 (1%) 30% 34%
3 (100%) 85% 92%
4 13% -7%
5 63% 34% 25% (-99%)
6 99% 99% 97%
7 100% 99% (100%)
8 49% 41% (39%)
9 99% 100%
10 (87%) 76%
11 73% 77%
12 98% 98%
13 98% (96%)
14 55% 61%
15 99% 100%
16 (85%) 97%
17 98% 98% (97%)
18 91% (76%)
19 100% 100% 99%
20 76% (85%) (83%)
21 100% (87%) (80%)
Table 4.6 - Intra-individual variability of PAT-5:LCr on 
separately collected stools. (Bracketed figures are from 
stools with low recovery of slCrCl3 ).
The intra-individual results were comparable in all cases 
except three (patients 3,4, and 5). Two of these patients 
(numbers 4 and 5) had gross malabsorption and so the 
variability was of no clinical relevance, but in one 
(number 3) the variability was of clinical relevance.
Although these results suggest that the rate of flow of 
51CrCl3 through the intestine is broadly similar to 14C- 
triolein there is a small separation of the isotopes in 
several samples. No overall trend in their relative 
movements was discernible with slCrCl3 sometimes having a
2 6 6
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more rapid intestinal transit than 14C-triolein.
In general, PAT-51Cr gave similar results to PAT-3H, ie 
between-stool reproducibility was good except in cases of 
severe malabsorption or when 51Cr recovery was low. There 
was some evidence that the transit of 51Cr through the gut 
was faster than for 14C. Results from stools containing 
the last traces of 51Cr to be excreted, tended to be low. 
This is in accord with Pederson's finding that the transit 
time of 53-CrCl3 (measured as the time taken from ingestion 
until 80% had been excreted) was less than for 14C- 
triolein (224) . They also found that the initial stool 
PAT-51Cr results were significantly higher suggesting that 
the non-absorbable marker is excreted rather more quickly 
than 14C-triolein. This would imply that the relative 
dispersals of slCr and 14C would correspond to the 
distributions illustrated (figure 4.12).
Stability of Radioisotopes to Colonic Bacteria
Some in vitro work was performed in this study to 
determine whether 3H-triether was resistant to colonic 
bacteria, the second criteria to be met by a non­
absorbable marker. This environment was simulated by 
incubating the isotope in a faecal suspension.
Using TLC/autoradiography it was found that the tritium 
was recovered as a discrete band indicating that 3H- 
triether was resistant to metabolism by colonic bacteria. 
This therefore indirectly corroborated previous work which 
showed that triether was excreted in unchanged form
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following its oral administration (220, 221).
No work has been performed regarding the stability of the 
absorbable marker to colonic bacteria. This may be of 
relevance in patients with malabsorption in whom the 
absorbable marker may reach the colon in significant 
amounts.
A similar experiment was therefore performed to assess the 
stability of ^C-triolein to colonic flora. As figure
4.13 illustrates 14C-triolein was predominantly degraded 
to 14C-oleic acid. This finding was not unexpected since 
it is already known that measurement of a faecal 
triglyceride/fatty acid ratio is not a valid means of 
establishing pancreatic dysfunction since the triglyceride 
is digested not only by pancreatic enzymes but also by 
colonic bacterial systems. However, an additional finding 
was that other more polar substances, possibly SCFAs, were 
also produced. It is known that SCFAs are absorbed in the 
colon and are an important energy source for colonic 
mucosa (44, 46), consequently some 14CC>2 excreted in the
breath in the triolein breath test may derive from colonic 
absorption and metabolism of 14C-triolein.
An additional experiment was performed to determine the 
amount of 14C02, and 14C-methane produced by colonic 
bacteria. Results for 14CC>2 generation are shown in table 
4.7.
The 14C dpm was high in the first tube and fell to near 
background counts in subsequent tubes, indicating a high
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recovery of 14C-carbon dioxide by hyamine hydroxide. 
Although there was a measurable production of 14C-carbon 
dioxide, the percentage of this compared to the total 14C- 
triolein incubated was very low (mean = 0.01%, sem =
0.003) .
Homogenate
Number
14
1
C DPM in Collection Tube 
2 3 4 5
Percentage
14C
1 81 35 20 33 — 0.005%
2 108 26 22 31 23 0.006%
3 489 26 31 36 23 0.018%
4 112 36 22 22 24 0.007%
5 598 36 22 27 31 0.022%
6 167 7 4 8 8 0.006%
Table 4.7 - 14C02 production by faecal homogenates.
With regard to the production of methane, no measureable 
14C levels were detected indicating that this is not a
product of bacterial metabolism of fatty acids.
The 53-CrCl3 isotope does not suffer from problems of
decomposition since it is comprised of basic elements.
Quantitation of Radioistopes
The third criterion to be satisfied by the non-absorbable 
marker is that it should be easily and reliably measured. 
The reason that isotopes are employed in PAT tests is to 
facilitate the final measurement of the chemical probes. 
However, with respect to the PAT-3H test several problems 
had to be initially overcome. The main difficulty was
caused by the large amount of colour quenching present in 
stool extracts. A simple means of obviating this problem 
was eventually discovered when it was found that the
chloroform extract could be decolourised by exposure to
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light (see pages 231 - 2) . Once colour quenching was
minimised, chemical quenching was readily compensated for 
by means of quench correction using commercially available 
standards.
Stability of Radioisotopes During Refluxing
Since an isotope ratio was measured, rather than absolute 
concentrations of each, it was important that not only
were the two isotopes inseparable in their transit through 
the intestine, but also during laboratory procedures prior 
to their measurement. This criterion was investigated, 
again using TLC/autoradiography methods. The refluxing
stage of the analytical procedure (page 234) involves
incubation of the sample at 100°C. To determine whether 
this condition had an effect on radioisotope stability and 
thus solvent partitioning, pure :L4C-triolein and 3H-
triether were exposed to typical refluxing conditions and 
then assessed by TLC/autoradiography. The results of this 
experiment demonstrated that both radioisotopes separated 
as discrete bands of appropriate mobility, indicating that 
both isotopes were stable under these refluxing 
conditions.
In addition the recovery of both isotopes by solvent 
extraction was high and had little effect on the 3H/14C 
ratio (see page 236).
* * * * * *
The liquid scintillation method for measuring p-emitters 
is not direct or specific, the energy of radioactive decay
2 7 2
Chapter 4 - Diagnosis of Steatorrhoea
being initially converted to photons of light energy. The 
discrete bursts of light produced by 3H and 14C during the 
liquid scintillation process vary only in their intensity, 
(3H: 0 - 18meV, 14C: 0 - 156meV). The quantitation of the 
actual dpm is achieved by complex computer calculation 
which incorporates information on the quenching and the 
spillover of counts from one channel to another.
As well as the liquid scintillation counter being able to 
count 14C and 3H simultaneously an additional requirement 
is that it should be capable of accurately measuring small 
amounts of 14C in the presence of large amounts of 3H. 
This is the situation when PAT-3H results are normal or 
near-normal. This demand was satisfied but only when the 
sample and instrument had been carefully prepared (see 
pages 238 - 9). Consequently a great deal of caution was 
necessary especially when normal or slightly low results 
were produced.
The accurate determination of 14C and 3H, then, is 
dependent upon access to a powerful liquid scintillation 
counter. Fortunately such an instrument was available to 
us but at £250,000 each its cost clearly limits this type 
of fat absorption test to institutions such as teaching 
hospitals with this level of technology at their disposal. 
Consequently this test would be impracticable for most 
District General Hospitals.
By replacing the p-emitters by K-isotopes a greater market 
potential for this test would exist. For this reason 
other workers have studied a similar dual isotope test,
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using triolein and triether labelled with 131I and 7SSe 
respectively. Following the validation of these probes in 
animal studies (233) the test was established in a 
clinical setting and judged to be satisfactory (237). 
Unfortunately these labels are no longer commercially
available, making this approach impracticable despite its 
potential.
* * * * * *
If slCrCl3 is used as non-absorbable marker, absolute 
quantitation of the faecal 51Cr and 14C is necessary since 
each has to be measured separately by & -counting and 
liquid scintillation counting respectively. 51Cr, being a
^-emitter is easily measured and is not affected by the
presence of 14C. Although K-emitters interfere with 
liquid scintillation counting we found that the two 
isotopes could be completely separated by solvent
extraction, thus avoiding this potential problem (pages 
235 -6).
When Pederson evaluated this method a biological oxidation 
technique was employed to separate 5:LCr and 14C (224) .
This procedure, as well as separating 14C from 51Cr also 
decolourises the sample, so facilitating liquid 
scintillation counting of the p-isotope. The technique is 
relatively straightforward but, like liquid scintillation 
counting, is only available to centres where a biological 
oxidiser, another expensive item, is available.
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Toxicity of Non-absorbable Marker
Perhaps the most important requirement of a non-absorbable 
marker is its lack of toxicity. Since 3H-triether is not 
absorbed then there should be no systemic toxicity. 
Morgan and Hofmann performed preliminary toxicity 
experiments on rats which were injected peritoneally with 
3H-triether. After twenty-three days they found no 
histological, haematological or biochemical evidence of 
pathology. We have had experience with the PAT-3H test on 
almost 1,000 patients over a twenty year period with no 
adverse reactions.
The radiological, rather than chemical, safety of the 
substance is probably of most relevance. Because 3H is 
non-absorbable and it does not penetrate the mucosa, the 
exposure is confined to the intestine where we have 
estimated the radiation dose equivalent at 1.28mSv 
(690pSv/Bq).
With respect to slCrCl3 the possible radiological hazard 
is again more relevant than the chemical toxicity. 
Pederson calculated the intestinal radiation dose to be 
less than 54psV/Bq with an effective dose equivalent of 
less than lOpsV/Bq (224).
Non-absorbablity of Marker
Finally one obvious criteria to be met by a non-absorbable 
marker is that it should not be absorbed. This has been 
assessed on several occasions previously and it is now 
well established that 3H-triether is not absorbed. When
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rats were fed 3H-triether via a gastric cannula the 
recovery in the lymph was measured and found to be 0.14% 
of the administered dose and that this small proportion 
was probably accounted for by radioactive impurities 
(220). The recovery from faeces and colonic and caecal 
contents was found to be 93.3% which was similar to the 
faecal recovery of 93.9% reported in a human study, which 
also demonstrated the absence of marker recovery from 
urine and blood (221).
53-CrCl3 has been used in tests for quantitating intestinal 
protein and blood loss since one of the important 
requirements of this test is that the labelled protein or 
red blood cells should not be absorbed from the intestine. 
It has been previously shown that when 51Cr is given 
orally (as labelled red blood cells) an average of 98.9% 
was recovered in the subsequent stool collection (238). 
Waldmann found similar results when 51Cr albumin was used 
(239) . Although the label was protein-bound in these 
studies it quickly becomes detached during digestion.
PAT-3H Results Using Single Stool Collections
PAT—3H tests were performed in thirty-one out-patients who 
were asked to collect a single stool sample after a 
certain time period depending on their bowel habit. The 
time of collection was selected in order to minimise the 
possibility of collecting a stool which did not contain 
any isotope.
Twenty (65%) who had normal bowel habit or intermittent
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mild diarrhoea collected a stool 24 hours after the start 
of the test, ten (32%) patients with severe diarrhoea were 
instructed to collect a single stool after twelve hours, 
and one patient who was slightly constipated collected a 
stool after 48 hours. All the stools analysed contained 
sufficient isotope for the result to be calculated. Two 
patients (6%) did not return their samples and so no 
results could be obtained.
EVALUATION OF THE TRIOLEIN BREATH TEST
In recent years breath tests have become more popular 
because of their technical simplicity and acceptability to 
patients and staff alike. This approach has been studied 
on numerous occasions but it is difficult to assess its 
general advantage since almost every study has employed 
differing protocols. Although the resulting conclusions 
have been diverse the overall opinion is positive.
Effect of Breath Sample Used
The triolein breath test (TBT) was certainly found to be a 
simple test to perform, involving only aliquotting hyamine 
hydroxide solution, collection of breath samples and 
liquid scintillation counting. Although the laboratory 
staff collected the hourly breath samples this could 
readily be performed on the ward or Gastroenterology Unit 
by nursing staff.
However, some patients found difficulty in following 
instructions for the collection of end-expired breath, the 
breath sample which is considered to be required for
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accurate estimation of the TBT result. We were concerned 
that the TBT results might be invalid in such patients and 
so we investigated the necessity of collecting 
specifically end-expired breath.
In seven patients, 24 samples each of end-expired breath 
and normal breath samples were collected. No statistical 
difference between the groups was found (p = 0.99), and 
the difference between the medians was zero (95% 
confidence interval for this difference of -21.6 to 26) 
(see Statistical Appendix, note 6) . This demonstrated
that normal breath samples give the same results as end- 
expiratory breath samples. Hence, it is not imperative 
that the breath samples collected are end-expiratory. 
Nevertheless for the purposes of this study, end- 
expiratory breath samples were collected whenever possible 
although results from patients who had difficulty in 
providing such samples were not excluded.
Triolein Breath Test Results
The TBT was performed on 68 consecutive patients for 
investigation of fat absorption. Results were expressed 
both as the peak 14COz excretion and the cumulative 14COz 
excretion over the six hours of the study. An assumed 
value of 9mmol/Kg/hour was initially used to calculate 
these results because of the limited number of patients on 
whom a calculated COz output was accurately measured (see 
page 293).
A reference group based on the results from healthy
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individuals was not available because ethical permission 
was not granted for performing the test on a group of 
healthy volunteers. Consequently, 33 patients who had no 
evidence of fat malabsorption on the basis of PAT-3H, PAT- 
5a-Cr and faecal fat results were used as an alternative 
means of attaining a control group. The reference ranges 
for these three fat absorption tests were: greater than
95% for PAT tests (based on results found in healthy 
volunteers) (222) and less than 25mmol/l for faecal fat.
By selecting those patients with abnormal PAT-3H, PAT-5:LCr 
and faecal fat results a corresponding group of twenty 
patients with malabsorption was established.
Results of the TBT in controls and malabsorbers are shown 
in figures 4.14 and 4.15. These initial results were 
disappointing showing a significant overlap of the two 
groups. This was the case no matter which system of 
expressing the results, as peak or cumulative, was 
employed.
The reference range found by Newcomer et al, using a 
similar protocol, was greater than 3.43% dose/hour. The 
spread of results from malabsorbers was similar to 
Newcomer's findings but there were a significant number of 
controls who gave false positive results.
—- Such a degree of overlap would make the TBT test of little 
value but before vilifying the TBT we were keen to ensure 
that such unimpressive results could not have been caused 
by any technical errors. In particular we were concerned
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that the six-hour duration of the test might be 
insufficient to 'catch' all the peaks.
The time of peak 14COa excretion was studied and it was 
found that in the great majority (79%) the peak in 14C02 
excretion came at the sixth, and last, hour of collection. 
(Peaks were also reached during the fourth hour in 3 (4%) 
and during the fifth hour in 11 (16%).) When the time of 
the peak X*C0* output is displayed in histogram form it is 
clear that a truncated distribution is present rather that 
the expected normal distribution (figure 4.16). It seemed 
possible therefore that in some patients the peak might 
have been reached during the seventh or eighth hour had 
these samples been collected.
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Figure 4.16 - Times of 14C 02 peaks.
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A similar distribution of the times of peak 14C02 
excretion was found by Newcomer et al (203) and Einersson 
et al (206) . In both cases a six hour test had been done 
and so some peaks may also have been missed. 
Nevertheless, despite this possibility both of these 
studies demonstrated a good discrimination between 
controls and malabsorbers.
The possibility of having missed late peaks prompted us to 
analyse the pattern of 14C02 excretion in more detail and 
so the graph of 14CC>2 with time was plotted for each test. 
In general, three graph types were produced; one showed a 
clear peak in 14CC>2 excretion (figure 4.17a) and in 
another the curve appeared to be plateauing at about six 
hours (figure 4.17b); However, in the third category a 
late exponential rise in breath 14C02 occurred (figure 
4.17c). It seemed possible that in those patients whose 
breath 14C02 excretion was still apparently increasing at 
six hours the peak might have been missed.
In addition, with this exponential peak type the earlier 
14CC>2 results, eg. at the third hour or fourth hour, were 
substantially lower than with the other two peak forms, 
suggesting that there was a delay in 14CC>2 excretion.
With the resultant suspicion that these data might be 
underestimates all patient data was reviewed in order to 
select those 14C02/time curves which corresponded to 
figure 4.17c. Of the 52 patients investigated, 18 were 
found to have exponential graphs of this type. In figures
4.14 and 4.15 which show the peak and cumulative 14C02
2 8 2
14
C0
2 
-%
do
se
/h
ou
r 
14
C0
2 
- %
do
se
/h
ou
r
Chapter 4 - Diagnosis of Steatorrhea
3O
SZ
Q>
COO
CM
O
8
6
Figure 4.17a
4
2
0
1.0 2.0 3.0 4.00.0 6.05.0
Time (hours)
8
6
Figure 4.17b
4
2
0
0.0 1.0 2.0 3.0 4.0 6.05.0
Time (hours)
5
4
Figure 4.17c
3
2
1
0
1 2 3 40 5 6 7
Time (hours)
Figure 4.17 - Types of breath 14C 02 curves 
in triolein breath test.
2 8 3
Chapter 4 - Diagnosis of Steatorrhoea
results, these patients are represented by open circles.
In the control group, twelve patients gave an exponential 
type of 14C02 excretion suggestive of a late 14COz peak. 
Of the six false positive results, ie lower than 3.43, 
five could be explained on the basis of a probable late 
14C02 peak. In the malabsorption group, six graphs were 
increasing at six hours suggesting a late peak. In only 
one of these was the result high enough (2.2% of 
dose/hour) that it might possibly have been misclassified 
as a false negative had a later breath sample been 
collected.
The control and malabsorption groups could each be sub- 
dividied into two categories in which a) the 14COz peak 
was late and had probably been missed, and b) those whose 
peaks were valid since they fell within the six hours of 
the test. The means of these data and statistical 
comparisons of groups (see Statistical Appendix, note 1) 
are shown in table 4.8.
Group Mean sem P
Controls (late peaks) 5.2 0.25
Controls (valid peaks) 3.3 0.24 < 0.0001
Malabsorbers (late peaks) 1.1 0.33 NS
Malabsorbers (valid peaks) 0.6 0.35
Table 4.8 - Comparisons of TBT results characterised by 
late or true peaks in controls and malabsorbers.
In both cases the mean results from each of the subgroups 
of late peaks are lower, in the case of the control group 
significantly so. (Because the malabsorbers are a 
heterogeneous group the TBT result is a factor of their
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degree of malabsorption as well as the lateness of the 
peak.) This provided further indirect evidence that 
patients with exponential graphs of 14C02 excretion vs 
time, produced late 14C02 peaks resulting in their TBT 
results being underestimated.
* * -k * * *
In view of the probable existence of late peaks, the 
results of TBT tests in controls and malabsorbers were 
replotted omitting all results in which the peak had 
probably been missed. When this was done there was only a 
small overlap of results of controls and malabsorbers 
(figure 4.18) putting the potential of the breath test in 
a much more favourable light. By adjusting the cut-off 
value from 3.43% to 3.2% only one false negative result 
was produced. The cumulative results were also replotted 
(figure 4.19) but a significant overlap of controls and 
malabsorbers was still apparent.
Although it is scientifically suspect to exclude data 
retrospectively in this way, it was felt that had this not 
been done the breath test might have been inappropriately 
condemned. Although the reasoning seems valid it is clear 
that before this interpretation is fully justified, 
further tests are required using a modified protocol. 
However, for the next part of the discussion it is assumed 
that our conclusion was correct, while appreciating that 
it had been made retrospectively using indirect evidence 
rather than by the preferred studied, scientific approach.
The time at which the 14CC>2 peak occurs is dependent on
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Figure 4.15 - Peak TBT results (excluding late 
peaks) in controls and malabsorbers.
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Figure 4.19 - Cumulative TBT results (excluding late 
peaks) in controls and malabsorbers
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the rate at which the 14C-triolein is digested, absorbed
and metabolised. This in turn is controlled by factors
such as gastric emptying, metabolic rate and the 
availability of alternative energy sources. The
metabolism of fatty acids such as oleic acid, is slower in 
the fed than the fasted state (240) because of the
availability of alternative substrates. Thus if a patient 
is not fasted prior to the TBT then the a-4C-triolein is 
metabolised over a longer period of time causing a later 
and smaller 14CC>2 peak.
Similarly a delayed 14C02 excretion has been reported in 
obese patients (203) who, as well as having a lower 
metabolic rate, have a larger supply of endogenous fat
which is available for preferential metabolism.
A small loading meal is usually given at the start of the 
TBT in order to provide a realistic challenge to the
absorptive capacity. The size and content of this meal 
has varied considerably in different studies with 
corresponding differences in the results. Because we 
standardised our TBT test as far as possible with the
protocol of Newcomer et al, like them we chose a fat meal 
of approximately 25g. The size of our 14C02 peak (lower 
limit of normal of 3.2%) was comparable to the 3.43% 
reported by Newcomer et al (203). In another study, when 
a 60g fat meal as buttered toast was given, the 14C02 
excretion was delayed with only 42% of the subjects 
showing a peak by the ninth hour (205) . Since a peak was
often not achieved or any peaks were broad and small, the
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cumulative value (at either seven or eight hours) was used 
and this provided a good diagnostic separation. Pederson 
gave a rather excessive test meal meal of 42g fat, 35g of 
carbohydrate and 26g of protein and found a lower limit of 
normal peak 14COz excretion of only 1.5% (211).
Newcomer et al compared the effect of using 20g and 50g 
fat meals and showed clearly that the peak of 14COz was 
substantially lower, by about 27%, when the higher fat
meal was eaten, and that the peak occurred later, by up to 
three hours (203) . Similarly, using the 14C-xylose test
it has been shown that 14COs results were an average of 
62% lower when the subject had consumed his normal 
breakfast rather than being fasted and that this effect 
was apparent after one hour (232).
The composition of the test meal also affects the time of 
14C02 peak. Fat is metabolised more slowly than carbo­
hydrate and protein and has less effect on the metabolism 
of 3-4C-triolein and so has been considered the best choice 
as test load. The presence of carbohydrates would be 
expected to retard the 14CC>2 peak because they inhibit fat 
oxidation (240, 241) . In contrast to the theory however,
Turner et al achieved very good results (209) . For 
reasons of palatability their diet comprised lOg of 
carbohydrate, 19.3g of fat and 1.4g of protein as a lemon
mousse. It seemed surprising therefore that a peak of
14C02 excretion was achieved within six hours in most 
(97%) of those studied. With more calories, especially 
in the form of carbohydrate the peak would be expected to
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be prolonged rather than expedited. Their reported lower 
limit of normal was only 2.8% but this might be have been 
due to the snack given to their subjects after the fourth 
hour. It is difficult to explain the reason for their 
relatively quick 14COz excretion but it may be the result 
of other components in their more complex mousse menu, 
perhaps by increasing the rate of gastric emptying.
As far as our study is concerned, the chances of attaining 
a peak would be improved by increasing the times of breath 
collection up to seven or eight hours, or decreasing the 
amount or calorific content of the test meal. The former 
modification would immediately make the test less 
practicable since it could barely be performed within the 
working day. In addition, it would become less acceptable 
for the patients who must remain fasted for its duration. 
Indeed the six hour fast imposed in this study was 
vigorously objected to by several patients. On the other 
hand, decreasing the amount of the test meal may confer a 
disadvantage since an insufficient intake might not stress 
the gut sufficiently. Thus patients with a mild degree of 
malabsorption might be able to absorb a lower calorific 
meal quite effectively and so give a false negative 
result. Pederson showed that by increasing the fat diet 
isocalorically from 30g to lOOg the faecal excretion of 
14C increased denoting a poorer absorption (224).
* * * * * *
As a means of determining the power of the TBT, 
malabsorbers were categorised into four groups according
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to the severity of malabsorption; a) mild degree of 
malabsorption - faecal fat of 25 to 35mmol/day, and PAT of 
between 90% and 95%; b) moderate malabsorption - faecal 
fat of 35 to 60mmol/day, and PAT of 75% to 90%; c) severe 
malabsorption - faecal fat of 50 to lOOmmol/day and PAT of 
50% - 75%; and d) gross malabsorption - faecal fat over 
100mmol/l and PAT less than 50% (see figure 4.20).
PAT
100*
Normal absorption
95!
Mild Malabsorption
90%
Moderate Malabsorption
75%
Severe Malabsorption
50%
Gross Malabsorption
0%
Faecal Fat 
Ommol/day
25
35
60
100
>100
Figure 4.20 - Absorption classification system
All abnormal results could be classified using this system 
except for three whose faecal fat and PAT-3H results were 
in adjacent groups. These results were not excluded but 
empirically placed into the less severe malabsorption 
group. Unfortunately with the exclusion of data showing 
an exponential rise in X4COz at six hours no patients were 
allocated into the 'mild malabsorption' group.
The peak 14C02 results are illustrated in figure 4.21.
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Although most patients with a gross degree of 
malabsorption had very low results this was not always the 
case. Similarly patients with moderate malabsorption had 
results ranging from near normal to very low. When this 
data was analysed statistically (see Statistical Appendix, 
note 4) there was a moderate degree of correlation between 
the various severities of malabsorption and peak breath 
test result (r« = -0.54). When the cumulative X4C02 
results were plotted in the same way (figure 4.22) a 
similar correlation resulted (r* = -0.50) but more
worrying was a result which overlapped with controls in a 
patient with gross malabsorption.
Unlike many previous studies we did not exclude patients 
because of metabolic or respiratory illnesses despite the 
theoretical possibility of invalid results.
The TBT was performed in seven patients with known 
diabetes, two of whom were poorly controlled, five 
patients with varying degrees of alcoholic liver disease 
and one patient with a respiratory disorder (chronic 
obstructive airways disease). In all patients the results 
of the TBT agreed with the other fat absorption tests and 
so none of these subjects had been misclassif ied. 
However, of the seven diabetics five produced late 14C02 
peaks (71%) as did three of the four patients with liver 
disease (75%). This may explain the unreliability of the 
TBT in patients with liver disease (242). The incidence 
of late peaks in the other patients studied, and who as
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far as was known did not have any metabolic abnormalities, 
was 17%. When these data were analysed statistically, 
there was a significantly increased incidence of late 
peaks in patients with diabetes (p = 0.007) or liver
disease (p = 0.027) (see Statistical Appendix, note 5).
Measurement of Carbon Dioxide Output
It was originally intended that, rather than use an 
assumed value of 9mmol/kg/hr for carbon dioxide excretion, 
this would be measured individually on each patient.
Carbon dioxide output was measured in triplicate or 
quadruplicate in each of 55 patients aged from 12 to 88 
(mean = 53, sem = 2.8). Nineteen (35%) were excluded
because the respiratory quotient (r) was higher than the 
reference range indicating possible hyperventilation (see 
page 243) . Results were also discounted in a further two 
(4%) in whom r was abnormally low. Finally in two 
instances no results were possible because the Douglas 
bags were empty: in each case the patient was very frail 
and and it was thought that their exhalations were too 
light to shut the membrane valve completely.
The precision of COs measurement was estimated and was 
found to be relatively poor in the thirty-two patients 
with normal respiratory quotient (sd = 1.05, CV = 6.7%) 
and worse in those with high respiratory quotient (sd = 
1.94, CV = 14.7%).
The results of carbon dioxide output (in patients with 
normal r values) are shown in figure 4.23 along with
2 9 3
Chapter 4 - Diagnosis of Steatorrboea
existing data from two previous studies. The average CO2 
excretion was calculated at 8.9mmol/Kg/hour which is in 
close agreement with the two other reports of 8.7 and 
8.lmmol/Kg/hour. We found that the range of results at 5 
to 12.4 was greater than previous studies: 7.1 to 12.1 and 
6 to 11. This is perhaps explainable on the basis of the 
numbers investigated: we obtained results from 32 subjects 
in comparison to 13 and 16 from the other two studies. By 
increasing the numbers the mean would be expected to be 
similar while the range would tend to increase.
The TBT results were recalculated using the measured CO2 
output rather than an assumed value, as a possible means 
of improving the separation. Unfortunately calculated 
values were only available on a limited number because of 
exclusion criteria (eg. late peaks and abnormal r values) 
referred to earlier.
Rather than improve the distinction between controls and 
malabsorbers, the opposite occurred (figure 4.24). 
However, we were not entirely happy with the Douglas bag 
method of collecting samples: the precision was not good; 
there was a problem in collecting valid samples from 
patients who were anxious and so tended to overbreathe; 
when the force of exhalation was slight the valves did not 
close effectively. In addition, in the absence of a 
definitive means of measuring the CO2 output we were 
unable to evaluate the Douglas bag system.
Consequently, we are disinclined to read too much into the
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apparent worsening of results when calculated CO2 results 
were used. Nevertheless in spite of our circumspection of 
the method some conclusions were possible.
If the results from the present study and the two 
published studies are averaged then the mean of results is 
approximately 9mmol/kg/hour and the results range from 6 
to 12mmol/Kg/hr approximately. Consequently TBT results 
using an assumed value of 9mmol/Kg/hr could be 
overestimated or underestimated by approximately a third. 
This would mean that at the lower limit of normal of 3.2% 
there is an effective grey area of from 2.13 to 4.27. As 
a result there is clearly a potential for
misclassification to occur. For example two possible 
extremes can be outlined in the theoretical situation of 
two patients having TBT results of 3.0 and 3.4 (ie on
either side of the lower limit of normal of 3.2) based on
an assumed value of 9mmol/Kg/hour. If the measured CO2 
outputs on these patients are 12 and 6mmol/kg/hour 
respectively, then their actual TBT results become 4 and 
2.26 respectively. Therefore false positive and false 
negative results are bound to occur from time to time 
because of the variability of the actual CO2 output.
The obvious option of measuring the C02 output on each 
occasion might not be entirely practicable: as well as
making the test more complex, the technology for measuring 
C02 output is not always available and it is sometimes
difficult to collect a representative breath collection 
especially in anxious subjects.
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Correlation of TBT with PAT Tests and Faecal Fat
The TBT was correlated with the PAT-3H and PAT-slCr tests 
and with the quantitative excretion of faecal fat. Good 
correlations were produced for each as indicated in 
figures 4.25, 4.26, and 4.27.
Retrospective review of Faecal Fat and PAT3H Results
In the preliminary part of this study patients were 
categorised as controls or malabsorbers according to 
results of their PAT tests and faecal fat excretion. On 
eight occasions conflicting results made it impossible to 
group the patients and so these results were excluded. 
The analyses were repeated on these eight tests to exclude 
technical error but on each occasion similar results were 
produced. With the knowledge of the TBT results, it was 
possible to review these results in order to determine 
which test was probably valid. Although it is emphasised 
that this is not a scientifically controlled experiment 
some tentative conclusions are nevertheless possible.
The results of the various absorption tests on these 
patients are tabulated (table 4.9).
Slightly elevated faecal fat results were found in four 
patients with normal PAT tests and normal TBT results (1, 
3, 4, and 8) and in three cases the TBT result was well 
into the normal range (4.4 or higher). This would 
indicate that the faecal fat excretions were falsely 
elevated.
In one case the PAT results were normal as was the TBT (at
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Figure 4.27 - Correlation of triolein 
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4.8) but the faecal fat was very appreciably elevated, at 
78mmol/day. When the patient's case-notes were reviewed 
there seemed no obvious reason for such a gross disparity 
in results. However, this patient was a diagnostic 
enigma. He had been admitted for investigation of leg and
Number PAT—3H PAT-51Cr Faecal Fat 
(mmol/day)
Breath 
Test 
(% dose/hr)
1 — 100% 32 4.4%
2 99% 99.5% 29 2.8%
3 100% 100% 36 6.3%
4 100% 100% 31 3.2%
5 100% 100% 78 4.8%
6 - 89% 19 0.5%
7 99% 99% 39 4.7%
8 73% 87% 24 2.5%
Table 4.9 - Absorption test results where faecal fat and
PAT test conflict.
arm oedema and was found to have hypoalbuminaemia and a 
slight protein losing enteropathy. He had no gastro­
intestinal symptoms and his protein status and oedema 
spontaneously settled while on the ward, and after about 
six months he remained well.
Two patients (numbers 6 and 8) had normal faecal fat 
excretions while the other two tests were abnormal. 
Finally in one patient the PAT results were apparently 
falsely normal (patient 2) . In this case the faecal fat 
and TBT results were marginally abnormal at 29mmol/day and 
2.8% respectively while the PAT results were normal.
Thus of the eight occasions when the PAT and faecal fat 
tests did not concur, the former was the most likely to be 
correct in seven.
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It was perhaps surprising that in only two cases were 
there apparently falsely normal faecal fat results. It is 
well known that problems of incomplete stool collection 
and/or poor dietary fat intake can cause such results. 
Conversely, the combination of an abnormal faecal fat and 
normal PAT and TBT is more difficult to interpret although 
the following three explanations are possible.
a) The simplest explanation is that the elevation in 
faecal fat, particularly if it is only slight, may be due 
to a greater dietary intake of fat .
b) The PAT-3H and TBT only give information about fat 
absorption at a specific period of time and so if the 
capacity to absorb shows a diurnal variation then the 
faecal fat would be more likely to be correct. This 
situation is possible if there is a small bile acid pool 
which, because of overnight concentration in the gall 
bladder, is capable of sustaining normal micelle formation 
in the morning only. However, in none of the five cases 
of apparently falsely elevated faecal fat did the patient 
have evidence of bile salt abnormalities.
c) A third possibility relates to the accuracy of a three 
day stool collection. It has been argued that in order to 
obtain a representative collection longer collection 
periods, even up to 21 days, are required. For reasons 
of staff acceptability and patient compliance the 
collection period is usually minimised to three days. 
This short collection period could result in an inaccurate 
stool collection. For example, if a patient is passing an
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average of one bowel movement each day then the situation
depicted in figure 4.28 could arise.
day 1 day 2 day 3 day 4 day 5 day 6 day 7
i-----1-----1-----1-----1-----1-----1-----1
© © © © © © ©
Figure 4.28 - Times of defaecation in a theoretical 
patient. (© - represents a bowel action).
A three-day collection period from day 1 - 3  would result 
in an underestimated result while a three-day collection 
over days 4 to 6 would produce an overestimate. Similar 
inaccuracies could occur in patients I with diarrhoea when 
an average of more than one stool sample is passed per 
day. In such a circumstance the error would be a smaller, 
while in constipated subjects it would be greater.
Comparison of Faecal Fat, PAT-51Cr, and PAT-3H
Comparisons were made for each combination of PAT-3H, PAT- 
51Cr and faecal fat test. Results are shown in figures 
4.29, 4.30, and 4.31.
PAT-3H and PAT-51Cr results showed high correlation (r =
0.89) as would be expected since both tests employ the 
same dual isotope principle (figure 4.29). The comparison 
of faecal fat excretion with each of the dual isotope 
tests ’ was less favourable with low negative correlations 
being obtained with each test: PAT-3H (r = -0.45) (figure 
4.30) and PAT-5;LCr (r = -0.39) (figure 4.31) (see
Statistical Appendix, note - 2) .
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Figure 4.31 - Comparsion of PAT-51Cr with 
faecal fat excretion.
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If the daily excretion of faecal fat is used as the 
reference method the PAT-3H gave a sensitivity of 78% and 
specificity of 91%, while the PAT-5:LCr test produced a 
sensitivity of 62% and a specificity of 96%.
OVERALL CONCLUSIONS
By using a fairly simple protocol we had the oppportunity 
of studying four different fat absorption tests, employing 
three different principles, in the investigation of 
absorptive capacity. The relative merits of these 
techniques were investigated in the study in the hope of 
selecting the best method.
By and large, the method chosen for evaluating new 
techniques is the quantitation of faecal fat. Despite its 
well-known drawbacks in terms of acceptability and poor 
sensitivity, this test has certainly stood the test of
time, which gives some idea of the paucity of good 
alternatives.
The quantitative faecal fat estimation has the benefit of 
being widely tested and probably still remains the 
commonest means of evaluating malabsorption. Its most 
troublesome disadvantage relates to the collection of 
stool samples over at least a three day period. This is
an unpleasant task for all concerned and a lack of co­
operation may lead to inaccuracies. The completeness of 
stool collection is a fundamental aspect of the test but 
one that may be difficult to achieve. Patients may 
accidentally fail to collect a sample, communication
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problems between different nursing shifts may lead to 
missed collections etc. In addition, it is difficult to 
introduce any quality control on the completeness of a 
collection. Many patients who are being investigated for 
gastrointestinal complaints have a poor appetite and so 
their fat intake may be low. As a result, a patient with 
fat malabsorption may have a normal excretion of faecal 
fat. The possibility of falsely negative results is well- 
known but our results would suggest that there is also a 
significant false positive rate.
In our past experience of measuring faecal fat and PAT-3H 
false positive and false negative results have both 
occurred. The combination of normal faecal fat and 
abnormal PAT-3H was more common and frequently we found 
the discrepancy could be explained on the grounds of a 
falsely low faecal fat result; eg, frequently caused by 
anorexia, and very low stool weights or poor three-day 
recovery of 3H-triether, implying incompleteness of 
collection.
In my experience, because of the unpopularity of 
performing faecal fat analyses, its quantitation is 
frequently delegated to the most inexperienced laboratory 
staff. During part of the study the faecal fat was being 
measured by two different laboratories using differing 
methods. In general, the two techniques agreed but it was 
not uncommon for marked variations to occur.
In faecal fat estimations, errors of its measurement can 
be minimised by paying attention to detail, eg. ensuring
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adequate fat intake and completeness of stool collections, 
as well as reliable analysis. When evaluations of fat 
absorption tests are performed using faecal fat as the 
reference method, it is likely that such meticulous care 
is taken. But in the 'real world' these aspects of 
control are, in the main, unlikely to be achieved so 
reducing its practical effectiveness.
In terms of simplicity and aesthetics, the TBT is the most 
preferable test of fat absorption. It is also relatively 
cheap, requires a minimum of analytical effort, and
provides results the following day. The test is tolerable 
to patients and is easily performed on an out-patient
basis, but the six hours of its duration is a slight
drawback.
Although this study did not provide the extent of 
assessment anticipated, preliminary results, excluding 
those in which the peak 14COz peak was probably missed, 
suggest that the specificity and sensitivity of the test 
is good. However, in the case of an abnormal result no 
conclusion can confidently be made regarding the severity 
of malabsorption.
The variability of C02 output and the inability to
accurately and easily measure this, makes the use of an 
assumed value preferable. However, this introduces an 
additional error which could lead to overestimation or 
underestimation of results by up to 33%. This may be of
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particular relevance in the assessment of patients with 
borderline results when small errors can result in normals 
being misclassified as mild malabsorbers and vice versa. 
Ironically, the ability of a test to detect mild degrees 
of malabsorption is often of particular importance, since 
the diagnosis of more severe malabsorption is less 
difficult.
As with alternative fat absorption methods, attention to 
detail is essential: the patient must remain relatively
inactive, should not smoke, and must be and remain fasted 
throughout the duration of the test, eg. succumbing to the 
temptation of Irn-Bru or Lucozade on the bedside table may 
invalidate results. An additional problem is that the 
test is inappropriate in assessing patients with liver 
abnormalities.
In terms of safety the test is acceptable. The radiation 
exposure is modest and indeed there is probably a greater 
hazard from the hyamine hydroxide solution which, being
r>
caustic could burn the mouth if the patient sucks rather 
than blows.
Unlike the quantitative faecal fat and TBT the theory 
behind the PAT tests is basically sound. The only 
possible theoretical flaw is that this approach, like the 
TBT, only tests fat absorption at a specific moment in 
time. As a result, malabsorption caused by a low pool of 
bile salts may be missed. However, unlike the TBT, it is
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practicable to start the test in the afternoon thus 
obviating this potential disadvantage.
Both non-absorbable markers investigated, 3H-triether and 
5:LCrCl3, satisfy all the necessary criteria except a 
slight degree of separation from the test probe. However, 
as long as the stool contains more than about 3% of the 
administered non-absorbable marker the results are valid.
There appears to be little to choose between slCrCl3 and 
3H-triether as non-absorbable marker although the latter 
is theoretically more acceptable and the intra-individual 
variability is slightly better. Although the PAT tests 
require a stool specimen, provided that the time of the 
collection is selected according to the patient's bowel 
habit, then a single sample will suffice.
Quantitation is relatively straightforward but there are 
pitfalls for the unwary in measuring small amounts of 14C 
in the presence of large amounts of 3H. As a result the 
technical aspects of the test must be carefully monitored 
and a good quality control procedure is essential.
Although more radiation is given than in the TBT test 3H- 
triether is unabsorbed and unmetabolised and totally 
excreted after a few days so the effective radiation 
exposure is low.
The main objection to the PAT tests is that because of the 
instrumentation required the test is suitable only in 
larger institutions. Also in the case of the PAT-3H test 
the label is not commercially available. Without
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commercial interest the routine availability of the test 
will probably be limited to the Glasgow area where it has 
been developed. It will probably continue to be used as 
the preferred method in the Royal Infirmary although 
perhaps in a modified way using the TBT as a screening 
test. Thus if the TBT is performed after administration 
of the PAT-3H and if the result is inconclusive, then a 
stool sample could still be collected for measurement of 
the PAT-3H.
For the reasons quoted, and in the absence of a reliable 
alternative, we would advocate the PAT method as being the 
best way of evaluating patients with possible absorption 
defects. However, if the facilities for measuring p- 
isotopes are not available so making the PAT tests 
impracticable, then the TBT because of its simplicity and 
better correlation with the PAT tests, is probably 
preferable.
Finally we would also suggest the PAT test has a role as 
the preferred method of choice in future evaluations of 
fat absorption tests. With this in mind it is interesting 
to note, that in comparison with the PAT tests, the 
quantitative faecal fat test produces a specificity of 85% 
and sensitivity of 95% while the corresponding estimates 
for the TBT are 95% and 100% respectively.
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INTRODUCTION
1Another use that has been assigned to the bile 
is that it exerts a stimulating action on the 
intestinal walls, and this acts as a natural 
purgative; and in support of this view, it may­
be mentioned that jaundice (in which the bile 
does not flow into the intestine) is often 
accompanied by extreme constipation, and that 
purified ox-gall, taken in the form of pill or 
enema, produces an undoubted purgative action' 
(243).
BILE ACID PHYSIOLOGY
Bile Acid Chemistry
Bile acids act as detergents and have an important role in 
the digestion of fats (page 202 - 5) . They are produced 
in the liver from- the precursor cholesterol following 
ring-hydroxylation and cleavage of the side chain. In 
man, the liver produces two bile acids, the so-called 
primary bile acids, cholic acid (CA, 3a, 7a, 12a-trihydroxy- 
53-cholanoic acid) and chenodeoxycholic acid (CDCA, 3a,7a- 
dihydroxy-53-cholanoic acid) (figure 5.1).
The bile acids are then amidated with either glycine or 
taurine to produce conjugated bile acids. Conjugation, 
particularly with taurine, has the important physiological 
role of lowering the pKa of bile acids. As such, they are 
stronger acids than their precursors and so are not
311
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precipitated in acidic conditions and are poorly absorbed 
by passive diffusion.
Once released into the ileum, a small proportion of bile 
salts (about 25%) is deconjugated (244). This process is 
mediated by bacteria since it is inhibited by treatment 
with ampicillin (245).
Bile salts reaching the colon are exposed to further 
anaerobic bacterial metabolism and are quickly 
deconjugated. A second important process mediated by 
colonic bacteria is 7a-dehydroxylation with the consequent 
production of secondary bile acids; hence CA is converted 
to deoxycholic acid (DCA, 3a,12a-dihydroxy-53-cholanoic 
acid) and CDCA to lithocholic acid (LCA, 3a-hydroxy-53~ 
cholanoic acid) (figure 5.1). LCA is hepatotoxic (246) 
and fortunately most of it is excreted, however, about 20% 
is delivered' to the liver where it is conjugated and 
sulphated, rendering it effectively unabsorbable, before 
secretion into the bile. Consequently, the potentially 
harmful LCA is quickly removed from the body.
A fifth bile acid, ursodeoxycholic acid (UDCA, 3a,73- 
dihydroxy-53-cholanoic acid), is produced from CDCA by 
colonic bacterial epimarases and also by the liver from 
its 7-keto derivative (3a, 7-keto-53-cholanoic acid or 7- 
keto-LCA) . CDCA can also be produced from this
intermediate making UDCA and CDCA in effect 
interconvertible, with the overall equilibrium lying 
heavily in favour of.CDCA production.
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Two enzymes in the bile acid pathway control the rate of 
synthesis: 3-hydroxy-3methyl glutaryl (HMG) CoA reductase
which is the rate limiting step in cholesterol production 
and 701-hydroxylase, the rate limiting enzyme in the 
conversion of cholesterol to bile acids. A relative 
deficiency of hepatic bile acids activates the hydroxylase 
enzyme and the resultant increase in bile acid production 
stimulates HMG-CoA-reductase to produce cholesterol. In 
turn there is up-regulation of the hepatic LDL (low 
density lipoprotein) receptor and accordingly an increased 
hepatic uptake of cholesterol.
The Enterohepatic Circulation
Relatively large quantities of bile acids are utilised 
during the digestive process and rather than waste these 
valuable molecules, the body operates an efficient 
recycling process, the enterohepatic circulation. After 
bile acids are synthesised they are secreted into the 
canaliculi and stored in the gallbladder. When food is 
eaten the gall bladder contracts under the influence of 
cholecystokinin, discharging its contents into the 
duodenum. In fasting states, the sphincter of Oddi 
contracts so that most bile salts are diverted for storage 
in the gall bladder.
Bile salts which are deconjugated proximally are absorbed 
by passive processes. However, the majority of bile acids 
escape deconjugation and are actively absorbed in the 
terminal ileum, by which time they have fulfilled their
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Total bile acid 
pool = 5 - 10mmol
gall bladder 
(50 - 200)
peripheral 
circulation 
(0.002 - 0.006)
liver
proximal ileum 
(10)
portal 
circulation 
(0.01 - 0.02)
terminal ileum
colon
faeces
(1.2 mmol/day)
Figure 5.2 - Enterohepatic and peripheral circulation of bile 
acids showing millimolar concentrations (313).
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physiological function in aiding fat digestion. This 
recovery system is highly efficient and 95% of the bile 
acids delivered to the terminal ileum are absorbed. The 
ileo-caecal valve also helps to delay the progress of 
luminal contents into the caecum so promoting more 
efficient absorption.
Once absorbed, the portal venous circulation delivers bile 
salts, predominantly protein-bound, back to the liver, 
from which they are rapidly re-secreted into the bile.
All of the bile acids, with the exception of LCA, take 
part in an enterohepatic circulation but at different 
rates, eg. DCA and CDCA conjugates have a greater passive 
absorption and so cycle more quickly that CA.
Colonic Handling of Bile Acids
Under normal circumstances the enterohepatic circulation 
cycles approximately five times per day and so about 25% 
of the bile acids delivered to the terminal ileum daily 
pass into the colon.
These bile acids are not all lost from the body because 
the colon also has the capacity for their absorption. 
This was initially demonstrated by injection of 14C-cholic 
acid into the caecum or colon during cholecystectomy and 
the subsequent recovery of large amounts of radioactivity 
(44% - 85%, mean 59%) from the duodenal T-tube (247) .
The importance of colonic absorption was re-emphasised in 
a perfusion experiment, which concluded that absorption
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rates from a lmmol/1 bile acid solution may be as high as
11.5, 8.2, and 1.2 mmol/day for CDCA, DCA, and CA
respectively (248). These figures represent a significant 
retrieval in cases of bile acid malabsorption (BAM) and 
indeed might be higher since the rate of absorption is 
concentration-dependent.
Most of the bile acids in the colon are not in solution 
but are bound to the solid phase. Although there is 
probably binding to bacteria (249) there is still 
significant association with the solid phase in germ-free 
animals (250). The nature of this sequestrant is probably 
unabsorbed dietary components especially lignin and bran 
251, 252).
BILE ACID INDUCED DIARRHOEA
Pathophysiology
The integrity of the enterohepatic circulation is 
essential in maintaining the bile acid pool. Where this 
is breached, an excess of bile acids is delivered to the 
colon. At higher concentrations bile acids can affect 
colonic mucosa causing secretion and bile acid induced 
diarrhoea (BAID) . Three types of BAID have been 
recognised. In type 1, disease or resection of the 
terminal ileum results in BAM and subsequent diarrhoea. 
The second is an impaired ability to absorb bile acids in 
an otherwise normal terminal ileum, so-called bile acid 
catharsis, and type 3 is associated with cholecystectomy 
and vagotomy (253).
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Terminal Ileal Disease. Much of the recent interest in 
BAID was stimulated in the late sixties when bile acids, 
which were known to be cathartics, were implicated in the 
diarrhoea which often follows resection of the terminal 
ileum. Since the site of bile acid absorption is removed 
by this operation, large amounts of bile acids reach the 
colon where they exert their cathartic effect. Hofmann, 
who, along with several co-workers, has performed much of 
the clinical and experimental research in this area, 
coined the term cholerheic enteropathy. His group showed 
that bile acids were present in the stool of such patients 
in elevated concentrations and that treatment with 
cholestyramine, which binds bile acids, relieves this 
diarrhoea (254).
If the length of terminal ileum resected is relatively 
short, less than 100cm, there is a moderate degree of BAM 
with a compensating stimulation of hepatic bile acid 
synthesis. As a result the bile acid pool is maintained. 
Nevertheless, increased concentrations of bile acids still 
reach the colon causing cholereic diarrhoea (245).
When more than 100cm of the terminal ileum is removed the 
losses of bile acids into the colon and faeces cannot be 
adequately compensated for, despite increased hepatic 
synthesis. As a result the bile acid pool is low, the 
critical micellar concentration (page 204) cannot be 
attained, and fat malabsorption results. Although such 
patients have increased colonic concentrations of bile 
acids, their diarrhoea does not settle with cholestyramine
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therapy (254) . Instead, the diarrhoea is due to the 
effects of increased colonic concentrations of fatty 
acids, and a restricted fat intake helps to control it 
(255) .
The amount of proximal colon removed with the terminal 
ileum and the degree of disruption to the ileo-caecal 
valve also influence the severity of BAID. Increased 
fluid is delivered to the colon because of the damaged 
ileo-caecal valve but colonic compensation (see page 43) 
is restricted in direct proportion to the length of 
missing colon (256, 257).
Primary Bile Acid Malabsorption. In the 1970s, Danish 
workers identified a number of patients with idiopathic 
BAM and diarrhoea (258). These patients had apparently 
normal terminal ilea with normal Schilling tests, but 
specific BAM identified by the glycocholic acid breath 
test (page 327 - 8). Although this test is not definitive 
for BAID, the finding that the diarrhoea was responsive to 
cholestyramine treatment, and that dihyroxy bile acid 
concentrations in faecal water were elevated, supports the 
supposition that bile acids were implicated. Other 
similar cases have been described since (259, 260) and one 
noted"increased titres of auto-antibodies suggesting that 
it may be an auto-immune disorder (261) .
Balistreri's group also identified a primary BAM in two 
neonates with diarrhoea: total stool water bile acids
were high (2.11mM and 7.67mM) and the disappearance rates
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of radio-labelled CA and CDCA were accelerated. They also 
showed a poor uptake of bile acids in biopsies from 
terminal ileum and jejunum. These patients developed fat 
malabsorption and were successfully treated with middle 
chain fatty acids (262) .
Post-Cholecystectomy Diarrhoea. An American group has 
been primarily responsible for the suggestion that bile 
acids are implicated in post-cholecystectomy diarrhoea 
(PCCD). They found that three patients with PCCD had BAM 
and that cholestyramine treatment was successful in two of 
them (253) . Other groups had previously shown that, 
following cholecystectomy, patients have an increased 
bacterial degradation of bile acids with an increased 
secondary bile acid pool (263, 264). Hutcheon also
reported a series of three PCCD patients, two of whom had 
high faecal bile acids and abnormal glycocholic acid 
breath tests, and all of whom responded to cholestyramine. 
(265).
The association of PCCD and bile acids has since been 
doubted by the group who originally suggested its 
existence. Fromm found that of twenty-one PCCD patients 
only five had BAM and although their concentrations of 
dihydfoxy bile acids in the stool water were increased, 
they considered these concentrations insufficient to 
provoke diarrhoea. In addition these patients derived
no benefit from the use of cholestyramine (266) . 
Nevertheless a brief therapeutic trial of cholestyramine 
may be justified (267) .
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Post-Vagotomy Diarrhoea. Diarrhoea occurs in some 25% of 
patients following truncal vagotomy, being particularly 
incapacitating in a small percentage (about 5%) . Because 
a drainage procedure such as pyloroplasty is usually 
performed at surgery, dumping syndrome can result to 
varying extents and this may result in an osmotic type of 
diarrhoea (see page 33).
In addition, these subjects excrete larger amounts of bile 
acids (268, 269) and these have also been implicated in
the pathogenesis of post-vagotomy diarrhoea (PVD). 
Although several studies have demonstrated that PVD is 
responsive to cholestyramine (270, 271, 272, 273), in most 
only a percentage of patients respond particularly those 
who have also had a cholecystectomy (274) .
The incidence of PVD has fallen since the introduction of 
more selective (post-gastric) vagotomies, implying that 
its pathogenesis is related to deactivation of non-gastric 
branches of the vagus nerve. The ileo-caecal valve is 
innervated by the vagus and so truncal vagotomy may 
possibly result in poorer sphincter control and rapid 
emptying of ileal contents into the caecum.
The contribution of bile acids to the pathogenesis of PVD 
is still controversial and it is unfortunate that, of the 
many studies performed, dihydroxy bile acids were not 
measured in the aqueous phase of the stool. Nevertheless 
there is a considerable body of indirect evidence in 
support of the theory that bile acids may play a part in
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the diarrhoea in some, but not all, patients following 
vagotomy.
Chendol Therapy. Diarrhoea is the most important side- 
effect of therapy with CDCA (Chendol) for the dissolution 
of cholesterol gall stones. It usually begins within the 
first few weeks, is dose related (affecting 25% of 
patients receiving 750mg/d and 50% of those on 
lOOOmg/day), and subsides after a few months or if the 
dose is reduced. The faecal excretion of bile acids 
increases dramatically 7.85 to 28.07 for non-sulphated and
0.91 to 8.05 for sulphated bile acids (275). The cause of 
the diarrhoea is thought to be a directly related to the 
high concentrations of CDCA in the colon (276).
Bile Acid Malabsorption Due To Increased Small Bowel 
Transit Time. It is possible that an increased intestinal 
transit time may compromise the absorptive capacity of the 
terminal ileum and so may be a factor in bile acid induced 
diarrhoea. In order to test this theory, Meihoff and Kern 
measured 14C-cholic acid decay rates in normal subjects 
who had mannitol-induced diarrhoea. They found that 
normal controls had an average oro-anal transit time of 26 
hours and a decay constant of 0.128/day, while subjects 
with ‘induced diarrhoea had a relative malabsorption of 
bile acid (decay constant of 0.253/day) and a much shorter 
transit time of 4.6hours. Thus, they demonstrated that 
diarrhoea can result in BAM, probably because of a rapid 
transit time. However, in terminal ileal resection the 
decay constant was much higher (1.43), suggesting that
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decreased transit time was a minor factor in causing 
faecal bile acid loss (277) . This work has been 
indirectly supported by the finding that the extent of BAM 
was not correlated with the small bowel transit time
(278).
Which Bile Acids Cause Diarrhoea?
Following the discovery of BAID as a clinical entity, 
further work was performed to identify the major causative 
agents. Accordingly, Mekhjian et al demonstrated in dogs 
that the dihydroxy bile acids DCA and CDCA inhibit 
absorption of water, DCA being more potent than CDCA
(279). More recent work using colonic perfusion in the 
rabbit has confirmed that CDCA (3a,7a dihydroxy), DCA 
(3a,12a dihyroxy) and the synthetic 7a,12a dihydroxy bile 
acids, at concentrations of 6mM, cause water secretion, 
increased mucosal permeability, and mucosal damage. The 
other bile acids tested 3a,70 (UDCA), 3a,7-keto; 3-keto,7- 
keto; 3a,7a,12a (CA); 3a,7a,12-keto; or 3-keto,7-keto,12-
keto had no effect. They concluded that two alpha hydroxyl 
groups, in positions 3, 7, or 12 are necessary for BAID
(280).
With improvements in GC and the introduction of capillary 
columns a much greater resolution of bile acids is 
possible and as many as 50 different types of bile acid 
can be found in stool (281). It is possible that some of 
these may also play a part in induction of diarrhoea (eg 
3a,6a-dihydroxy).
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Colonic Conditions Associated with Bile Acid Induced
Diarrhoea
Hofmann showed that before bile acids cause catharsis they
had to be in solution in the colon. His patients with
short terminal ileal resections had high concentrations of 
total bile acids in solution (255). Although patients 
with large ileal resections were associated with higher 
daily outputs of bile acids the bile acids were mainly 
undissolved (248) . More recently Rafter has shown that in
rats, a high solubility of bile acids in the aqueous phase
is required before histological or microscopic damage to 
the colon occurs (282).
Further work has demonstrated that intracolonic pH is a 
major factor governing the solubility of bile acids and 
that in small terminal ileal resections faecal pH was high 
(6.8 - 8.5), whereas in large ileal resections pH was
lower (5.4 - 6.5). The solubility of CDCA and DCA is low 
at pHs less than 6.8 and 7.0 respectively. (283). This 
may partially explain the relatively small bile acid pool 
found in some patients with steatorrhoea (284).
The presence of unabsorbed dietary factors may also affect 
the availability of bile acids for colonic absorption, by 
increasing the bound undissolved fraction.
DIAGNOSIS OF BILE ACID INDUCED DIARRHOEA
BAID is usually responsive to treatment with 
cholestyramine but unfortunately this drug can be 
unpalatable and not without side-effects. Consequently,
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rather than start this long-term therapy empirically it is 
considered wise to confirm the diagnosis of BAID.
With the possibility that BAID may be the cause of 
diarrhoea in a sub-group of IBS patients, there is also a 
strong research interest in having a definitive diagnostic 
test. The problem of not having a straightforward 
diagnostic method is highlighted by the observation that 
despite the number of studies published there is still 
controversy concerning the causal relationship between PVD 
and PCCD, and BAID.
Measurement of Faecal Water Dihydroxy-Bile Acids
Measurement of the faecal concentration of the diarrhoea- 
inducing bile acids (DCA and CDCA) would seem to be the 
obvious means of diagnosing BAID. Although the total 
concentration of dihydroxy bile acids in the faeces gives 
information on the degree of malabsorption of bile acids 
it gives only indirect evidence of BAID. Because bile 
acids are only injurious to the intestine when in 
solution, it is their concentration in this phase which 
must be measured in the form of faecal aqueous dihydroxy 
bile acid (FADBA) concentrations.
Measurement of faecal bile acids has, however, proved to 
be very difficult. Immunoassay methods have been thwarted 
by the difficulty in producing specific antibodies to bile 
acids. Although an enzymic method exists, it measures 
total and not individual bile acids. The methods most 
commonly applied are GC and HPLC, but the huge number of
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published references using these techniques is a testament 
to their inherent problems. With HPLC the main challenge 
is extracting bile acids from such a heterogeneous matrix 
in a 'clean' enough form for injection. Although the 
requirements for purity are less stringent with GC, the 
method usually involves hydrolysis, two derivatisation 
procedures and several extraction steps, making this 
approach exceedingly time-consuming with little 
opportunity for automation. Despite these objections GC 
is the technique most frequently applied.
Once a result has been obtained there remains the problem 
of interpretation because of doubt about the 
concentrations of dihydroxy bile acids that induce 
diarrhoea. In colonic perfusion studies in man it has 
been demonstrated that DCA and CDCA at lmmol/1 do not 
cause secretion, but DCA at 3mmol/l and CDCA at 5mmol/l 
cause significant secretion of water and electrolytes 
(248). Despite these findings, in two studies, (248, 283) 
FADBA concentrations were frequently much lower in 
patients with apparent BAID; in the study by Mekhjian et 
al the patients had short terminal ileal resections and in 
McJunkin et al's patients, cholestyramine-treatable 
diarrhoea. (table 5.1).
Glycocholic Acid Breath Test.
The principle of the glycocholic acid test is that orally 
administered cholyl-glycine-l-14C is deconjugated when it 
reaches the colon in individuals who are malabsorbing bile
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Mekhjian et al McJunkin et al
DCA CDCA DCA CDCA
0.9 - 2.2 0.4 - 1.4 3.55 0.22
4.1 - 5.0 0.1 - 0.13 0.79 0.75
0.2 - 1.2 0 - 0.5 0.67 0.01
0.9 - 1.9 0.4 - 0.5 1.63 0.2
0.69 0
0 2.25
0 1.63
0.02 1.19
0 0.64
Table 5.1 - Concentrations (in mmol/1) of faecal dihydroxy 
bile acids in patients with BAID.
acids (285). The 14C labelled glycine is then metabolised 
to 14C02 which is either absorbed and exhaled or 
excretedin the stool. Interpretation of the results is 
made following the measurement of breath and faecal 14C; 
in cases of bile acid malabsorption either or both faecal 
14C or breath 14C is increased. The design of this test 
in diagnosing BAM is intrinsically poor since it follows 
the course of metabolised glycine rather than the molecule 
of interest, namely cholic acid. In addition, the test 
has more practical drawbacks: interpretation of the
results is not straightforward, since the ratio of 
faecal/breath 14C can vary widely depending on the 
location and speed of deconjugation of the cholyl glycine; 
it is likely that 14C02 in the flatus is not measured; the 
test requires breath as well as stool analysis; and the 
test does not allow quantitation of the severity of BAM. 
The test can also produce false negatives even with severe 
bile acid malabsorption (271), and false positive results 
have also been reported (269) . This test has been widely 
used in the investigation of BAID but it is important to
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realise that it only gives information about the
absorption of bile acids and not whether malabsorption is 
the cause of BAID. With this in mind it is not surprising 
that the results do not show a good correlation with the 
degree of diarrhoea (285).
Clinical Response to Cholestyramine Treatment
There is good evidence that diarrhoea is caused by bile
acids if it resolves during a course of cholestyramine
therapy. This approach has been fairly widely used and is
probably a valid course of action in patients with 
diarrhoea following a short terminal ileal resection.
SeHCAT Test
The use of radioactively labelled bile acids to
investigate BAM has been previously used mainly as a 
research tool (286, 287, 288, 289). These tests have not 
been used in routine settings, principally because they
involve the use of 3-emitting isotopes so making stool 
collections essential. The recent development of tauro- 
23-[75Se]-selena-25-homocholic acid (SeHCAT), a bile acid 
attached to a V -emitter, has simplified bile acid 
investigations and has particular application in the
diagnosis of BAM (290). SeHCAT is given orally and after 
seven days its retention is measured by a whole body
counter or an uncollimated ^-camera.
It is considered to be a valuable tool in assessing the 
role of bile acids in idiopathic chronic diarrhoea (291) .
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However, with respect to its use in patients with 
diarrhoea, the test suffers the same drawback as the
glycocholic acid test, that is, it gives only indirect 
evidence of BAID and so cannot be considered to be
diagnostic.
Although the SeHCAT test does not provide direct evidence 
of BAID it is possible that a modification may make it 
useful as a diagnostic test. In the presence of BAM a
patient is likely to develop diarrhoea only if the bile 
acids in the colonic lumen are in solution. It is
feasible that this information may be readily attained 
during the SeHCAT test by simply measuring the proportion 
of malabsorbed SeHCAT in the aqueous portion of the stool. 
If this were the case then diagnosis of BAID would become 
relatively straightforward.
This concept in diagnosing BAID would only be applicable 
if 75Se remained attached to bile acids in the colon, and 
the 75Se label did not affect the metabolism of the cholic 
acid to which it was attached.
STABILITY OF 7sSEHCAT
Before SeHCAT was marketed as a suitable probe for 
investigating bile acid absorption, several studies were 
performed to establish that this synthetic bile acid acted 
in the same way as physiological bile acids. Initial 
experiments in rats, following intravenous and oral 
administration, demonstrated that SeHCAT, was almost 
entirely confined to the enterohepatic circulation and so
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was apparently distributed in the body in the same way as 
bile acids (292).
Subsequent studies in man demonstrated that SeHCAT behaves 
similarly to 14C-labeled cholic acid in that both appear 
in bile at similar rates after both oral and intravenous 
administration, indicating that the secretion and
absorption rates are similar (293).
Although these studies have confirmed that SeHCAT behaves 
physiologically like an endogenous bile acid, they have
not considered the stability or behaviour of SeHCAT in the
environment of colonic bacteria.
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OBJECTIVES
1. INVESTIGATION OF THE FAECAL AQUEOUS BILE ACID 
CONCENTRATIONS ASSOCIATED WITH BAID
Although there are several investigations which give 
indirect evidence of BAID, there is no test available which 
can claim to be diagnostic. Perhaps the test which comes 
closest is the measurement of dihydroxy bile acid 
concentrations in stool water. The measurement itself can 
be performed, albeit with some difficulty; the problem lies 
in deciding the concentration above which BAID can be said 
to occur. The initial aim of this study was to determine 
the cut-off concentration in this respect.
2. DIAGNOSIS OF BILE ACID INDUCED DIARRHOEA USING A RANDOM
STOOL COLLECTION
BAID is diagnosed by measurement of the concentration 
rather than the daily output of dihydroxy bile acids in 
stool water. Therefore it seemed likely that as long as a 
patient had diarrhoea, it could be investigated using a 
single random stool sample. To investigate this 
possibility, individual stool samples were collected over a 
24 hour period and measured separately.
'3. DEVELOPMENT OF A METHOD FOR MEASURING FAECAL 
CONCENTRATIONS OF BILE ACIDS
A reliable method for measuring bile acids in stool was 
necessaryl to reach the objectives of this study. In the 
routine functioning of the Gastroenterology Laboratory a GC 
method dating from 1965 had been established (294) . This
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has been a well-tested and widely used method but its main 
drawback is the time and labour required.
The measurement of faecal bile acids involves several 
steps: hydrolysis of conjugated bile acids, extraction,
derivatisation to volatile forms, and estimation by GC. 
The existing method in use by the Gastroenterology 
Laboratory involved an initial liquid:liquid extraction 
step; saponification (alkaline hydrolysis); four 
liquid:liquid extractions to obtain neutral steroids; three 
liquid:liquid extractions from acidic medium to prepare 
bile acids; methylation of bile acids using diazomethane; 
three liquid:liquid extractions of the methyl esters; 
acetylation of methyl esters; three liquid:liquid 
extractions; chromatography; and finally calculation of 
results. Each of these steps was highly labour-intensive: 
extraction and derivatisation took three days followed by 
GC taking one to two days and culminating in a complex 
calculation which took several hours. The whole procedure 
took up to five days for processing a batch of twelve 
samples. With such a large number of individual procedures 
there were numerous possibilities for error, indeed the 
precision was such that duplicate samples were measured. 
To account for losses in the various extraction steps 
internal standardisation was employed.
It was intended to evaluate several modifications to this 
method in an attempt to simplify it and also avoid the use 
of hazardous chemicals such as benzene and diazomethane.
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4. EVALUATION OF A MODIFICATION OF THE SEHCAT TEST TO
DIAGNOSE BAID
The proportion of malabsorbed SeHCAT in the stool 
supernatant (PMSS) was measured in order to determine
whether this information could be used, in conjunction with 
the result of the SeHCAT test, to identify patients with 
BAID.
5. MEASUREMENT OF THE STABILITY OF 75SEHCAT
Finally the stability of SeHCAT was determined after its 
exposure to conditions found in the colon. This was
assessed by in vitro and in vivo experiments.
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MATERIALS PATIENTS AND
  m e t h o d s
PATIENTS
Most of the patients used were in-patients and out-patients 
under the care of Dr. R. I. Russell and Dr. J. F. McKenzie 
at Glasgow Royal Infirmary. Most were being investigated 
for suspected BAID with Crohn's disease being the 
predominant diagnosis: 23 patients had Crohn's disease with 
involvment of the terminal ileum or terminal ileal 
resection, five had diarrhoea following gastric surgery, 
one patient had radiation enteritis, and one had probable 
irritable bowel syndrome.
The faecal aqueous dihydroxy bile acid (FADBA) 
concentrations in patients with suspected BAID were 
measured and the response to cholestyramine determined in 
those with significant results. The FADBA concentration of 
0.5mmol/l was chosen initially as the action limit above 
which cholestyramine was administered. Response to bile 
acid sequestrant therapy (cholestyramine or sucralfate) was 
evaluated by asking the patients to record the number and 
fluidity of motions passed each day over a period of two 
weeks. During the first week they were on their usual 
medication and on the second week a bile acid sequestrant 
was taken.
STOOL COLLECTIONS
Stool samples were collected into 2.51 plastic containers
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and stored immediately after collection in a freezer (at - 
15°C). In the case of out-patients a portable freezer was 
delivered to the patients' home and stool collected 
individually over a 24 hour period. The faecal weight was 
measured and faecal supernatant obtained by centrifugation 
(14/00rpm) of an aliquot of the homogenate. The liquidity 
of the stool was expressed as a percentage (PWC, see page 
75).
MEASUREMENT OF FAECAL BILE ACIDS
j
Faecal bile acids were measured by a modification (283) of 
a published method (294) which was further modified to 
facilitate derivatisation and minimise the potentially 
hazardous steps of a) methylating with the carcinogen 
diazomethane, and b) solubilising bile acids prior to 
Florisil purification into a solvent containing the 
carcinogen benzene.
In brief 1ml of 0.3mmol/l nor-deoxycholic acid (Maybridge 
Chemical Co, Tintagel, England) in methanol was added to 
50ml stoppered test tubes, followed by 2ml aliquots of 
stool water or standard (0.3mmol/l each of LCA, CDCA, DCA, 
UDCA and CA in methanol) or lOOmg of faecal lyophylate. 
Bile* acid conjugates were hydrolysed using 3ml of 2N sodium 
hydroxide in 50% methanol at 110°C for sixteen hours. 
Stoppers were removed to allow any methanol to evaporate 
and the samples were cooled and resuspended in 35ml of 
distilled water making the solution 0.1mol/l in sodium 
hydroxide. One gram of Amberlite-XAD-7 resin was added and
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the suspension mixed by rotary mixer for one hour. The 
aqueous portion was discarded and washed with a further 
10ml of distilled water. Bile acids were solubilised by 
addition of a small volume (approximately 2ml) of methanol 
which was then transferred to separate 50ml stoppered 
tubes. After evaporation of methanol the residue was 
dissolved in a small quantity of iso-octane:- 
isopropanol:glacial acetic acid (70:13:17) and added to a 
column containing 60-100 mesh Florisil (activated by 
heating overnight at 200°C). The eluent was discarded and 
bile acids were eluted with 25ml of acetic acid:ethyl ether 
(1:9) into stoppered tubes. Ten millilitres of distilled 
water and 15ml of ethyl acetate was added and the solvents 
mixed. The upper solvent layer was transferred to 
stoppered tubes and dried. Bile acids were derivatised by 
methylation (2001 of acetyl chloride reagent) at 55°C for 
20minutes and acetylation (250ul of acetyl chloride at room 
temperature for 30 minutes. Ten millilitres each of ethyl 
ether and 20% sodium chloride was added and the ether layer 
transferred to separate tubes and dried. The methylated, 
acetylated bile acids were solubilised in a small quantity 
of acetone and measured by gas chromatography (Pye-Unicam 4 
Series, Cambridge) with flame ionisation detection. A 3% 
OV-17 on Chromosorb glass column with nitrogen flow rate of 
55ml/min and an oven temperature of 265°C.
The various modifications made to the method decreased the 
time of assay and replaced several steps in which dangerous 
chemicals had been used. The precision of the assay was
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improved slightly but was still poor at over 10%. For this 
reason each sample was measured in duplicate and a mean 
result calculated assuming that the reproducibility was 
acceptable.
THIN LAYER CHROMATOGRAPHY/AUTORADIOGRAPHY OF FAECAL BILE
ACIDS
Bile acids were separated by thin layer chromatography 
(295) and detected by autoradiography as follows. Five ml 
of faecal supernatant was mixed with 15ml of 
methanol:acetone (1:1) and heated in a waterbath at 37°C 
for ten minutes in order to precipitate proteins. After 
centrifugation (3000rpm for 10 minutes) the supernatant was 
transferred to another tube. The residue was washed with 
5ml of methanol:acetone (1:1), centrifuged and the two 
supernatants were pooled and evaporated to dryness The 
residue was dissolved in 0.2ml of methanol and 100|il 
applied onto a silica gel plate (20cm x 20cm silica gel G) 
and dried in an unheated airstream. As standards, 50p.l of 
a methanolic solution of lmmol/1 cholic acid and lmmol/1 
taurocholic acid and 50^1 of 7SSeHCAT were added. The 
plate was chromatographed in a saturated TLC chamber using 
two developments in the same direction of the same solvent 
system of iso-octane (2,2,4-trimethylpentane): ethyl
acetate: glacial acetic acid (5:5:1). Development time for 
each run was 45 minutes. In order to separate conjugated 
bile acids the solvent system of butan-l-ol: water: glacial 
acetic acid (10:1:1) was used.
Bile acids were detected by spraying with 15%
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molybdatophosphoric acid in ethanol (this was prepared on 
the day before use and after standing overnight was 
filtered and stored in a dark flask) and heating in an oven 
at 110°C for 6 minutes. Bile acids stain blue. The
radioactivity was detected by exposing the TLC plate to 
photographic film for a time which was judged according to 
the amount of radiactivity present.
On day 1 the total body radioactivity was measured using a 
whole body radioisotope counter (in the Department of 
Nuclear Medicine, at Glasgow Royal Infirmary) in order to
(SC.510P, from Amersham International, Little Chalfont, 
Bucks) containing 370kBq was then given orally. On day 7 
the patient returned for measurement of the whole body 
retention of 75Se. The SeHCAT result was expressed as a 
percentage of administered 75Se that remained after seven 
days.
75Se was measured in aliquots of urine, whole stool, and 
stool supernatant by means of a gamma counter (Canberra 
Packard) with the window settings at 60 - 240keV. The
percentage of malabsorbed 75SeHCAT in the stool supernatant 
(PMSS) was calculated as follows.
5 S e w h o l e  stool/PWC
= dpm/ml x PWC
dpm/g
The form of 75Se in the stool was assessed by performing
SEHCAT TEST
provide a basal value. A single capsule of 75SeHCAT
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TLC/autoradiography as described above.
The pH and osmolality of the stool supernatant were 
measured using conventional methods.
STABILITY OF 7sSEHCAT TO COLONIC BACTERIA
The stability of SeHCAT to the conditions within the colon 
was determined in the following in vitro experiment. Four 
grams of faecal homogenate were added to screw-top vials 
along with 300^1 of 3.3kBq/ml solution of 7SSeHCAT 
solubilised in 25mmol/l sodium bicarbonate (total of lkBq 
per vial). To a similar set of vials containing faecal 
homogenates, 300ul of 70mmol/l taurocholic acid in 25mmol/l 
sodium bicarbonate was added. Control tubes consisted of 
either SeHCAT or TCA being added to 4ml of 0.9% saline.
The faecal suspensions were incubated overnight at 37 °C 
prior to TLC/autoradiography.
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RESULTS A l s T D DISCUSSION
The practical application and usefulness of clinically 
orientated research is often evident and of direct 
benefit. However, in the case of bile acid induced
diarrhoea (BAID) there remains several voids between the 
knowledge that has been uncovered and the relevance of 
this learning to the patient. For example it is known 
that an excess of DCA or CDCA in the colon can cause 
diarrhoea, that these bile acids must be soluble in the 
colon to have this effect, and the fluid and electrolyte 
secretion is mediated by cAMP. On the other hand tests 
for diagnosing BAID are poor, the FADBA concentrations 
which induce diarrhoea are not known, and the specific 
treatment of BAID is poorly tolerated and not without 
side-effects.
FAECAL BILE ACIDS IN PATIENTS WITH BILE ACID INDUCED
DIARRHOEA
The primary objective in this study was to establish the 
quantitation of FADBA concentrations as a reliable method 
for diagnosing BAID and then utilise this method to 
evaluate a simpler radioisotopic approach.
It is' well known that if high concentrations of DCA and 
CDCA are perfused through the colon of man that a 
secretory state is induced (248). Conversely then, it is 
likely that the diarrhoea in patients with very high FADBA 
concentrations is bile acid induced. However, when 
diagnosing BAID by measuring FADBA concentrations there is
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an interpretative dilemma, namely deciding an appropriate 
cut-off concentration above which it can be stated with a 
reasonable degree of confidence that the diarrhoea is 
induced by bile acids.
To determine this value we ideally wanted stool samples 
from patients who had uncomplicated BAID. Although BAID 
occurs in several different pathologies there are only two 
situations in which it is uncomplicated, namely patients 
with the rare idiopathic bile acid catharsis, and as a 
side-effect of Chendol (CDCA) in the treatment of 
gallstones. Because of the rarity of the former we 
planned to induce diarrhoea in healthy patients by the use 
of Chendol. Unfortunately ethical permission was denied 
because of its documented effect in increasing liver 
enzymes (296, 297) . Gallstone patients on Chendol were
not available since it has been superseded by UDCA in the 
medical treatment of gallstones because of the side-effect 
of the former. Consequently we recruited patients, mainly 
with Crohn's disease, who were being routinely 
investigated for suspected BAID.
In order to determine the upper limit of 'normal' FADBA 
concentrations, we monitored the response of diarrhoea to 
a bile acid sequestrant in those patients with 
comparatively high concentrations. For this purpose we 
initially had to choose a realistic provisional FADBA 
concentration at which to start this therapy.
The concentrations of bile acids normally found in the
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aqueous phase of stool supernatant has been quoted as 
being between 0.9 and 1.9mraol/l (248), however, of the
three references quoted, in two only total faecal bile 
acids were measured and in the third (255) the system of 
preparing the supernatant (centrifugation at 100,000g for 
2 - 4  hours at 25 - 40 °C) may have affected the
partitioning of bile acids between solid and liquid 
phases.
From our experience most patients with diarrhoea caused by 
agents other than bile acids excrete very low 
concentrations of FADBAs. For example, of 34 patients 
with diarrhoea caused by agents other than bile acids, we 
found that the mean FADBA concentration was 0.101mmol/l 
(sd = 0.08, range 0.01 to 0.3mmol/l).
A FADBA concentration of 0.5mmol/l was initially selected 
as a suitable provisional 'action' level. This
concentration was chosen because it is higher than the
concentration found in our patients with non-BAID 
diarrhoea, and comparable to the lowest reported 
concentrations (0.64, 0.69mmol/l) found in patients who
were diagnosed as having BAID (see data of McJunkin et al 
table 5.1, page 327). A concentration slightly less than 
0.64mmol/l was considered appropriate since it allows for 
some degree of error and at the same time will not result 
in large numbers being inappropriately treated.
During the course of the study fifteen patients were found 
to have 24 hour FADBA concentrations above this proposed
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action limit. Eleven of the patients (numbers 1 to 11) 
had Crohn's disease affecting the terminal ileum and four 
of them had had resections of the terminal ileum (numbers 
3, 5, 6, and 9) . Three patients (numbers 12 to 14) had
post-vagotomy diarrhoea and one patient (number 15) was 
suffering from radiation enteritis following radiotherapy 
for an ovarian malignancy.
These faecal aqueous bile acid results are listed in table
5.2.
Number LCA DCA CDCA UDCA CA FADBA
la 0.01 0.02 2.1 0.11 3.24 2.12
lb 0.00 0.00 1.25 0.00 1.79 1.25
2 0.01 0.03 1.0 0.68 4.50 1.03
3 0.13 1.3 1.67 0.17 3.03 2.97
4 0.01 0.05 3.2 0.36 4.49 3.25
5 0.00 0.02 1.78 0.06 3.27 1.8
6 0.06 0.88 1. 14 0.17 2.74 2.02
7 0.24 0.5 0.71 0.1 0.96 1.21
8 0.06 0.53 0.2 0.05 0.21 0.83
9 0.01 0.05 0.48 0.02 3.22 0.53
10 0.02 0.04 3.11 0.03 4.54 3.15
11 0.00 0.04 1.38 0.04 3.02 1.42
12 0.07 0.62 0.23 0.00 0.49 0.85
13 0.05 0.46 0.12 0.02 0.41 0.58
14 0.01 0.04 1.30 0.01 1.95 1.34
15 0.05 0.06 0.44 0.05 1.45 0.5
Means 0.05 0.29 1.26 0.12 2.46 1.55
Table 5.2 - Bile acid concentrations (mmol/l) in patients 
with elevated FADBA concentrations.
The bile acid most commonly implicated in the diarrhoea of 
these patients was CDCA although in two patients (number 8 
and 12) DCA was the predominant diarrhoea-inducing bile 
acid. The cholic acid concentration closely mirrored the 
CDCA concentration (r = 0.78, see Statistical Appendix,
note 2), and the other two bile acids LCA and UDCA were
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usually in relatively low concentrations.
Although it was the objective of this study to assess the 
response of these patients' diarrhoea to cholestyramine, 
unfortunately for reasons outwith our control 
cholestyramine treatment was not initiated in seven. Of 
the eight patients who were started on cholestyramine, two 
patients (numbers 1 and 10) could not tolerate the drug 
and so treatment was discontinued before a response could 
be assessed. In the remaining six patients (numbers 2, 5, 
8, 11, 12, and 14) all showed a significant response in
terms of amelioration of their diarrhoea.
It was fortunate that all the patients with the lowest, 
and so the most pertinent, FADBA concentrations were given 
cholestyramine. Consequently we were able to show an 
improvement in the diarrhoea of those patients whose FADBA 
concentrations were as low as 0.58mmol/l. FADBA
concentrations in the other patients who responded were 
0.83, 0.85, 1.03, 1.8 and 2.02 (mean = 1.2mmol/l).
Although one patient with a concentration of 0.5mmol/l 
responded to cholestyramine, this patient had documented 
fat malabsorption (PAT-3H = 19%) and so the improvement in 
her diarrhoea could have been due to sequestration of 
malabsorbed fatty acids.
On the basis of these results it was concluded that BAID 
was associated with FADBA concentrations exceeding 
0.58mmol/l. In contrast, the few studies that report 
FADBA concentrations suggest higher cut-off values than
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this. Aldini et al (259) quote a figure of 3.0mmol/l but 
have misguidedly taken this from a study (255) in which 
bile acids were measured in the whole stool rather than 
the stool water. A figure of 1.5mmol/l, which in turn was 
taken from a colonic perfusion study in man, (248) has 
also been cited (283). However, careful scrutiny of the 
original paper revealed that no experiments using such a 
concentration had been performed. The paper in fact 
showed that perfusion of CDCA and DCA at respective 
concentrations of 5.0mmol/l and 3.0mmol/l produced 
secretion into the colon.
Reasons that could account for our finding of such a low 
cut-off FADBA concentration were considered. In the 
patients with BAID secondary to Crohn's disease of the 
terminal ileum, it is possible that co-existing Crohn's 
colitis could make these patients more sensitive to the 
presence of dihydroxy bile acids. However, to counter 
this possibility six patients were known to have Crohn's 
disease affecting the terminal ileum only. In addition, 
no such hypersensitivity would be expected in the patients 
with post-vagotomy diarrheoa who had BAID characterised by 
lower concentrations of FADBAs (mean of our three patients 
of 0.92mmol/l).
Several factors could account for this discrepancy between 
the perfusion experiments and our patient results. 1. 
Faecal bile acid concentrations may be lower than the 
corresponding intracolonic concentrations. The colon is 
known to absorb bile acids (247, 248) and this would
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effectively lower the stool concentrations. In addition, 
faecal bile acid concentrations measured in BAID patients 
may be diluted by the secretion which they cause. In two 
colonic perfusion studies performed in Hofmanns 
laboratory the concentrations in the stool water were 
lower than those perfused (74, 248) (table 5.3). On the 
other hand it has been shown in four subjects that 
intracolonic and faecal concentrations are comparable in
patients with BAID (283).
.•Hekh jian -.et ajl ,('74;) y;': ~
■ DCA (mmol/1) CDCA (mmol/l) [
(Concentration Faecal Concentration Faecal 1 #
( Perfused Concentration Perfused Concentration' *
1 0.76 1 0.77 ; ^
' 1 0.57 1 0.34 ; i
; i 0.79 1 0.51 | "
3 2.3 3 1.35 •
3 2.7 3 1.69 j
3 2.16 3 1.44 {■ ;
3 2.49 5 4.54 :
6 4.69 5 3.67 ;
5 4.09 J ;
10 7.06
Mekhjian et al (248) i
DCA (mmol/1) CDCA (mmol/l)
^Concentration Faecal Concentration Faecal
Perfused Concentration Perfused Concentration
1 (n = 4) 0.7 ± 0.06 1 (n = 2) 0.6 ± 0.1 i 1
2 (n = 3) 1.47 ± 0.1 2 (n = 2) 1.1 ± 0.2 \
3 ,(,n ■= 3.) - . ~ .2 .,41 ± -0r 1,.. . -  _...l.^45.,l±^ 0..1 - .i
\ • . , . ‘ j
} 5 ( n .= ;3 ) i 4 .1 -± {0. 2
Table 5.3 - Difference between colonic and faecal 
concentration of bile acids. (5)
2. The colonic perfusion studies were not representative
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of the clinical situation. These were acute experiments 
performed on fit subjects, whereas our patients were 
exposed to chronic hyperconcentrations of bile acids. 
Bile acids are known to cause a morphological change in 
mucosa (282) and so it is possible that the colon may 
become sensitised to lower bile acids concentrations.
The likely reason for the discrepancy between the higher 
values in the perfusion study and our suggested limit of 
O.SSmmol/l, is probably a combination of these two 
factors.
It is possible that our cut-off value of 0.58mmol/l may 
still be an overestimate. Consequently our current policy 
is to suggest a trial of cholestyramine if the FADBA 
concentrations are as low as 0.5mmol/l. With further 
experience the action limit may be modified to a new and 
possibly lower level.
*  * * * * *
The conclusions above were based on FADBA results from a 
stool collection that had been made over at least a one 
day period. It was felt that a single days1 collection 
was adequate because these patients usually had severe 
diarrhoea and so passed several bowel motions per day. 
Therefore the inaccuracies described earlier, (pages 300 - 
301) of collecting stools over a short time period, were 
minimised. In addition, a concentration rather than an 
daily output was measured and so some degree of inaccuracy 
of collection was therefore considered tolerable.
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INTRA-INDIVIDUAL VARIATIONS IN FAECAL AQUEOUS BILE ACID
CONCENTRATIONS
Initially, for reasons of practicability, some FADBA
measurements were made in collections from out-patients
who had provided only a single random sample of stool
rather than a complete days collection. These samples
were not always delivered to us on the day of their
collection and so we initially investigated the storage
conditions required for stability of the bile acids. We
found that the FADBA concentrations tended to decrease in
stools stored at room temperature. Under such conditions,
bacterial metabolism causes the stool pH to decrease (see
page 92), so making bile acids less soluble in faecal
fluid. We investigated the possibility of preventing this
change by addition of an anti-bacterial agent but found
that even when concentrated merthiolate solutions were
added, bacterial processes continued. Furthermore, the
addition of a solution had other potential disadvantages.
The antibacterial solution would a) require to be well
mixed with the stool, and b) result in a dilution of
FADBAs. In order to circumvent these difficulties a
>
portable freezer was delivered to the patients home to 
enable the collection to be frozen immediately, a step 
that we found resulted in no measureable change in FADBA 
concentrations.
The rationale behind using a random stool was that, as 
long as a patient was suffering from diarrhoea and that 
this was caused by an excess of bile acids, measurement of 
any stool should reveal elevated FADBA concentrations.
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However, to ensure that this approach was valid we 
measured FADBA concentrations in individual stools 
collected over a period of a day.
Individual stools were collected over a 24 hour period in 
eighteen patients and FADBA concentrations were measured 
in the stool supernatant. The results are listed in table
5.4.
Patient Dihydroxy bile acid Concentrations 
(mmol/1)
Early am Late am Early pm Late pm
Patients with BAID
1 0.6 0.66 — 1.6 6.1 -
2 1.32 - - 0.72 1.97 2.54
3 0.84 0.77 1.99 - — —
4 0.42 0.44 - 3.68 1.96 —
5 1.15 3.31 - 6.62 5.36
6 0.47 0.6 2.94 4.37 — —
7 0.18 1.09 1.66 6.52 0.9 —
8 0.33 - 1.35 - - 0.18
9 0.87 0.24 2.48 4.68 — —
10 0.31 0.22 - 4.96 0.5 —
11 0.79 0.83 - 0.35 0.41 0.95
12 0.76 1.28 3.98 0.76
Patients with non-BAID
12 0.24 _ — 0.41 0.43 -
13 0.09 - - - —  ■ 0.04
14 0.18 0.35 - - 0.23 0.1
15 0.24 0.17 - - 0.4 0.26
16 0.21 0.31 - 0.52 1.21 0.42
17 0.25 0.29 - 0.41 — —
18 0.2 - 0.05 0.23 — —
19 0.23 — 0. 14 0.04 0.05
Table 5.4 - Aqueous faecal dihydroxy bile acid 
concentrations in individual stools throughout the day.
In contrast to our expectations, we found that the bile 
acid concentrations in separate stools varied widely 
during the day (table 5.4). For example in two extreme
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cases, FADBA concentrations varied from 0.24 - 4.68mmol/l 
and 0.18 - 6.52mmol/l in stools specimens collected during 
the same day. Clearly our supposition that patients with 
BAID would always have elevated FADBA concentrations, was 
invalid. Indeed the concentrations varied so widely, that 
results based on certain samples could easily have 
resulted in the diagnosis of BAID being missed. For 
example, misleadingly low results could have been produced 
in some patients (numbers 9, 11, 14, 15 and 16) with BAID, 
particularly if a morning stool had been collected. With 
these large intra-individual differences it is clearly not 
valid to diagnose BAID using a single random stool sample. 
As a consequence of this discovery, subsequent measure­
ments were made using stools collected over at least a one 
day period.
These results demonstrated that it was relatively common 
for patients with BAID to excrete stools with FADBA 
concentrations of less than 0.5mmol/l and still to have 
diarrhoea. Therefore it was considered quite likely that 
on occasions during the day such patients had hypo- 
secretory concentrations of dihydroxy bile acids in the 
colonic lumen and yet still be in a secretory state.
This tentative conclusion of a lack of direct relationship 
of colonic dihydroxy bile acid concentrations with colonic 
fluid secretion was also given further credence. In 
patients with BAID the effect of FADBA concentrations on 
the severity of diarrhoea (as expressed by PWC, see page 
75) was assessed. The results illustrated in figure 5.3
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show a 'blunderbuss' pattern (r = 0.12, see Statistical 
Appendix, note 2)) suggesting that there was little or no 
relationship between these two parameters. However, this 
lack of correlation may have been caused by differing 
sensitivities of the patients to bile acids. To ascertain 
whether this was the case, individual linear regressions 
were assessed for each subject with BAID. Of the ten 
patients with BAID the graphs of FADBA concentration vs 
PWC gave positive slopes in seven (5.9, 10.9, 32.5, 0.5,
32.5, 3.6, and 3.9) and a negative slopes in three (-8.8, 
-0.5, and -12.7). The slope of this line gives details 
about the relationship between pH and FADBA concentration, 
a positive slope indicating a proportional association 
while an inversely proportional relationship was 
represented by a negative slope. When analysed
statistically it was again revealed that even within 
individuals there was no statistical relationship between 
the severity of diarrhoea and the concentration of FADBAs 
(p = 0.19, 95% confidence interval -4.1 to 17.6, 90
%confidence interval -2 to 15.6, see Statistical Appendix, 
note 8) . Thus, although patients with BAID had elevated 
FADBA concentrations in stools collected over a 24 hour 
period, there was no direct association of these 
concentrations with the severity of diarrhoea.
These results can be interpreted in several ways. a) The
most immediately evident explanation is that the patients'
diarrhoea was not mediated by bile acids. However, there
was good theoretical reason to support the notion that
these patients did in fact have BAID: they each had
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Figure 5.3 - Effect of FADBA concentration 
on severity of diarrhoea.
y = 1.1X-5.6 
r = 0.32
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Figure 5.4- Effect of pH on 
bile acid concentration.
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pathologies, such as terminal ileal disease or PVD, which 
are often associated with BAID, and in all patients 
tested, their diarrhoea settled or improved significantly 
when a bile acid sequestrant was administered. b) The 
mucosal sensitivity to dihydroxy bile acids is increased 
in patients with BAID, perhaps as a result of chronic 
exposure to them. To support this possibility,
morphological changes to the colonic mucosal architecture 
can be seen when bile acids are given in higher 
concentrations (282). On the other hand, iatrogenic BAID 
(following treatment of gallstones with CDCA) often 
settles in time (298). This would suggest that rather 
than mucosal sensitisation developing, the reverse in fact 
occurs. c) The concentration of FADBAs in the stool do 
not correspond with the concentrations in the colon. This 
possibility seemed unlikely for the following reasons. 
During colonic perfusion studies (78, 248) stool
concentrations were shown to be only slightly lower than 
those in the colon; proximal colonic contents were 
aspirated in a group of patients with BAID and the bile 
acid concentrations were similar to those found in stool 
water (283) . d) There is not a direct temporal 
relationship between the dihydroxy bile acids and
secretion. That is, it is possible that following
exposure to bile acids the secretory effect may not be 
immediate and/or may be long-lived. This seemed to be the 
most likely explanation. For example, in some infectious 
diarrhoeas which, like BAID, are mediated by cAMP, a 
secretory state can still occur during the convalescent
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stage when the toxigenic organisms have been cleared from 
the intestine (56).
* * * * * *
The relationship of individual stool pHs and the 
concentration of FADBA were analysed in the same way 
(Statistical Appendix, note 8). When all FADBA results 
were plotted against pH very poor correlation (r = 0.32) 
was seen (figure 5.4) indicating little or no apparent 
association. When graphs of FADBA and stool pH were 
plotted individually for each patient, thirteen graphs 
gave a positive correlation and five gave a negative 
correlation. The individual gradients were 1.9, 0.9, -
0.5, -2.5, -1.0, 15.1,3.7, 5.2, 1.3, 3.8, 3.0, 0.6, 0.2, -
0.3, 0.4, -0.4, 0.2, and 1.4. When assessed statistically 
(statistical note - 8) this showed a statisically
significant relationship (p = 0.04) suggesting that there 
is an association, viz as pH increases bile acids become 
more soluble. Since the solubility of bile acids, like 
other chemical species, is affected by pH (283) such a 
relationship was not unexpected.
* * * * * *
When stools were collected individually, the time of day 
that the stools were passed was also recorded and so we 
were able to determine if there was a predictable pattern 
of bile acid excretion during the day.
In general, we found that the bile acid concentrations
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tended to be lowest in the morning, increasing to a
maximum in the afternoon and falling again in the evening 
(table 5.4). This diurnal variation was particularly
noticeable in those patients with BAID.
Bile acid secretion into the duodenum is stimulated by
food and normally mans' eating habits also follow a 
regular time pattern. Consequently, in retrospect, it is 
predictable that in patients with diarrhoea, this diurnal 
trend should be reflected in the stool. The body’s bile 
acid pool concentrates in the gall bladder during the late 
evening and night so that, when stimulated by breakfast, 
there is a large outflow of bile acids into the duodenum. 
Therefore in patients with diarrhoea, and in particular 
BAID, any malabsorbed bile acids would be excreted in the 
stool, reaching a peak after a time period that was 
dependent on the duodeno-anal transit time. In our 
patients this corresponded approximately to six to ten 
hours.
A circadian fluctuation of bile acids has previously been 
demonstrated in the enterohepatic circulation of hamsters 
(299) and is present even in animals lacking a gallbladder 
(300, 301).
SEHCAT TEST
The recent development of the SeHCAT test has provided an 
effective alternative to the Schilling test in evaluating 
terminal ileal function (290, 302) . It has also been
investigated, and by and large recommended, as a way of
3 5 5
Cbapter 4 - Diagnosis of Bile Acid Induced Diarrhoea
detecting those patients whose diarrhoea is induced by 
bile acids (291).
The SeHCAT test was performed on a total of twelve 
patients in whom BAID was suspected. The results of the 
SeHCAT test, FADBA concentrations, percentage of faecal 
aqueous ‘75SeHCAT, and the response to cholestyramine are 
listed in table 5.5. Nine patients had Crohn's disease of 
the terminal ileum (numbers 1 - ) of whom five had had
resection of the terminal ileum, and one patient each with 
irritable bowel disease (number 10) , post vagotomy 
diarrhoea (number 11) and terminal ileal resection for 
radiation enteritis (number 12). The diarrhoea in one of 
these patients (number 12) had resolved by the time of the
test.
Patient Faecal 
Dihydroxy 
Bile acids 
(mmol/1) -
SeHCAT
retained
SeHCAT i 
super­
natant
n Response to 
Bile acid 
binder
BAID?
1 0.1 3.2% 0.7% none NO
2 0.01 0% 43% - NO
j 0. 02 14% 5% - NO
4 1.55 0.3% 36% yes (c) YES
5 - 7.2% - - NO
6 0.15 8.6% 18% - NO
7 1.6 5.3% 16% yes (c) YES
8 3.47 0% 27% not tol.(c) YES
9 0.1 26% 0.4% - NO
10 0.07 39% - - NO
11 0.85 30% 33% yes (s) YES
12 0.45 0.2% — yes (c) ?
Table 5.5 - Results in patients given 75SeHCAT (c = 
cholestyramine, s = sucralfate).
The SeHCAT test was abnormally low in eight of the nine 
patients with Crohn's disease (numbers 1 - 8 ) ,  and also in 
the patient with radiation enteritis (number 12). Six
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patients with terminal ileal resection (numbers 1, 2, 3,
4, 5 and 12) retained an average of 4.9%, while the four 
with no resection retained 10.0%. Faecal fat was measured 
on four of the six patients (numbers 1, 2, 3, and 12) with 
terminal ileal resection and was grossly elevated in each. 
All other patients had normal results.
Hofmann originally reported that the fat malabsorption 
that can occur is associated with patients with a\, large 
terminal ileal resection and is caused by an inability to 
emulsify the fats due to a diminished bile acid pool 
(255) . These patients frequently develop fatty acid 
induced diarrhoea which is treatable by replacement of 
dietary fats, which are mostly long chain, with medium 
chain fatty acids (255). It was interesting that three 
patients with an intact, although diseased, terminal ileum 
had very poor bile acid absorption but no steatorrhoea. 
In these patients the liver was presumably able to 
increase bile acid production sufficiently to compensate 
for the losses.
Four patients had BAID and one other may have had BAID
(number 12 who is the patient referred to earlier with 
cholestyramine responsive diarrhoea, moderately raised 
FADBA,' and steatorrhoea) . Of the four patients who had 
clearly elevated FADBA concentrations, three responded to 
cholestyramine and the third could not tolerate it.
Five patients had very low FADBA concentrations and so 
were not started on cholestyramine except one lady (number
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2) whose diarrhoea, not surprisingly, did not respond.
The SeHCAT test, although apparently giving a good 
indication of BAM was unable to identify those patients 
with BAID. Results of the SeHCAT test were found to be 
very low in three patients with BAID but were also very 
low in three of the five patients who did not have BAID. 
Thus of the six patients whose retention was abnormal only 
•three had BAID. In addition, another patient with BAID 
following vagotomy had a normal SeHCAT retention. It is 
perhaps relevant that during the seven day course of the 
SeHCAT test this patient had severe diarrhoea on only two 
days. Since his diarrhoea was intermittent it is possible 
that BAM might also have been intermittent hence a normal 
SeHCAT result. This is consistent with the variation in 
bile acid excretion sometimes seen in this condition 
(272) .
This initial result demonstrating the ineffectiveness of 
the SeHCAT test in detecting patients with BAID, was not 
unexpected. Although BAM is a pre-requisite for BAID, 
other conditions must also be met, most importantly the 
solubilisation of malabsorbed FADBAs in the colon (283) . 
Thus in patients with large terminal ileal resections 
there'is a considerable loss of bile acids into the colon, 
but because the pH tends to be low, the bile acids are not 
dissolved and so are not implicated in the diarrhoea. 
Similarly, treatment of BAID with cholestyramine causes a 
paradoxical increase in BAM but although the amounts of 
bile acids in the colon are correspondingly higher, being
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bound to the resin, they are again in an inactive form
Abnormal SeHCAT retention has previously been demonstrated 
in individuals who were expected to have BAID, such as
patients with Crohn's disease, post-vagotomy diarrhoea or 
post-cholecystectomy diarrhoea. However, the potential 
usefulness of the SeHCAT test has also been investigated 
in other groups of patients with diarrhoea. The 
specificity of the SeHCAT test in detecting patients with 
BAID has been claimed in two studies to be 100% (303,
304). In conflict with these conclusions, Orholm et al
found that the SeHCAT test was frequently positive in 
patients whose diarrhoea was not related to bile acids; 3 
of 5 with acute gastroenteritis, 5 of 6 with drug induced 
diarrhoea, and one each with ulcerative colitis, medullary 
carcinoma of the thyroid, and collagenous colitis (305) . 
In addition, four patients with IBS gave positive results 
only one of whom responded, albeit transiently, with
cholestyramine.
The Edinburgh group who developed the SeHCAT test, 
demonstrated that 6 of 4 3 patients with suspected IBS gave 
positive results and the four who were started on 
cholestyramine treatment all responded (291) . Similarly 
an Italian group showed that seven of thirteen IBS 
patients had abnormal retentions and all responded to 
cholestyramine, while the seven who had normal results did 
not respond (306).
However, in none of these studies had BAID been
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specifically diagnosed and in contrast with them, a third 
study reported 14 of 17 patients with idiopathic chronic 
diarrhoea and relative BAM, whose symptoms did not resolve 
with cholestyramine (307). They concluded that BAM may be 
a manifestation of an underlying motility or absorptive 
defect rather than the primary cause of diarrhoea.
Nevertheless it is becoming generally accepted that the 
syndrome of idiopathic bile acid catharsis, masking as 
IBS, may be considerably more common than realised. Such 
conclusions, however, should be considered with some 
caution. For example, in one study only patients with 
abnormal SeHCAT tests were given cholestyramine and so 
this study was not properly controlled (291) .
It is also worthwhile remembering that the diarrhoea of 
patients with IBS often shows a significant response (35%) 
to placebo (308). In addition, another study found that 
14 of 17 patients with idiopathic chronic diarrhoea had a 
decreased half life of SeHCAT (an alternative means of 
expressing the result), and that their symptoms did not 
resolve with cholestyramine (309). Their interpretation 
of this finding was that an underlying motility problem 
caused the diarrhoea and an incidental malabsorption of 
bile acids.
This opens up a further area of some controversy in that 
it is possible that an increased intestinal transit time 
may limit the absorptive capacity of the terminal ileum 
and so be result in BAID. In order to test this theory
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Meihoff and Kern measured 14C-cholic acid decay rates in 
normal subjects who had mannitol-induced diarrhoea. They 
found that normal controls had an average oro-anal transit 
time of 26 hours and a decay constant of 0.128/day, while 
subjects with induced diarrhoea had a relative 
malabsorption of bile acid (decay constant of 0.253/day) 
and a much shorter transit time of 4.6 hours. Thus, they 
demonstrated that diarrhoea can result in BAM, probably 
because of a rapid transit time. However, in terminal 
ileal resection the decay constant was much higher (1.43), 
suggesting that decreased transit time was a minor factor 
in causing faecal bile acid loss (310) . This work has 
been indirectly supported by the finding that the extent 
of BAM was not correlated with the small bowel transit 
time (311) .
Thus there is considerable evidence supporting the theory 
that in patients with diarrhoea there is a relative 
secondary malabsorption of bile acids. However, this BAM 
may be incidental, playing no active role in worsening the 
diarrhoea. We tried to determine whether this was the 
case. Accordingly those patients with diarrhoea and a 
probable rapid intestinal transit time were investigated 
for BAID. FADBA concentrations were measured in ten 
patients with diarrhoea and symptoms suggestive of a rapid 
intestinal transit. The diagnoses were infectious
diarrhoea in two, saline laxative induced diarrhoea in 4, 
and one each of carcinoid syndrome, alcohol-induced 
diarrhoea, diabetes, dumping syndrome and unexplained
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diarrhoea. The mean concentration was 0.10mmol/l (sem =
0.028) as compared with 1.70mmol/l (sem = 0.225) in nine 
patients with bile acid induced diarrhoea. The FADBA 
concentrations were significantly different in the two 
groups (p < 0.001, see Statistical Appendix, note 1).
This suggests that patients with diarrhoea and rapid 
transit do not have BAID and that any BAM does not have 
any pathophysiological involvement with the diarrhoea..
The considerable analytical effort required to measure 
dihydroxy bile acids in faecal supernatant makes this an 
impracticable means of routinely diagnosing BAID.
We therefore investigated the possibility of modifying the 
SeHCAT test so that BAID could be more readily diagnosed.
We speculated that the required information regarding the 
colonic solubility of bile acids might be provided by 
collecting a stool during the SeHCAT test and determining 
the percentage of the radioactivity in solution. In 
patients with BAID we expected to find an abnormal SeHCAT 
retention, in the presence of increased proportion of 7SSe 
in stool water.
Although the four patients with BAID had significant 
percentages of 7SSe present in the supernatant (16%, 27%,
i
33% and 36%) two other patients (numbers 2 and 6, table I
5.5, page 356) who did not have BAID also had high results 
(43% and 18%) (figure 5.5).
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Figure 5.5 - Percentage 75Se in stool supernatant 
in BAID and non-BAID.
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In the four patients with BAID the percentage of 
radioactivity in the water phase was surprisingly low 
(mean of 28%). In addition, this data provided little 
extra information regarding the diagnosis of BAID. 
Although non-BAID patients had a lower proportion of Se in 
the supernatant (mean = 13.4%) there was an overlap with 
BAID patients (see figure 5.5). Despite the small number 
of patients investigated it was obvious that this would 
not be a successful way of detecting BAID and so further 
tests were not performed.
A possible reason for this disappointing finding became 
apparent when the results of in vivo and in vitro SeHCAT 
stability experiments were analysed.
STABILITY OF SEHCAT
The rationale of measuring Se in the stool water would 
only be applicable if SeHCAT behaved as other endogenous 
bile acids. The SeHCAT molecule is structurally very 
similar to TCA the only difference being that the 
methylene group at C23 is replaced by 75selenium.
In this study we assessed the in vivo and in vitro 
stability of the SeHCAT. The chemical form of the 7SSe in 
stool* samples from patients on whom the SeHCAT test was 
performed was determined in 4 patients by TLC/auto- 
radiography. Figure 5.6 shows a typical autoradiograph: 
TCA has a mobility of 0 and CA has a mobility of 0.5Z. In 
each case the 75Se was present predominantly as 75Se-TCA 
and not 75Se-CA as had been expected.
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Figure 5.6 - Autoradiograph of 7sSe from stool after
75SeHCAT test.
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This finding was also supported by an in vitro experiment 
in which SeHCAT was exposed to faecal suspension and the 
resultant radioisotopic products detected by 
TLC/autoradiography.
The SeHCAT ran at a slightly slower mobility than the 
taurocholic acid standard and this was presumably due to 
the presence of the relatively large selenium atom within 
each bile acid molecule. If SeHCAT behaved similarly to 
its physiological counterpart, taurocholic acid, then 
deconjugation to cholic acid and dehydroxylation to 
deoxycholic acid would be expected.
The Rf values of CA and TCA after bile acid staining were 
found to be 0.88 and 0.28 respectively, while that of 
SeHCAT (by autoradiographic visualisation) was 0.08. The 
presence of the selenium molecule in the TCA molecule 
clearly retards its retention time. Since other 75Se- 
labeled bile acids presumably are similarly affected, this 
made definitive identification of the isotope bands 
difficult. Unfortunately we did not have access to 
standard 75Se-bile acids such as 75Se-deoxycholic acid, 
75Se-cholic acid or 75Se-taurodeoxycholic acid. However, 
isotope bands which probably corresponded to these 
substances, ie that moved slower than their unlabelled 
counterparts, were detected. The approximate percentages 
of each breakdown product was analysed and is shown in 
table 5.6.
In comparison when TCA was incubated with the same five
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faecal samples there was almost complete deconjugation to 
cholic acid.
Bile acid Sample
1
Sample
2
Sample
3
Sample
4
Sample
5
Standard
SeHCAT 30% 25% 45% 30% 55% 100%
Se-CA 20% 15% 15% 25% 5% 0%
Se-DCA 15% 5% 10% 25% 0% 0%
Se-TCA 30% 45% 25% 20% 35% 0%
Table 5.6 - Percentage of 75Se-labeled substances after 
faecal incubation of 75SeHCAT.
Our in vivo and in vitro studies demonstrated that SeHCAT 
is not as readily deconjugated to cholic acid and
consequently, unlike physiological bile acids, it is
excreted in the faeces as a conjugate. This concurs with 
a previous report which showed that when exposed to 
cholylglycine hydrolase, there was 58% deconjugation of 
TCA in two hours but only 8% deconjugation of SeHCAT, with 
a further 5% being converted to an unknown product,
probably selenium labeled tauro-deoxycholic acid.
Anaerobic incubation with three bacteria normally resident 
in the colon, resulted in considerable deconjugation, 7a- 
dehydroxylation and dehydrogenation (312) .
These^ results demonstrate that 75SeHCAT does not behave 
like its physiological counterpart TCA. The presence of a 
large additional atom, in 75Se in the bile acid molecule 
affects the way that it is metabolised by colonic 
bacteria, perhaps as a result of steric hindrance in its 
association with enzymes. The result is that colonic
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deconjugation of SeHCAT is limited.
This could explain the poor result of faecal water '75Se 
concentration in discriminating between patients with and 
without BAID. For this concept to work 75SeHCAT (or 75Se- 
bile acid) would have to behave like physiological bile 
acids expecially with respect to solubility, the most 
important factor in controlling the proportion of 75SeHCAT 
in solution. By remaining as a conjugate the solubility
of 75SeHCAT is considerably affected. For example CA has 
a pKa of around 6 while the pKa of TCA, and presumably 
75SeHCAT/ is much lower at 2.5.
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F U R T H E R  W O R K
Gastroenterology is a discipline in which simple tests of 
function or integrity are at a premium. Some of the 
difficulties in evaluating gut function were illustrated
in this study. The intestine is more difficult to 
investigate compared to other organs. For example, in 
contrast to the investigation of organs such as liver, 
kidney and heart there are no simple tests which reflect 
intestinal function or integrity in the same way as liver 
function tests, urea and cardiac enzymes. Absorptive
capacity is a good example of a fundamental gut function
test which is surprisingly difficult to measure.
Because of the problems in assessing intestinal function 
directly, many indirect function tests have been
developed; eg. the triolein breath test for malabsorption, 
^C-xylose test for small bowel overgrowth, the 
pancreolauryl test of pancreatic function and hydrogen 
breath test for carbohydrate intolerance. The development 
of such indirect tests all tend to follow a similar 
evolution: an initial study demonstrates encouraging
results and considerable promise for the test, while 
subsequent reports reveal practical difficulties and 
highlight problems of interpretation and limitations with 
regard to the predictive value. Ultimately, each test has 
its protagonists and so it usually survives in a small 
number of individual laboratories. The differing, and at 
times conflicting, conclusions of published assessments
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also confuse the issue. These variations are often the 
result of differing protocols employed, choice of control 
subjects and/or different methodologies.
The triolein breath test has achieved more success than
most, but this is probably due more to the severe 
limitations of alternatives. Following the present 
evaluation of this test, albeit incomplete, our 
conclusions are that it is the 'best of a bad lot'. The 
design of the dual isotope fat absorption test is 
theoretically more sound and in practice it is more 
reliable as a test. Nevertheless we also appreciate that 
in its present form it has a poor market potential.
However, we would strongly advocate it as the definitive 
approach for assessing other fat absorption tests. Even 
in this role the test would prove invaluable; one of the 
greatest difficulties in evaluating a new approach is that 
there is usually no adequate 'reference method'.
For the same reason the potential use of the osmotic gap
has not been fully evaluated. Despite the fact that only
one (very ineffective) evaluation of the osmotic gap has 
been published (118), it is recommended in almost all 
major Gastroenterology textbooks as a useful test in 
descriminating between osmotic and secretory diarrheoa. 
Its reputation as a worthwhile test has even resulted in 
its inclusion as a topic in a current Mastership in 
Clinical Biochemistry examination. Our conclusion with 
regard to the value of the osmotic gap (and also 
potassium/sodium ratios) is that it has little place in
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the investigation of diarrhoea. Its only possible (and at 
present unevaluated) use is to exclude secretory or 
osmotic diarrhoea. Because of the rarity of pure forms of 
these two types it would take a lengthy study to fully 
determine its predictive value in this respect.
* * * * * *
The time limitations of this study resulted in some 
aspects not being fully explored. For this reason, 
various aspects of the work presented here are being 
continued or extended.
1. Measurement of cAMP in stool water. During the course
of this study aliquots of stool samples were collected in
such a way as to enable subsequent measurement of cyclic 
AMP. Consequently, an opportunistic study is possible to 
determine its role in identifying those causes of
diarrhoea in which cyclic AMP acts as an intracellular 
mediator. It may also be useful in determining whether 
cAMP is incriminated in the pathogenesis of some 
diarrhoeal illnesses.
Only one group have measured faecal cAMP concentrations 
and found them to be considerably elevated in patients 
with cholera (1248 t 344pmol/l), rotavirus (353 ±
183pmol/l) and E. coli (heat labile toxin producing)
diarrhoea (870 £ 250pmol/l) compared with lavage fluid
from normal subjects (33 ± 4pmol/l) (314).
2. Treatment of laxative induced diarrhoea. Most studies
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of this condition have concentrated on aspects other than 
its treatment. Since the Gastroenterology Laboratory 
provides a diagnostic service by performing laxative 
screens we are in a position to co-ordinate further 
prospective studies regarding its treatment.
Psychiatrists are aware of the reluctance of the patient 
being referred to them, because of the refusal to accept 
that a mental problem exists. Rather than the patient 
going to a psychiatrist the reverse is increasingly done 
as a way of avoiding the stigma of classing the patient as 
a'psychiatric case'.
In the present study little information was gleaned about 
possible therapeutic approaches since only three patients 
admitted taking laxatives, and only one subsequently 
received psychiatric treatment. As a way of circumventing 
the issue of psychiatric referral we are now liaising with 
a psychiatrist, who will attend the Gastroenterology 
clinic to review the patient in the guise of a physician.
3. Full evaluation of the triolein breath test. Although 
several conclusions regarding the triolein breath test 
were made, some were based on circumstantial evidence. We 
have altered the design of the test (reducing the fat load 
from 25 to 18g, and increasing the breath sampling time 
from 6 to 7 hours) to maximise the possibility of catching 
the peak of 14COz excretion. An animal study may also be 
performed to determine the necessity of administering a 
fat load when performing fat absorption tests.
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4. Evaluation of Treatment of BAID. The treatment of BAID 
remains a difficult medical challenge and the present 
approach of using cholestyramine is unsatisfactory because 
of side-effects. By binding bile acids, cholestyramine 
not only reduces the risk of BAID but also decreases their 
absorption and so leads to further bile acid malabsorption 
and sometimes to steatorrhoea. The drug also has to be 
taken in large doses to be effective in treating 
diarrhoea. These side-effects are the result of bile 
salts being sequestered in the small bowel. By
administering cholestyramine in an enteric coated form to 
enable its delivery direct to the colon it may be possible 
to circumvent such problems. This approach had been 
successfully investigated in the past but in the absence 
of a diagnostic test of BAID the patient group was poorly 
defined (315). The measurement of FADBA as a means of 
diagnoising BAID has enabled us to investigate enteric 
coated cholestyramine more fully.
Since bile acids are also bound by other exogenous 
susbtances in the diet (251) it is possible that its 
treatment may be achieved by dietary manipulation. This 
possibility will also be studied.
Depending on the success of enteric coated cholestyramine 
in treating BAID further studies of a more speculative 
nature may be possible with respect to its potential in 
treating some patients with IBS. Excess colonic bile 
acids cause diarrhoea (245) while in their absence severe 
constipation results (316). Although the diarrhoea in
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such patients is not related to bile acid abnormalities/ 
an agent which can control the 'activity' of colonic bile 
acids may also control bowel movements.
5. Use of TLC to diagnose BAID. With the failure of the 
SeHCAT modification in diagnosing BAID/ TLC has been 
considered as a simpler, alternative methodology to GC 
for the measurement of dihydroxy bile acids. Although TLC 
only provides a semi-quantitative result, it is likely 
that this will be adequate. BAID is normally associated 
with gross elevations of FADBA concentrations while 
patients with diarrhoea caused by other agents have very 
low concentrations.
With this in mind we are at present evaluating the 
possibility of semi-quantitation of bile acids by this 
means. Figure 6.1 shows a TLC plate of faecal water bile 
acids in various concentrations as well as a set of 
standards. The patients with BAID (numbers 4, 13, 14, 16, 
and 17) can be readily identified while those with non- 
BAID show absent or very faint bile acid bands. Only at 
concentrations of less than 1.0mmol/l is there likely to 
be any difficulty in deciding whether diarrhoea is caused 
by bile acids.
Other improvements can be made to TLC techniques to render 
them more quantitative; eg. scraping off the bile acids 
spots and quantitating the relevant dihydroxy bile acids 
enzymatically (295) or densitometrically (317) . These 
will be investigated as part of future trials.
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* * * * * *
The main objective of this project was to perform a 
thorough evaluation of several methods of relevance to the 
investigation of patients with diarrhoea. The methods 
studied have already been in routine use to a greater or 
lesser extent but from a scrutiny of the literature it was 
felt that none had been either effectively or 
comprehensively evaluated. For example, despite the
concept of the faecal osmotic gap being formulated over 
ten years ago, the first full evaluation was performed in 
the present study; the potential value of the K/Na ratio 
was suggested in 1984 but until now had not been assessed; 
the role of bile acids in inducing diarrhoea was
appreciated in the late 1960s and yet little work has been 
performed since to establish a diagnostic test.
Most gastrointestinal assays are performed relatively 
infrequently in the Manual Laboratory of Biochemistry 
Departments and quality control and standardisation tend 
to be poor compared with the more automated tests. 
Working in a laboratory dedicated to Gastroenterology 
investigations provided the opportunity to perform this
project and also supported the notion that there is merit
in centralising Gastrointestinal Laboratory facilities in 
order to provide a better diagnostic service, increase 
technical and interpretative expertise, and enable further 
development of diagnostic tests.
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Note 1 - Mann-Whitney U-test.
Note 2 - Pearson product moment correlation.
Note 3 - The comparison of the variabilities of 0G1 and 
0G2 in stools collected consecutively from the same 
patient, presented a statistical dilemma. At first 
thought, the variation in results were calculable simply 
by comparing the standard deviation or coefficient of 
variation. However, it was inappropriate to compare the 
standard deviations for each group of data since those 
from the 0G1 group were higher simply because the 0G1 
results were higher than 0G2 results. Similarly the 
coefficients of variation (sd/mean expressed as a 
percentage) could not be used because very low means 
sometimes arose because of negative OG results, so making 
the cv erroneously high. Comparison of inter-quartile 
ranges was also impossible since in each group of results 
there were usually only three or four data points. For 
these reasons the ranges of OG results were compared using 
the Mann-Whitney U-test.
Note 4 - Spearman rank order correlation.
Note 5 - Fischer's exact probability test.
Note 6 - Student's t-ratio two-sample test.
Note 7 - Wilcoxon matched-pairs signed-rank test.
Note 8 - The line of regression was calculated for each
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individual and then the difference of these gradients from 
0 were assessed using a one-sample Student's t-test with 
the Null hypothesis that the sample mean did not differ 
significantly from zero.
Note 9 - The intra-individual differences for each analyte 
were measured and these were then used to determine the 
statistical correlations by the Spearman rank moment 
correlation.
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